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Abstract
This research project focused on the formation of novel, high-contrast MRI agents 
based on cyclen (1,4,7,10-tetraazacyclododecane) for the complexation of Gd^ "". The 
aim of the project was to attach a number of these gadolinium contrast agents to a 
silicon-based central scaffold. This would allow several cyclen units to be attached to 
the scaffold, producing a contrast agent in which the number of bound gadoliniums 
was limited only by the number of binding sites on the scaffold.
The Gd^ "^  was complexed in a ligand based on a tetrasubstituted cyclen (1,4,7,10- 
tetraazacyclododecane) in which three of the four amines were used for attachment 
of carboxylic acids for complexation to the gadolinium, while the fourth amine was 
used for the attachment of the linking arm used to bind to the silicon-based scaffold. 
Two types of cyclen ligand were investigated. Firstly, an eight-coordinate cyclen 
ligand based on acetic acid arms with but-3-enal for the binding arm, where the 
carbonyl on the but-3-enal was bound to the gadolinium to improve complex stability; 
and secondly, a seven-coordinate cyclen system consisting of succinic acid arms 
and a straight-chain alkene for the hydrosilylation reaction.
While the acetic acid based complexes failed due to stability issues, with the but-3- 
enal linking arm being hydrolysed during the deprotection of the acetic acid groups. 
As a result of this the research concentrated on the seven-coordinate ligand system. 
The advantage of the seven-coordinated system was that the extra non-coordinating 
three acid groups from the succinic acid on the cyclen would increase the solubility 
of the target molecules, and would also repel any anions in solution when used in 
biological systems.
The first scaffolds investigated were based on silsesquioxane cages. The 
experiments showed that this approach was problematic due to the decomposition of 
the cyclen system and the silsesquioxane cage to form an insoluble gel like product. 
This decomposition was found to be due to several unforeseen factors, which 
included the trapping of water with in the cyclen molecule, the decomposition of the 
cyclen ligand by the platinum catalyst producing a secondary amine. The 
decomposition of the silsesquioxane cage was inpart due to this secondary amine. 
Because of these problems an alternative scaffold was used. The new scaffold was 
based on silanes attached to a benzene ring, rather than to the siloxanes of the 
cages.
The MRI T2 relaxation rates showed that the complexes that contained one or two 
gadoliniums had a relaxivity in relation to molar concentration of complex of 4.8 
rip/mM"^s"  ^ and 4.5 rip/mM"^s"  ^ (or 2.25 rip/mM"^s"  ^ per gadolinium) respectively, 
and so were similar to the commercial MRI contrast agent DOTA-Gd (4.3 
rip/mM"^s"”'). The trisubstituted scaffold compound 1,3,5-tris((pentane- 
sD03A)dimethylsilyl)benzene-Gd3 (247) showed a marked increase in the relaxivity 
(13.1 rip/mM” s^"^ ) in relation to molar concentration, and 4.3 rip/mM“ s^“ i^n relation to 
the gadolinium concentration.
The thesis is split into six chapters, with the first one covering the background of the 
MRI technique and current research into MRI contrast agents. The second chapter 
deals with the formation of the cyclen ligands. The third chapter is about the 
attachment of the cyclen ligands to the silicon scaffold. The fourth chapter concerns 
the formation of the lanthanide complexes and the measurements undertaken. The 
final two chapters involve the conclusion and the experimental section.
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Chapter 1: Introduction
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1.1: Principles of MRI and NMR
Medical Imaging is a powerful diagnostic tool used in modern medicine, allowing the 
non-invasive examination of patients, such as diagnosis of problems or investigation 
of neural activity. The term ‘Medical Imaging' relates to several different methods of 
imaging, which are characterised by the energy sources used and the method of 
detection. The main distinction is between ionising and non-ionising sources.
There are several different techniques of medical imaging that use ionising radiation, 
either as an external source -  for example, in radiography or fluoroscopy -  or as an 
internal source, as seen in Positron Emission Tomography (PET). While these 
techniques produce good images, there is a limited time they can be used owing to 
the effect of ionising radiation on the tissues (Figure 1.1.1).
Figure 1.1.1: Radiogram of my left shoulder, showing possible detail
obtainable using x-rays.
Non-ionising medical imaging techniques include Ultrasound and Magnetic 
Resonance Imaging (MRI). MRI is based upon Nuclear Magnetic Resonance (NMR). 
The application of NMR to a biological sample was first reported in 1971 by
24
Raymond Damadia, who discovered that certain mouse tumours gave elevated 
relaxation times when compared to those of non-cancerous tissue. In 1973 Paul 
Lauterbur^ proposed using magnetic field gradients to distinguish between NMR 
signals originating from different locations, as the strength of the field is proportional 
to the radiofrequency. Between 1974 and 1980 further developments in detection 
and sensitising methods allowed for the first image of the human head to be 
published in 1978 by Clow and Young^. Since the introduction of the first MRI 
scanner at Hammersmith Hospital, London, with a field strength of 0.15T, the 
technique has greatly improved, to the point where a field strength of 3T is now 
commonplace in hospitals^’  ^ (Figure 1.1.2).
-
Figure 1.1.2: Image of a typical MRI scan.^
NMR and MRI rely on the interaction of atomic nuclei possessing a spin angular 
momentum with a magnetic field. The magnetic moment of the nucleus due to the 
nuclear spin arises from the spins of the individual protons and neutrons within the 
nucleus. This is seen as the angular momentum, where the rotation of the nucleus is 
around the central axis. This is shown in Equation 1.1.1, where I is the spin quantum 
number of the nucleus, and h is Planck’s constant at 6.626 068 96 x 10"^ "^  J s.
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|/| = {h! 27r)yjl{I+l) Equation 1.1.1
Nuclei with an even mass number have spin quantum numbers as even multiples of 
>2 (/ = 0, 1, 2...), while nuclei with odd mass numbers will have odd multiples of % (/ 
= %, 3/2...). A nucleus with / = 0 is insensitive to magnetic fields. The most 
commonly studied nuclei have a quantum number of 1/2, such as ^H, and
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In practice, the subject is placed within the magnet of the MRI, whereupon the 
protons of the water molecules in the body are magnetised and align themselves 
with the magnetic field along the longitudinal axis. As the aligned protons cannot be 
measured, they need to be tipped out of alignment by the use of a pulsed 
radiofrequency (RF) into the x- or y-axis. As the proton realigns with the magnetic 
field the proton emits a pulse of energy in the form of radio waves, which are then 
detected by the MRI. It is also useful to probe the proton population with a second 
RF pulse to aid in the detection of the relaxation rate.
The strength of the signal received depends upon the relaxation of the protons within 
its environment such as proton concentration, viscosity of the tissue and changes in 
chemical shift because of pH and proton exchange.^ It is important to note that MRI 
does not focus on a single molecule, but the protons in a local environment, thus the 
signal emitted by the protons will vary in its wavelength depending on the statistical 
populations of the area.
26
The energy needed to change the proton from one energy level, and thus spin state, 
to another is shown in Equation 1.1.2, where So is the magnetic field strength. ®
AE = ^ B q Equation 1.1.2
It is possible to introduce energy in the form of radiofrequencies (vi) to effect the 
transition between the energy levels in a fixed magnetic field of a known strength 
(So). The radiofrequency for a known magnetic field in an MRI can be calculated 
using Equation 17.3®’ ® where y is the magnetogyric ratio, which is the fundamental 
nuclear constant of the nuclei being monitored. In the case of ^H, y = 2.675 [s"^T“ ]^
10
V; =— jBo Equation 1.1.3
2n
When the protons are in the magnetic field, the initial populations of the energy 
levels are determined by thermodynamics, as described by the Boltzmann 
distribution. This means that the lower energy level (A/a) will contain slightly more 
nuclei than the higher level (A/p). It is possible to excite these nuclei into a higher 
level with electromagnetic radiation. In the case of NMR with a magnetic field of 9.4 
Tesla, a radiofrequency of 400 MHz is needed to effect the transition of the proton 
between the spin states. In MRI the magnetic field is lower than that of NMR; 
therefore the energy needed to affect the spin states is lower. For example, if an MRI 
has a magnetic field strength (Bo) of 1.5 Tesla, the energy gap between the two spin 
states is 64 MHz (Figure 1.1.3).
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Figure 1.1.3: Proton energy levels for different magnetic field strengths for
NMR.
The protons then return to alignment via a process called ‘relaxation’. There are two 
different types of relaxation that occur in NMR and MRI. The first type of relaxation is 
known as Ti relaxation and involves a return of the protons to the original alignment 
with the static magnetic field. This is expressed as longitudinal or spin-lattice 
relaxation. The term ‘spin-lattice’ refers to the interactions of the protons (spins) with 
their surroundings (lattice). This interaction causes a release of energy as the 
protons return to the original energy state of al ignment.Owing to the slow 
molecular motion of the fat molecules, Ti relaxation occurs more rapidly -  hence a 
shorter time Ti. Water molecules have higher mobility when compared to fat 
molecules; this movement induces inefficiency in the relaxation of the protons, as 
they do not have the possibility of interaction; therefore the loss of energy to other 
nuclei is slower. That results in greater values of Ti, as it takes longer for the proton
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spins to realign with the main magnetic field. Also Ti times are highly dependent on 
the field strength of the MRI scanner.®
The second type of relaxation, referred to as T2 , is transverse or spin-spin 
relaxation. The protons are aligned at right angles to the magnetic field. The energy 
is lost by the interaction of the proton spin with the spin of a neighbouring proton. 
This interaction reduces the phase coherence and cuts the signal strength down to 
37% of its original strength. This loss in signal strength occurs because the magnetic 
moments of the random-orientated protons tend to cancel each other out (Figure 
1.1.4). The T2 times for different environments arise because water is less efficient in 
the exchange of energies than fat is, meaning that fat has shorter T2 times compared 
with water, which has increased T2 times.^^
The rate at which the relaxation occurs differs, depending on the local environment 
in which the proton is found. Ti times may be of the order of several hundred 
milliseconds, whereas T2 times are of the order of tens of milliseconds. This is due to 
spin-spin interactions being more efficient than spin-lattice interactions.^^
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Figure 1.1.4: Diagram of the Spin-SpIn interactions, showing the path of signal 
loss over time. A: The magnetic moment is aligned with the magnetic field. B: 
After the RF pulse (1) the magnetic moment can be represented as a single 
vector. C: The vector begins to break up as a result of localised non­
uniformities in the applied field. The components of the vector move into the 
xy plane. D: The vectors spread out in an even pattern, cancelling each other 
out. E: With time, the cone representing the vectors narrows until the vector is
again aligned with the magnetic field.^ ^
Signal pulses are applied in specific sequences that depend on the technique used. 
There are several different techniques and each has several different subcategories, 
depending on whether Ti or T2 is being measured. Biological materials are 
distinguished by their Ti and T2 values, but the exact values are not unique for the 
different tissues (Table 1.1.1). The different values seen in Ti or T2 measurements 
arise from the correlation time of the water molecules in tissues. In liquids and 
semisolids the water molecules are free to rotate, while small molecules within the
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liquid have higher rotational correlation times and have a greater chance of 
interacting with neighbouring molecules. This interaction between molecules allows 
relaxation to occur more rapidly and so the relaxation time is shorter.  ^^
TISSUE
TI % +/- T2 % + /-
Skeletal
muscle
732 18 47 27
Liver 423 22 43 32
Kidney 589 27 58 41
Adipose 241 28 84 42
Brain
Grey matter 813 17 101 12
White matter 683 17 92 23
Table 1.1.1: Table of relaxation times in miiliseconds for tissues at 1 Tesla 
static magnetic field strength (42.6 MHz) and the percentage error.^^
This interaction of the spin and the microenvironment allows the distinction between 
water in bone, fats, muscles, body cavities, etc. in the MRI scan. However, the 
difference between tissue types can be hard to identify. Whilst with a large amount of 
time it is possible to find the optimum contrast between any tissues, it is not practical 
in a clinical setting. One way around this problem is by the use of contrast agents, 
which alter the relaxation rates.
While MRI is a more complex application of NMR spectroscopy, there are several 
differences which are apparent. The first is in the detail of information gained. An 
NMR instrument has a greater magnetic strength and thus has a greater resolution, 
due to the increase in the range of radiofrequencies available. There are two 
methods of obtaining an NMR spectrum. The first is continuous-wave, which uses a 
fixed radiofrequency pulse for the excitation of the protons. The different proton
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environments are analysed by changing the current within the magnet, thus altering 
the magnetic field so that different protons are excited.® The second NMR method 
involves a Fourier transformation, where the radio pulse contains several different 
frequencies, scanning the whole range of the spectrum; this is used in the presence 
of a fixed magnetic field.® In MRI only a small set of radiofrequencies are used, as it 
is the relaxation time of the water in different environments that are being monitored, 
so structural information about the nuclear environment is not needed.
The second major difference between MRI and NMR is the way in which the sample 
is analysed. In NMR the sample is spun at around 17Hz; this creates a homogenous 
field within the sample tube and therefore in the probe. In MRI it is not possible to do 
this, and instead the MRI must focus on a small section or voxel of the subject at a 
time. This is done by the use of a secondary magnetic field in the form of a field 
gradient, which can change the strength of the magnetic field over the whole of the 
bore in all three axes. By changing the field strength in a certain location the 
resonance conditions for certain radiofrequencies are created, allowing for only the 
protons in that voxel to contribute to the image.
1.2: MRI image enhancement by contrast agents
The contrast within an MRI image is what allows for the identification of the tissues 
and fluids, owing to the signal strengths of the different environments. As the 
environments are similar, the detail that can be extracted from the image is limited. 
To improve the contrast between the tissues a contrast agent is employed. Contrast 
agents alter the rate of relaxation of the protons in nearby water molecules. Ti
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agents shorten the longitudinal relaxation time, allowing a faster recovery of the 
spins to their thermodynamic equilibrium. That allows subsequent pulses to be 
formed without diminution in the signal intensity. In Ti images, the shortened Ti 
leads to an increase in the intensity, and thus the brightness of the image. T2 agents 
shorten the transverse relaxation time, leading to a decrease in the MRI signal 
intensities. The effect of a contrast agent can be seen in the diagram below, which 
shows a comparison of images with no contrast agent and with a Ti contrast agent 
(Figure 1.2.1).
w
Figure 1.2.1: Comparison of MRI images of the human knee: normal contrast 
(left); with Ti contrast agent (right).^^
The gadolinium(lll) ion is the core of the great majority of Ti contrast agents owing to 
its paramagnetic properties, which arise from the seven unpaired electrons of the 
gadolinium. Electrons, like atomic nuclei, have spin and magnetic moments. The 
magnetic moment of an electron is 100 times greater than that of a nucleus. 
However, owing to the alignment of electrons in the orbital shells with electrons of an
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alternate spin, the magnetic moment has a net sum of zero in molecules and 
diamagnetic ions. The magnetic moment in a magnetic field is seen when an 
electron is unpaired in ions such as Gd®^  and Mn^ ,^ with 7 and 5 unpaired electrons, 
respectively; or in molecules such as organic free radicals with 1 unpaired electron, 
and diatomic oxygen.
In the case of paramagnetic contrast agents the tumbling of the Gd®^  ion in solution 
develops an alternating magnetic field, which interacts with the smaller magnetic 
moments of the protons of the surrounding water molecules. These dipolar magnetic 
interactions have natural random fluctuations that reduce both the longitudal (Ti) and 
the transverse (T2) relaxation times for the protons by increasing the rate of 
dephasing.^'^^
The observed solvent relaxation rate (1/Tj)obs is the combination of the paramagnetic 
(1/Ti)p and diamagnetic (1/Tj)d relaxation rates (where i = 1 or 2), as shown in 
Equation 1.2.1
(1/Tj)obs = (1/T|)d + (1/Tj)p Equation 1.2.1
The relaxivity (n) is defined as the gradient of the concentration-dependent term of 
Equation 1.2.2, and is commonly expressed in mM"^s"\
(1/T,)obs = (1/Tj)d + n[Gd] Equation 1.2.2
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1.3: Solomon-Bloembergen-Morgan equation
Paramagnetic relaxation can be divided into three types, based on the way in which 
the water coordinates to the Gd complex. These are the inner-sphere type, where 
the water complexes directly with the gadolinium; and the second sphere, where the 
water interacts with the surface of the gadolinium complex. It is as a result of the 
outer-sphere relaxation effect that compounds with a water coordination number of 
zero are able to have a relaxation effect on w ater.(F igure 1.3.1).
Outer SphereSphere
Second Sphere
Figure 1.3.1: Diagram showing the inner, second and outer water coordination
spheres of DOSA-Gd
The inner sphere is where the solvent is directly coordinated with the Gd(lll) ion. The 
outer sphere includes the water molecules adjacent to the complex next to the bulk 
water. The Solomon-Bloembergen-Morgan equations are used to calculate the 
relaxation rates for the inner sphere. The lifetime and the relaxation rate of the 
solvent molecules in the inner sphere (is) can be expressed by Equations 1.3.1 to 
1.3.3:
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A©. Equation 1.3.3
Where Pm is the mole fraction of the bound water nuclei; q is the water coordination 
number of the gadolinium ions; Tm is the lifetime of the water molecule within the 
complex (this is the reciprocal of the water exchange rate, Kex); and Aw refers to the 
difference in the chemical shift between the paramagnetic and diamagnetic 
reference. The subscript {m) refers to the relaxation rate of the water molecule in the 
inner sphere."*®
If the water exchange rate is fast the main factor influencing relaxation in the inner 
sphere is the q value. While if the water exchange rate is slow, i.e. rim «  then the 
exchange rate itself becomes the main factor influencing the relaxation rate in the 
inner sphere.
For the majority of current monomeric Gd(lll) complexes the inner and outer sphere 
mechanisms contribute approximately equal amounts to the observed relaxivity. 
However it is easier to affect the inner sphere relaxivity than the relaxivity induced by
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the outer sphere. The contribution of the outer and second spheres can be increased 
by Increasing the number of hydrogen bonding sites on the complex by using non 
coordinating groups such as carboxylic acids, esters and amines. These can affect 
the relaxivity by ordering the second sphere of water molecules around the surface 
of the complex, allowing them to be relaxed and facilitate the interchange between 
the inner and the outer sphere. The eq 1.3.1 shows the how the inner sphere 
relaxivity may be influenced by the properties of the complex, these are the q value, 
and the rotational correlation times.
1.4.1 : Methods of improving the efficacy of contrast agents
There are several ways in which the contrast-agent efficiency can be improved. 
Since the number of paramagnetic nuclei available is limited, one of the routes to 
increasing efficiency is to alter the ligands to improve the inner-sphere water 
relaxation.This is seen in the inner-sphere relaxivity equation (Equation 1.4.1):
IS = Equation 1.4.1.
where Tim is the Ti of the water hydrogen in the inner-sphere, and [H2O] is the 
concentration of water in mMol. To increase relaxivity (r'®i), the Tim or tm would have 
to be decreased, or q would have to be increased.
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1.4.2: Effect of hydration number on a contrast agent
The hydration number plays a major role in the effectiveness of the contrast agent. 
The vast majority of contrast agents are mono-aqua-based (i.e. q = 1), although 
there is an increasing number of di-aqua species being reported. The problem with 
di-aqua species is that they have reduced kinetic and thermodynamic stability with 
respect to acid- or cation-mediated dissociation.^® This makes them potentially 
unsuitable for safe use in vivo, although there are some agents -  such as D03A-Gd 
(1) -  that are sufficiently stable to be safe in vivo. The effect of increasing the q 
value can be seen between DOTA-Gd (2) and D03A-Gd (1). The removal of one of 
the arms increases the relaxivity by 45%, from 4.2 to 6.0 rip®/mM“  ^ s"’'.”'^  (Figure
1.4.2.1).
1 2
Figure 1.4.2.1: Structures of D03A~Gd (1) and DOTA-Gd (2)
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1.4.3: Effect of the rotational correlation time on a contrast agent
Rotational correlation time (xd) is controlled by three factors, which are molecular 
rotation, electronic relaxation and chemical exchange rate of water molecules. 
Studies have shown that the dominant factor is the molecular rotation time (tr).^ ®
1 1 1 1  
—  = ----- 1------ 1 ;i  =  1,2
^ci '^ m  ^ie
Equation 1.4.3.1
The molecular rotation time is influenced by the molecular weight. For a small- 
molecule contrast agent such as DOTA-Gd (2), the rotational correlation time is of 
the order of 0.1 ns, giving a relaxivity of 4.2 mM'^S"^ while RIME-type agents 
(Receptor Induced Magnetic Enhancement -  where a contrast agent attaches to a 
protein or large biomolecule) have a time of 10.0 ns. Intermediate high molecular 
weight compounds such as P792 (3) have a rotational time of tr = 2 ns, with a
relaxivity of 25.5 mM"^S“  ^ (Figure 1.4.3.2). RIME agents are discussed in detail 
later in section 1.6.5, dealing with types of contrast agent.
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P792 = R=
Figure 1.4.3.2: Structure of P792 (Z)
There are several ways of increasing the rotational times of the molecule through 
increasing its size by making it a part of a linear oligomer; using a branched 
molecule, where the lanthanide groups are on the terminal ends of the chains 
radiating from the central core; or creating a barycentre, where the lanthanide group 
is placed centrally within the molecule (Figure 1.4.3.3).
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(a) (b) (c)
Figure 1.4.3.3: Different methods of increasing the rotationai correiation times: 
(a) iinear oiigomer; (b) branched; (c) barycentre.^^ Key: Red corresponds to 
G(f* compiex; yeiiow corresponds to stabie groups to add mass; dark blue 
corresponds to a stabie centrai core. The black arrows show the movement of 
the molecule, and the purple arrows show the movement of the Gd-ligand
group within the molecule.
A linear oligomer may be formed by linking several contrast-agent groups together to 
form a linear chain. This is seen in contrast agents such as NMS60-Gd (4) (Figure 
1.4.3.4). The problem with linear oligomers is that they will undergo anisotropic 
rotation around the linking arms, where the linked Gd-complexes move directionally 
and are independent of each other as the molecule rotates. This in effect limits the 
advantages gained by the formation of the linear oligomer.
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Figure 1.4.3.4: Structure of NMS60-Gd (4)
The second approach is the formation of a branched polymer- or dendrimer-based 
contrast agent. This is where the Gd-complexes are attached by organic chains to a 
central core. The size of the dendrimer will have an impact on the rotational 
dynamics, as larger molecules rotate at a slower speed and so have higher rotational 
correlation times than those of smaller molecules with lower rotational correlation 
times. The amount of branching in the dendrimer is denoted by the generation 
number. For example, PAMAM-Gd-1BAM-DPTA (5) is a fourth-generation 
dendrimer which is denoted as G4 (Figure 1.4.3.5). The PAMAM (polyamidoamine) 
core has attached 50 Gd-1BAM-DPTA functional groups. The relaxivity of this 
dendrimer is 12.2 rip/mM'^ s~\ which is three times greater than that of DOTA-Gd 
(3) at 4.2 rip/mM"  ^ s"^  while the relaxivity per Gd^ "" is 0.244 rip/mM"  ^ s~\ The 
compound's half-life within the body before being excreted (ti/2) is 87 minutes, 
compared to DOTA-Gd (2) at 36 minutes, which allows for more scans for the same 
dosage of contrast agent.^^
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Figure 1.4.3.5: Example of a branched, fourth-generation dendrimer MRI 
contrast agent, where PAMAM G4 is functionalised with Gd-1BAM-DPTA?^
The effect of increasing the mass, and thus increasing the rotational correlation 
time, can be seen in the linear relationship between relaxivity per Gd(lll) and 
molecular weight^®, as shown in Graph 1.4.3.1.
Plot of relaxivity versus molecular 
weight
30 -1 
25 - 
20 -
10 -
M olecu lar W e ig h t
Graph 1.4.3.1: Plot of the relaxivity per gadolinium versus molecular weight of
contrast agent (20 MHz)}^
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An example of a dendrimer-type contrast agent is the tetra-gadolinium(lll) complex 
[Gd4dmpD03A4] (6), which is based on 4 D03A-Gd (1) groups attached to a 
dimethylpropane framework. The complex has a relaxivity of 28.13 mM"^s"  ^ (24 
MHz, 35 °C, pH 5.6) which is 4.7 times the value for GdD03A of 6.0 mM"^s"  ^ (20 
MHz, 20 °C).^®. This is caused by a combination of the increasing rotational 
correlation time and the increase in the concentration of the gadolinium(lll). It should 
be noted that the complex shows a relaxivity of 28.13 mM"^s"\ giving a relaxation 
per Gd(lll) of 7.03 mM‘”^s"\ which is an increase of 16% (Figure 1.4.3.6).
N N
........0
Figure 1.4.3.6: Structure of [Gd4dmpD03A4] (S)
The third method is to simply increase the mass of a single complex molecule, which 
may be achieved in two ways. The first possibility is the attachment of polymeric 
arms, such as PEG (poly(ethylene glycol)); this increases the mass of the molecule 
up to 5 KDa by forming a barycentre-type contrast agent. An alternative method of 
increasing the mass is through the binding of the contrast agent to a biological 
protein in vitro, as in the case of RIME agents.
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The drawback to barycentre-type molecules is that if the rotational time of the 
molecule becomes too low, then the relaxivity of the molecule will drop owing to 
water exchange inefficiencies in the water diffusion rate. This is due to the relaxed 
water molecule being released from the contrast agent and then becoming re­
coordinated to the agent, reducing the number of molecules which can be relaxed in 
a given time frame.
1.4.4: Effect of water exchange rate between lanthanides and the surrounding 
bulk water
The water exchange rate is an important factor in the ability of a contrast agent to 
induce relaxivity. On the one hand, if the water exchange rate is too slow the 
relaxation effect is not transmitted effectively to the bulk water; on the other hand, if 
the water exchange rate is too fast the water coordinates to the Gd®^  ion, but does 
not dwell long enough to be relaxed.
The rotational diffusion rate also has an effect on the size of the window of the 
optimum time for water exchange, producing a relaxivity with 20% of the maximum. 
For a compound with tr = 0.1 ns, then the optimum window is between 1 and 1000 
ns, while if Tr = 1 ns then the window is reduced to between 3 and 200 ns. If the Tr is 
increased to 10 ns, then the window is even smaller, at 2-30ns.^® This increase in 
the coordination lifetime effectively reduces the relaxation of the agent to a few per 
cent of the theoretical limit, because of long water-coordination lifetimes.^^
The rate of water exchange is also affected by the structure of the contrast agent. A 
small change in the structure can make a marked difference to the lifetime of the
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coordinated water molecule.^® An example can be seen in [GdaDOTA]^" (7) and 
[GdgDOTA]^" (8), where an increase of one carbon in a chain can change the water 
exchange lifetime (Tm/ns) from 68 ns to 200 ns. This limits the relaxivity of the 
complex, as the longer the lifetime of the water exchange rate, the lower will be the 
relaxivity^  ^ (Figure 1.4.4.1). The water exchange rate is also influenced by the 
isomeric structure of the Gd^  ^ complex. For example, the three isomeric forms for 
[GdgDOTAf" are (RRRR), (RRRS) and (RSRS), which have corresponding water 
exchange rates of 68, 140 and 270 ns at 298K.^° This shows that the twisted 
square-antiprismatic isomer increases the time in which the water is bound, thus 
reducing the water exchange rate. The effect of this changing of the water exchange 
rate can be seen in the relaxivity values, which are approximately 7.7, 7.6 and 6.8 
mM"^s“  ^ respectively at 20 MHz, 25 °C.^°
Gd-
R = (CH2)2C02- = [GdaDOTA]^- (7) 
R = (CH2)3C02- = [GdgDOTA]^- (8)
Figure 1.4.4.1: Structures of [GdaDOTAf^ and[GdgDOTAf
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1.5: Why is cycien used in contrast agents?
Cyclen (9) (Figure 1.5.1), when substituted with suitable pendant arms, such as 
acetic acid in the case of DOTA (13), will readily form stable complexes with 
lanthanides such as gadolinium to give DOTA-Gd (2). Cyclen-based compounds will 
also complex with a wide range of different metals, such as Eu(lll), Cu(ll), Ni(ll), 
Co(ll),^  ^ Cd(ll), Pb(ll) and Rh(ll).^^’^^  The stability of the cyclen/cation complex is due 
to the stabilisation afforded to the complex by the macrocycle effect, which forms 
complexes with high thermodynamic stability and kinetic inertness. Also, they are 
able to satisfy 7 of the 9 coordination sites required by the lanthanide metal ions.^ "^ ’
NH HN'
NH HN'
W
Figure 1.5.1: Structure of cyclen (9)
In the cyclen-based molecules, four of the coordination sites on the lanthanide are 
filled with the lone pairs of the nitrogens of the cyclen ring (10), with three more sites 
occupied by the lone pairs of the carbonyl oxygen of the esters (11), or directly via 
the oxygen anion of the acid groups (12) (Figure 1.5.2). This chemical flexibility 
makes the cyclen an ideal substructure for contrast agents.
47
.O'—'p* 
10
\ [ f \ .
N <> N-
5
r/ V j \
11
\ / f \ ' > — " N N----
Ln
r/ V j \
12
Figure 1.5.2: The coordination of the lanthanide within the complexes
A key requirement of any pharmaceutical metal complex is the formation of stable 
chelates. This prevents the toxic effect that the free metal ions may have upon the 
body. The gadolinium may replace metals within the body, especially the metals 
present in metallo-proteins and enzymes, and that could alter the biochemical 
systems. Also, the toxicity can be affected by the pharmacokinetic properties of the 
agent, since the longer the duration in the body, the greater will be the risk of a toxic 
effect occurring.
1.6.0; Classification of MRI contrast agent
Contrast agents can be grouped into loosely bound classes according to their 
properties, structural make-up and mode of use, and a particular agent can belong to 
more than one group.
1.6.1: Extracellular fluid agents
DOTAREM™ (DOTA-Gd) (2) is the most commonly used extracellular agent^®, 
owing to its strong contrast effect and relatively low cost. GdD0TA-4AmP‘® (14) is a 
DOTA (13) -based extracellular agent that allows the non-invasive measurement of
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pH within the body of the subject.^  ^ The change in pH is seen in the increase of 
relaxation, which is governed by the phosphonate group that catalyses the proton 
exchange in the bulk water. For example, at pH 2-4  the enhancement is 25%, 
whereas at pH 6-9  the enhancement effect is increased to 84%.^®
The ability to detect differences in the pH gradient of tissues helps in the detection of 
certain cancers, as the cancer cells are slightly more acidic compared to normal 
tissue, with a difference of 0.1-0.2 in pH. The variation is caused by differences in 
metabolic pathways in the tissue types. The pH difference induces a gradient change 
in the extracellar environment, which can be signalled by the contrast agent^® (Figure
1.6 .1.1).
Figure 1.6.1.1: Structures of some extracellular contrast agents: (13) DOTA;
(U ) GdDOTA‘4AmP‘5
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1.6.2: Blood-pool contrast agents
Blood-pool agents enhance the vascular structures of the subject, so are therefore 
used as an alternative to X-ray angiography. For example, abnormal angiogenesis 
can be seen in developing tumours.^® The efficiency of the blood-pool agents 
depends upon the time the agents spend in circulation, their tendency not to 
redistribute in the interstitial space, and the resistance to glomerular filtration in the 
kidney. Best results are achieved by the use of high-molecular-weight MRI contrast 
agents. D0TA-(B0M)3 (15) is a DOTA (13) derivative with benzyloxymethyl (BOM) 
groups. The BOM groups are hydrophobic, which helps them to bind to HSA (Human 
Serum Albumin). This substance is used as an angiographic MRI contrast agent, 
with a relaxivity of 53.2 mM'^s"  ^ (Figure 1.6.2.1).
COO" ooc
15
Figure 1.6.2.1: Structure of D0TA~(B0M)3 {\ 6)
Not all blood-pool agents need to bind to proteins; an example is blood-pool agent 
P760 (16), with relaxivity of 24.7 mM“ s^"^  (60 MHz, 310K).'^° This large relaxivity is 
due to the size of the complex conferring a slow rotational time^° (Figure 1.6.2.2).
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Figure 1.6.2.2: Structure of P760 (^6) 20. 40
1.6.3: Particulate I polymeric-based contrast agents
Particulate and polymeric contrast agents are macromolecular contrast agents, and 
are a subset of blood-pool agents. Owing to their large size these contrast agents 
increase the blood retention times by avoiding glomerular filtration, while also 
affecting the rotational correlation times of the molecule."^  ^ However, particulate 
agents such as ultra-small superparamagnetic iron oxides (USPIOS) decrease 
rapidly in the bloodstream owing to reticulo-endothelial affinity, and they may also be 
phagocytosed by macrophages in the liver, spleen and bone marrow -  although 
dextran coatings help to reduce this effect."^  ^ Several particulate contrast agents 
have been found to be effective in human trials; examples are particulate contrast
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agents such as gadolinium(lll)-loaded zeolite clays, like Gadolite™, and more 
recently nanoparticles consisting of gadolinium(lll) bound with methacrylic acid- 
ethyl acrylate copolymer encapsulated within a polymeric shell,^ ’^ which allows the 
sequestration of the gadolinium ion while still enabling water exchange. Other 
polymeric contrast agents have been developed using gadolinium chelating agents 
coupled with high-molecular-weight biological proteins such as HAS,^  ^ or polymers 
such as polyaminoacids (polylysine) or oligosaccharides (dextrans or dendrimers).^^ 
There have been several polymeric contrast agents that have a high gadolinium 
content; for example, polylysine-GdDTPA^® has up to 70 gadolinium(lll) ions per 
molecule. The addition of biocompatible polymers such as PEG or MPEG to the 
contrast agent provides protection from interaction with blood cells and plasma 
proteins, as well as increasing the molecular mass of the agent.
1.6.4: Liposomal-based contrast agents
Liposomal agents are based on a spherical vessel made from lipid compounds, 
which possess both hydrophilic and hydrophobic properties. The lipids then combine 
to form a membrane with the hydrophilic groups on one side and the hydrophobic 
ones on the other side. These vessels have high biocompatibility"^  ^(Figure 1.6.4.1).
External Surface
Hydrophilic Hydrophobic
Internal Surface
Figure 1.6.4.1: Structure of a lipid membrane
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There are two main types of liposomal contrast agent. In the first, the liposome 
incorporates the metal ion -  for example iron, manganese or gadolinium -  within the
centre of the lipid membrane structure"^ ® (Figure 1.6.4.2).
Figure 1.6.4.2: Liposomal contrast agent with gadolinium at the centre
In the second type the gadolinium is complexed with a ligand, to which is attached a 
long hydrophobic chain. These types of liposomal agent can mimic the behaviour of 
the circulating cells in situations where direct labelling of the cells would cause 
problems, such as in the case of red blood cells, which need high amounts of 
contrast agent to achieve a good contrast. The main problem with liposomal contrast 
agents is that the membranes are easily disrupted or taken up by the reticular- 
endothelial system"^ ® (Figure 1.6.4.3).
uTj-u-Lru-
Figure 1.6.4.3: Liposomal contrast agent with gadolinium in the outer sphere
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One way around this is the surface modification of the liposomes, for example by 
PEG grafting, which increases the lifetime of the contrast agent. Polymerisation of 
the lipid layer can also achieve the same effect. Liposomal agents have a high 
relaxivity, owing to their high molecular weight and the restricted free rotation of the 
low-molecular-weight species within the cavity of the vesicle.^®’
1.6.5: Receptor-Induced Magnetic Enhancement (RIME) agents
Receptor-Induced Magnetic Enhancement, or RIME, agents are contrast agents that 
bind to the targeted biomolecule. For example, EP-2104R is currently in phase 2a 
clinical trials as a RIME agent for binding to fibrin, for use in the imaging of coronary 
thrombosis.®  ^ Another example of a RIME agent is MS-325 (16), produced by EPIX 
pharmaceuticals. MS-325 (16) reversibly binds via a non-covalent bond to the blood 
protein albumin, allowing the imaging of the blood vessels for up to one hour.®  ^ MS- 
325 (17) binds to the albumin via an aromatic ring set. The increased MRI contrast 
relaxivity is due to the decrease in rotation speed arising from the presence of 
aromatic rings that bind to albumin."*® Cs-DOTP (18) was also found to bind to HAS 
and has been approved for clinical use. Cg-DOTP binds to the albumin in several 
places via the fatty-acid chain®® (Figure 1.6.5.1).
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Figure 1.6.5.1: Structures of (17) MS-325; and (IS) Ca-DOTP
1.6.6: Non-clinical research contrast agents
One area of current research into MRI contrast agents is in complexes which have a 
q value of 2. These have two main problems: stability of the complex, and 
complexation with anions within the environment. While the stability of GdDOSA (21) 
may be slightly lower than that of DOTA-Gd (3) -  with logKeq M“  ^ values of 21.2 and 
25.8 respectively at 25 °C with tétraméthylammonium chloride (O.IM)^"  ^-  that is still 
greater than some compounds used in animal studies, such as DTPA-BMA (19) 
with a logKeq M"^  value of 16.84 at 25 °C with tétraméthylammonium chloride 
(O.IM).^® The stability can be increased by small changes that increase the steric 
hindrance in the structure and limit arm movement, thus limiting the rate of 
dissociation; for example, D03A-BMA (20) has a logKeq M"^  of 25.3 (Figure
1.6 .6 .1).
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Figure 1.6.6.1: Structures of DTPA-BMA (19)
D03A-BMA (20) and Gd-D03A (21)^ ®
The main problem with compounds with two water binding sites is that the inner- 
sphere water molecules can be replaced by anions such as phosphate, carbonate, 
lactate or HAS, which are found within biological environments.^^’ This poses a 
problem, as the anions coordinate to the Gd^ ,^ effectively reducing the q value to 1 
or 0. This lowering in the q value has a direct effect on the relaxation value for the 
complex; the unwanted complexation of these anions can be limited by the Gd^ "" 
complex having a net negative charge. This has been achieved by the use of di-acid 
pendant arms such as adipic acid (24) and glutaric acid (23) (Figure 1.6.6.2). These 
have been used in several different complexes based on DOTA (13) and D03A  
(22)
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Figure 1.6.6.2: Structures of D03A (22), glutaric acid (23) and adipic acid (24)
The two compounds of interest based on D03A (22) are gD03A (25) and aD03A  
(26), with relaxivity values of 12.3 mM~^s"  ^ and 5.4 mM"^s“  ^ respectively. These are 
higher than that for Gd(DOTA) (3) at 4.2 under the same conditions (20
MHz, 298K, pH 7.2).^® The change in the relaxivity is due to the increase in the 
number of coordinated water molecules, and also to the negative charge of the 
contrast agent, which has the effect of increasing the hydrophilic nature of the 
molecule. This causes a decrease in the water exchange times, thus improving 
contrast.®® This can be seen in the difference between Gd(aD03A) and Gd(D03A), 
which had a relaxation value of 6.0 mM"^S"  ^ (Figure 1.6.6.3).
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Figure 1.6.6.3 Structures of gDOSA (25) and aDOSA (26)
The difference in the relaxivity between the gadolinium complexes of gD03A (25) 
and aDOSA (26) is due to intramolecular binding; the second carboxylic acid on the 
redundant glutaric acid arm binds with the Ln, reducing the q values of the complex. 
This intramolecular binding occurs at pH > 8 for the case of Eu-gD03A, which has 
been shown to displace one of the water binding sites on the Ln. The effect is less 
apparent with Eu-aD03A, owing to the increased ring strain of the eight-membered 
ring as compared to the seven-membered ring (28) formed by the cross binding of 
gD03A (25) (Figure 16.6.4).
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Figure 1.6.6.4: intramolecular binding of gD03ALn
1.7.1 : Aim of the thesis
A key objective in MRI contrast-agent research is to devise covalently linked or non- 
covalently bound conjugates that efficiently promote the rate of relaxation of the bulk 
water proton signal. The target molecule (29) consists of a central core consisting of 
a silsesquioxane cage, (see Section 1.7.2) to which several Gd^ "" satellite complexes 
are attached via linker arms. This silsesquioxane cage would impart to the molecule 
the rigidity needed to reduce the internal movement of the molecule, which would 
have an effect upon the overall relaxivity (Figure 1.7.1.1). This asymmetrically tetra 
substituted cyclen would provide eight coordination sites for the Gd(lll) to bind, along 
with an alkene for attachment to the silsesquioxane core.
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Figure 1.7.1.1: The target molecule (29), a dendrimer-based contrast agent with 
a silsesquioxane core and up to eight Gd-Cycien tendrils.
The second target molecule (30) is based on a di-acid-armed cyclen (Figure 1.7.1 .2 ). 
Compared to lanthanides, such molecules would have greater stability when 
complexed than the D03A (22) -based molecules discussed earlier. This added 
stability would allow for the molecule to have a coordination number of 7, and hence
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an hydration number of 2  by replacing the complexing linking arm seen in the first 
target molecule with a non-complexing linking arm, such as a straight-chain alkene.
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Figurel.7.1.2: The secondary target molecule (30)
As discussed earlier, di-acid compounds such as gD03A present a problem with 
cross-binding within the molecule. The length of the carbon chain between the two 
carboxylic acid groups is important, owing to the possibility of intermolecular
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complexation between two cyclen-Ln pendant arms once attached to the siloxane 
cage. This would be more likely with a longer-chain acid such as adipic acid (24), as 
used in aDOSA (26). This pendant-pendant binding would reduce the anisotropic 
rotation of the cyclen-Ln pendant arms in relation to the central siloxane cage by 
increasing the rigidity of the molecule. Whilst this reduction of the anisotropic rotation 
would lead to greater relaxation, it would cause a reduction in the q value, thus 
effectively reducing the relaxation value of the complex (Figure 1.7.1.3).
Figure 1.7.1.3: Change in the osciliations of the siioxane cage with iinked
cycien-Ln pendant arms.
A cyclen based on glutaric acid (23), such as g DOSA (25), would reduce the 
possibility of pendant-pendant binding occurring, owing to the shorter chain length. 
However, the intramolecular binding discussed earlier would mean that the gain from 
the increasing q value would be lost. One way around this intramolecular binding 
would be the use of a shorter chain length, such as with malonic and succinic acids, 
to give mDOSA (31) and sDOSA (32) (Figure 1.7.1.4). These shorter chains would
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increase the ring strain between the second acid group and the lanthanide, thereby 
making intramolecular binding more difficult.
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Figure 1.7.1.4: Structures of mDOSA (31) and sDOSA (32)
1.7.2; Silicon cages
At the core of the dendrimer molecule is a silsesquioxane, a six-faced S i-O -Si cube 
with a formula of Si8 0 i2 (33). Silicon can form stable chains interlinked with oxygen 
(34). These chains can form rings (35), which when cross-linked form cages of 
various sizes. The cubic cages have the benefit of having eight corner sites for 
addition of ligands or the attachment of, for example, biological coordinating systems 
to form RIME-type agents. The advantage gained by the use of the silsesquioxane 
cage would be the rigidity to the molecule that it would impose on the dendrimer 
structure (Figure 1.7.2.1).
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Figure 1.7.2.1: Types of silicon chains and rings
1.7.3: Properties of silicon cages
Silsesquioxanes or polysilsesquioxanes have a general formula of (RSiOi.5)n, 
forming a cube in the case where n = 8. They are often referred to as Tn compounds, 
where n is the number of silicon atoms in the compound. Silicon compounds are 
often referred to in general by a letter corresponding to the number of oxygen atoms 
bound to the silicon; D means di-oxygen functional, T is tri-oxygen functional and Q 
stands for tetra-oxygen functional. Under the right conditions, silicon can also form 5 
oxygen bonds. The most studied type of double-ring silicate system is the cubic 
(SisOi2) silicate, or T8 . Octahydridosilsesquioxane, (H8Si8 0 i2) or (T8H8) (33), was 
first prepared in 1959 with yields of 0.1% by Muller et al.®^  It was improved upon by 
Agaskar et al.®^  to give a mixture of H8Si8 0 i2 (33) and HioSiioOi5 , with yields of 27%. 
Silsesquioxanes may be prepared by the condensation of tri-functional silanes. The 
cage system contains a functional group at each of the corners; in the case of T 8H8 
(33) the functional groups are hydrogens, and in the case of Q8M8  ^ (38) the
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functional groups are oxysilanes. Generally they are stable and, depending on the 
functional groups, they are also inert to most reagents.®"  ^Their inertness is a result of 
the stability and strength of the silicon-oxygen bond and the silicon-carbon bonds.®®
Silsesquioxanes are divided into two main classes, functional and non-functional, 
depending on whether the group can undergo other reactions. The non-functional 
silsesquioxanes contain groups such as alkyl or aryl, whereas the functional 
silsesquioxanes can contain a range of organic functional groups such as vinyl, 
alcohol and carboxylic acid esters. There are several synthetically useful cages, 
such as Si-H (33), Si-OH (36), Si-vinyl (37), and O-Si-MeaH (38); (36) and (38) are 
examples of Og cages (Figure 1.7.3.1).
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Figure 1.7.3.1: Some useful cages
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Silsesquioxanes are often used in the coating industry, as a precursor for silicon 
oxycarbide ceramics, as a nanofiller for load-bearing plastics®®, or as a scaffold for 
molecular nanotechnology.®^ They are also used as copolymers, when the chain is 
extended with suitable functional groups to form a dendrimer species in the shape of 
a star. The group of compounds formed in this way are often referred to as octopus- 
silsesquioxanes. The functional groups of the cubes may also be able to cross-link 
with other monomers, dendrimers or Polyhedral Oligomeric Silsesquioxanes 
(ROSS).
Another important group of silsesquioxanes are the incompletely condensed 
polyhedral oligosilsesquioxanes (39), which contain essentially a silsesquioxane 
cage missing one of its corners. These silsesquioxanes may be formed by hydrolytic 
condensation reactions of alkyl or aryltrichlorosilanes,®® in a similar manner to the 
formation of the TgHg (33) cages. An alternative preparation is the incomplete 
hydrolysis of octa-polyhedral silsesquioxanes (RaSisOia) with strong acids, such as 
HBF4 .0 Me2 or triflic acid (CF3SO3H), over a period of several hours at room 
temperature or in a brief reflux®"^ ’ ®^
It is important to note that the silsesquioxane cages are completely condensed 
before they are used for imaging agents, owing to the possible formation of a 
complex between the lanthanide and the incompletely condensed 
polyoligosilsesquioxane cage. These complexes form dimeric lanthanides, where 
two lanthanide-silsesquioxanes come together to form a stable complex (40) at low 
temperature, which may be capped with a strong donor ion such as 
pentamethyldiethylenetriamime to form a stable complex (39).^° These complexes
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are stable in non-aprotic solvents, have limited solubility, and their stability in 
aqueous solution is limited owing to their ease of hydrolysis^  ^ (Figure 1.7.3.2).
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70Figure 1.7.3.2: Structures of lanthanide-silsesquioxane complexes
While the silsesquioxanes cage may be stable in acid and neutral conditions, the 
cage can undergo decomposition in a basic environment. This occurs slowly when 
the compound is exposed to an amine such as EtsN in wet solvents, but much more 
slowly when in anhydrous solvents.^  ^The reaction with the base Et4 N0 H (aqueous) 
in THF has been investigated as a method for producing incompletely condensed 
silsesquioxanes.^® Amine-induced hydrolysis is more common when the amine in 
question is a primary amine, such as compound (41). The amine breaks the S i-0  
bond to form an intermediate structure (42), which would then undergo condensation 
with another Si-OH group or, if water is present, would form Si-OH directly (43) 
(Figure 1.7.3.3).
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Figure 1.7.3.3: Mechanism for decomposition of a T8 cage via a primary
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1.7.4: Methods of forming bonds between silsesquioxanes and cyclens
The linking reaction between a substituted cyclen and a silsesquioxane is the key 
step in the formation of the target ligands. There are several ways to form Si-C  
bonds, such as the direct reaction -  used in industry -  of silicon with an alkyl halide 
using a metal catalyst such as silver, nickel or copper under high temperatures, 
which yields a mixture of reaction products. Other laboratory Si-C-based bond 
formations are based on the formation of a carbanion; such methods include 
Grignard-type reactions using a silyl halide such as MesSiCI, with RMgX in ether The 
alkali metals lithium and sodium can also be used in the formation of the Si-C  
bond^ ®
The problem with these methods is that they rely on the generation of a carbanion, 
which may react with the cyclen system. An alternative, which does not rely on the 
formation of a carbanion, is hydrosilylation^®. This is the reaction of an alkene with 
Si-H to form an Si-C bond, using platinum catalysis. The alkene butene-mDOSA 
(44) would be attached to the cyclen via a short arm (Figure 1 .7.4.1). The length of
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the arm linking the cyclen ligand to the silsesquioxane cage is critical to limiting the 
amount of anisotropic rotation which could occur, in the same manner as in the 
oligomers seen in section 1.4.3.
/ r ? i
R— Si— 0 -j-S I— R 
I R— S I-l-0 — Si
Î /  iXi
R— Si— O— Si
I
R
30
HSi O— SiH
)  » s i 4 s ' ' °  Î
I HSi—1-0— SiH
HSi— O— Si 
H
33
HO
OH
OH
8
44
Figure 1.7.4.1: Retrosynthesis analysis of the target moiecuie for the formation
of the Si-C bond
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1.7.5: Hydrosilylation-based bond formation
Hydrosilylation is the addition reaction of Si-H across a tt bond, such as in alkenes 
and alkynes, forming an Si-C bond by taking advantage of the low strength of the 
Si-H bonds. This is performed using two main methods, radical and transition-metal 
catalysis, with the latter being the more synthetically useful. The main transition 
metal used as a catalyst in hydrosilylation is platinum, normally as chloroplatinic acid 
(HaPtCle) in propan-2 -ol.
The formation of the bond is favoured because of the increase in bond strength. This 
provides a good synthetic route for the attachment of arms with different functional 
groups to the octahydridosilsesquioxane (TgHg) (33). Another advantage of platinum 
catalysts is that they are tolerant of a wide range of function groups and would not be 
expected to react with the esters and amines of the compound^®'^® (Figure 1.7.5.1).
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R
Figure 1.7.5.1: Addition o f an aikene (45) to T8H8 (33) via Speir’s catalyst to
1/ .  1/u HSi O— Si
give the substituted silsesquioxane cage (45) 61
There are possible side reactions which could occur with the hydrosilylation reaction 
between the alkene-cyclen and the hydrosilane. These side reactions are caused by
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the difference between the bond energies of Si-H and S i-0 , suggesting that 
hydrosilanes would react rapidly with alcohols. Alcoholysis reactions with 
hydrosilanes are kinetically quite slow under neutral conditions. For example, the 
ethanolysis of HSi(0 Et)3  (47) needs to be performed in a sealed tube at a 
temperature of 100 °C, producing Si(0 Et)4  (48) with yields of 50% (Figure 1.7.5.2).
Q—Si----- H + EtOH ------------ Q—Si 0  + ^2(g)
Et 1  s /  1
Et Et
47 48
Figure 1.7.5.2: Aicohoiysis ofHSi(OEt)s (47) with ethanoi to form Si(0Et)4 (4S)
and hydrogen gas
To be able to react with an alcohol in a synthetically useful way, hydrosilanes need 
the presence of a strong acid, a base, radical conditions or the presence of metals 
such as colloidal copper or a transition metal, for example palladium and nickel 
complexes.^®'®  ^ Bases are typically more efficient as catalysts than are acids, but 
both have the drawback of being able to hydrolyse the ester-protecting group of the 
carboxylic acid on the ligand. This is crucial, as the carboxylic acid, propanoic acid, 
(49) can react with the triethoxyhydrosilane (47) to form the corresponding silyl 
carbonate, triethoxysilyl propionate (50) (Figure 1.7.5.2).
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Figure 1.7.5.3: Reaction of triethoxyhydrosiiane (47) with propanoic acid (49) to
form triethoxysilyl propionate (50)
Thus the cyclen ligand must be attached to the silsesquioxane cage before the 
hydrolysis of the esters and the formation of the lanthanide complexes; otherwise the 
three unbound carboxylic acid groups would react with other cages to form an 
insoluble polymer. To avoid the unwanted hydrosilylation between the carboxylic 
acids and the silsesquioxane cage, the other Si-H sites on the silsesquioxane would 
have to be protected, or have their functionality changed to avoid unwanted side 
reactions.
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Chapter 2.0: Formation of the cyclen moiety- results and 
discussion
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2.1 ; Strategies for the substitution of cycien
There are two main synthetic strategies possible for the asymmetric derivatisation of 
cyclen (9), depending on the way in which the different arms are attached (Figure 
2 .1 .1 ). Each strategy has its own problems, which will be discussed later. The first 
method is referred to as the 1+3 strategy, where the first step is the attachment onto 
one of the nitrogens of the alkene linking group for the attachment to the siloxane 
cage (51); that is followed by the attachment of the complexing arms onto the three 
remaining nitrogens (53). The second method is referred to as the 3+1 strategy, 
where the first step is the attachment of the complexing arms to the three nitrogens 
(52), followed by the attachment of the linking group on the fourth nitrogen (53).
/ \  / \ 7\ / \
N  k '
R2 \ ___ /  R2
51 53
7  / \ h7 w \ R2 \ ___ /  R2
52 53
Figure 2.1.1: The two strategies for asymmetric cyciens: top, 1+3 strategy;
bottom, 3+1 strategy
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Both the 1+3 and 3+1 routes have similar problems with over-substitution during the 
asymmetric substitution of cycien (9). This is possibly due to two factors: the pKa of 
the amines and the steric effect of the groups. The pKa of the amines varies 
depending upon the extent of quarterisation and can be split into two phases. The 
first two protonations have higher pKa values -  between 10.6 (^ /_ 0.1) (54) and 9.6 
Cl- 0.1) (55) -  while the second set of protonations have lower pKa values -  between 
1.7 f/-0 .1 1 ) (56) and 0.8 (V-0.1) (57) (Figure 2.1.2).
H+ r  + 1
H+ + +
:N N:
56 57
Figure 2.1.2: pKgS of cycien In water; conditions 25 °C, 0.1 M NaNOs
This grouping of the pKaS proves to be a problem with the asymmetric substitution, 
as the conditions needed to alkylate one of the nitrogens are ideal for the alkylation 
of the other nitrogen within the pKa pair. This over-alkylation was a key problem in 
both routes. In the 1+3 route over-alkylation occurs on the nitrogen, trans to the first 
site of alkylation (58). In the 3+1 route the over-alkylation produces a tetrasubstituted 
cycien (59) (Figure 2.1.3).
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Figure 2.1.3: Products o f over-alkylation. Left: the over-alkylated product from 
the 1+3 strategy. Right the over-alkylated product from the 3+1 strategy
There are several ways to prevent over-alkylation in both routes. The first was to use 
a higher dilution and/or arrange for the number of equivalents of the alkylation arms 
to be slightly less than that of the cycien. Alternatively, it might be prevented by the 
use of a suitable protection group such as BOC (A/-tert-butoxycarbonyl).
2.2.1: Synthesis of 1-pent-4-enoy 1-1,4,7,10-tetraazacyclododecane (66)
The first cycien system investigated was based upon D03A (22), with the linking arm 
between the cycien and the siloxane being pent-4-enoyl chloride (63), which has the 
functionalities of the acid chloride for the substitution reaction on the cycien as well 
as the alkene needed for the hydrosilylation reaction onto the silicon cage. The pent- 
4-enoyl chloride (63) arm would need to be attached to the cycien (9) before the 
hydrosilylation reaction with TgHg (33) could be performed, to prevent possible side 
reactions between the siloxane and the acid chloride (Figure 2.2.1.1).
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Figure 2.2.1.1: Retrosynthetic analysis o f compound (60)
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There are two possible routes to the formation of pent-4-enoyl-D03A (61). The first, 
labelled Route A (Figure 2.2.1.2), is the 1+3 route, where the cycien (9) is first 
acylated with pent-4-enoyl chloride (63) to give the monosubstituted cycien (66), 
which was then reacted with ethyl 2-bromoacetate (65) to give the target molecule 
(61). The second route, labelled Route B, is the 3+1 route, where the cycien (9) was 
first alkylated by ethyl 2-bromoacetate (65) to give the trisubstituted cycien (67), 
which was then acylated by pent-4-enoyl chloride (63) to give the target molecule 
(61).
o Route A
N HN
NH HN
V J
NH HN
NH HN
NH N
Route B
Figure 2.2.1.2: Two reaction pathways for the formation o f the ethyi ester form
of pent~4~enoyi~D03A (61)
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There are two methods for the formation of 1 -pent-4-enoyl-1,4,7,10- 
tetraazaoyclododecane (6 6 ). The first was the direct alkylation of the cycien (9) by 
pent-4-enoyl chloride (63) (Figure 2.2.2.1). In the second method the cycien (9) was 
first protected on three of the nitrogens, and then reacted with pent-4-enoyl chloride 
(63) before being deprotected to give the 1 -pent-4-enoyl-1,4,7,10- 
tetraazacyclododecane (6 6 ).
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Figure 2.2.2.1: The 1+3 route for the synthesis o f 1~pent-4-enoyF1,4,7,10-
tetraazacyciododecane (66)
In the first method the pent-4-enoyl chloride (63) was reacted with cycien (9), using 
powdered activated molecular sieve and anhydrous chloroform. The molecular sieve 
has two functions in this reaction: the first is to act as an acid scavenger, removing 
the HCI produced, and the second is to remove any residual water present, thus 
preventing the hydrolysis of the acid chloride.®"^
The LCMS of the crude reaction product showed that the reaction had produced a 
mixture of substituted cyclens ranging from 1 to 4 substituted cyclens with the 
following m/z results 255.21 [IVI(6 6 )^"], 337.21 [M(6 8 )'^ ]^, 419.31 [M(69)'"^] and 
501.33 [IVI(70)^"] (Figure 22.2.2). The separation of the reaction products proved to
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be unsuccessful, by TLC (chloroform 90%, methanol 10% on silica) RF 0.01. So the 
second method, using the tri-protected cycien, was investigated.
69 70
Figure 2.2.22; Reaction products o f cycien (9) and pent-4-enoyl chloride f63)
2.2.3: Protected cycien route for the synthesis of 1-pent-4-enoyl-1,4,7,10- 
tetraazacyclododecane (87)
In the second method the cycien is first protected with di-fe/t-butyldicarbonate (71) to 
give the tri-BOC-cyclen (72) giving yields of 40%, proven by NMR, NMR and 
FTIR which showed the presence of the carbonyl at 1691 cm"\ The tri-BOC-cyclen 
is then alkylated with pent-4-enoyl chloride (63) to give the fully substituted cycien
80
(73). That would then be deprotected to give 1 -pent-4-enoyl-1,4,7,10- 
tetraazacyclododecane (6 6 ) (Figure 2.2.3.1).
NH HN
NH HN
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Figure 2.2.3.1: Second method for the formation o f 1-pent-4-enoyl-1,4J,10-
tetraazacyclododecane (66).
Tri-BOC-cyclen (72) was dissolved in chloroform and powdered molecular sieve 
added as before, to which a solution of pent-4-enoyl chloride (63) in chloroform was 
added dropwise. The reaction mixture was chromatographed on alumina using 
chloroform (95%) and methanol (5%) as the eluant. A clear oil was produced in a 
yield greater than 60%. The NMR showed the presence of the alkene at 4.92 (H2) 
and 5.76 (H) ppm. The compound was also confirmed by ^^ C NMR, FTIR and LCMS 
(555.72 [M(73)^"]
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The next step in the synthesis was the removal of the BOC protecting groups using 
trifluoroacetic acid, monitored by LCMS, to give 1 -pent-4-enoyl-1,4,7,10- 
tetraazacyclododecane (6 6 ). While this step did remove the BOC groups, the TFA 
removed the pent-4-enoyl group from the cycien as well. LCMS 173.19 [M(9)^"], 
255.24 [M(6 6 )^"] (trace only).
The removal of the linking arm rendered the method of protection using BOC-groups 
void. Therefore alternative protection was investigated, using milder conditions for 
the removal of the protection groups. Formyl protection of cycien, 1,4,7,10- 
tetraazacyclododecane-1,4,7-tricarbaldehyde (triformylcyclen) (74), is a synthetically 
useful procedure used for the regio-selective substitution of cycien and the formyl 
groups can easily be removed using weak acids or bases.®® ®® (Figure 2.2.3.2).
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Figure 2.2.3.2: FormyFprotected cycien route for the synthesis o f compound
(6 6 ;
1,4,7,10-tetraazacyclododecane-1,4,7-tricarbaldehyde (triformylcyclen) (74) was 
synthesised by the reaction of 2,2,2-trichloroethane-1,1 -diol (76) (chloral hydrate) 
with cycien (9) dissolved in ethanol and heated to 60 °C for 3 hours. The crude 
product, consisting of mainly di- and trisubstituted cycien, was purified using silica
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chromatography with a short silica column, eluting with a solution of 89.9% DCM, 
10% MeOH and 0.1% ammonia solution (35%). This process eluted the target 
molecule in a yield of 80%, with a retention factor (Rf) of 0.25. The solution was then 
dried over magnesium sulfate and the organic solvents removed using reduced 
pressure to give a transparent viscous oil in 84% yield®^  The product was confirmed 
by LCMS [257.39 [M(74)^"], FTIR which showed the presence of the carbonyl at 
1669 cm'  ^ and the carbonyl was also confirmed by and NMR at 8.06ppm and 
162.71 ppm respectively. (Figure 2.2.3.3).
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Figure 2.2.3 3 Synthesis of triformyl cycien (74)
The triformyl cycien (74) was reacted with pent-4-enoyl chloride (63) in chloroform 
with powdered activated molecular sieve. The reaction produced a mixture of 
compounds, as seen in the LCMS which showed that the target molecule 10-pent-4- 
enoyl-1,4,7,10-tetraazacyclododecane-1,4,7-tricarbaldeyde (75) was present as a 
minor trace, along with a mixture of pent-4-enoyl substituted cyclens. This was due 
to the acidic nature of the molecular sieve®® removing the formyl protecting groups 
from the cycien, allowing the pent-4-enoyl chloride (63) to produce polysubstituted 
cyclens. The attempted separation of the target compound on silica failed, resulting 
in a mixture of different compounds that eluted all at the same time.
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To prevent the loss of the formyl protecting groups by the side reaction with the 
molecular sieve, potassium carbonate was used as the base. The removal of the 
residual acid chloride was achieved by the reaction of TEA with the excess pent-4- 
enoyl chloride to form the corresponding salts. This method prevents the formation of 
HCI, as would happen in, for example, biphasic extraction using water and 
chloroform.
The potassium carbonate was removed from the chloroform by filtration, and TEA 
was added to the reaction and stirred for 30 minutes to neutralise the acid chloride. 
The solvents were removed using reduced pressure, followed by high vacuum to 
remove any remaining TEA. The crude oil was then dissolved in acetone, causing 
the TEA-CI present in the crude product to form a precipitate that was filtered from 
the reaction mixture. The solvent was then removed and the crude oil passed though 
a silica chromatography column eluted with 90%DCM, 10%MeOH and 0.1% 
ammonia solution. The 10-pent-4-enoyl-1,4,7,10-tetraazacyclododecane-1,4,7- 
tricarbaldeyde (75) was then added to a solution of sodium hydroxide solution (0.2M) 
to yield the deprotected cycien 1-pent-4-enoyl-1,4,7,10-tetraazacyclododecane (6 6 ). 
The LCMS of the product showed the target molecule at 254.31 [M(6 6 )^"] along with 
a trace of the monoformyl-protected product (77) at 282.48 [M(77)"^ (Figure 2.2.3.4).
N
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Figure 2.2.3A: Structure o f monoformyFprotected product (77)
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The LCMS is sensitive to sodium ions, this leads to ion saturation of the detector, 
thus reducing the signal output of the LCMS. In an attempt to remove the sodium 
ions, a 2 ml fraction of the reaction was removed and freeze-dried. The product was 
extracted from the solid by using CDCI3. The ^^ C NMR indicated that the hydrolysis 
reaction had worked, by the loss of carbonyl peaks at 162 ppm corresponding to the 
formyl groups. The LCMS of the CDCI3 solution still showed, however, a large 
amount of ion saturation caused by the sodium ions. Because of the limited solubility 
an alternative method of removing the sodium ions was attempted, by retaining the 
product on a C l 8  reverse-phase column and eluting off the sodium hydroxide. The 
Cl 8  stationary-phase-chromatography approach failed owing to the polar nature of 
the cycien compound in basic solution, meaning that it was eluted along with the 
sodium hydroxide
An alternative way to neutralise the sodium hydroxide is with hydrochloric acid 
(0.2M), then removal of the salt formed using a Cl 8  reverse-phase column. The 
LCMS spectrum showed that compound (75) had been hydrolysed to form a range of 
products at 254.37 [M(6 6 ) 282.51 [M(77)"'"] and 171.41 [IVI(9)* "] which
correspond to compounds (6 6 ), (77) and cycien (9) respectively. This indicated that 
the linking group could be hydrolysed from the cycien compound rendering this route 
unfeasible. (Figure 2.2.3.5).
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Figure 2 2.3.5; Hydrolysis of compound (75J to form 1~pent~4-enoy!-1,4J,10-
tetraazacyclododecane (66)
2.2.4: Conclusion
The failure to attach the carbonyl-based lining arm was due to the sensitivity of the 
arm to acids. This ease of elimination of the carboxyl linker arm presented a 
problem, as it would be easily removed at later stages of the synthesis. The main 
inconvenience would be the hydrolysis of the cyclen-siloxane cage to remove the 
ester protection groups. The nature of the silicon cage means that a strong base is 
not viable for carrying out this hydrolysis, as it would destroy the cage. The use of an 
acid for the hydrolysis would hydrolyse the linking arm of the cycien, which would 
result in the decomposition of the target molecule. An alternative to the acid chloride 
arms is a haloalkene arm such as 4-bromobut-1-ene (78) (Figure 2.2.4.1). The use
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of such an arm would change the water coordination number of the Gd-cyclen 
complex from q = 1 to g = 2 , caused by the loss of the carbonyl group on the linking 
arm reducing the 8  coordinating ligands to 7.
Figure 2.2.4.1: Structure o f 4-bromobut-1-ene (78)
The loss of the coordinating arm would have an effect on the stability of the G d- 
cyclen complex. The stability of 7 coordinate ligands can be improved by the use of 
di-acid pendant arms, for example aDOSA (26). This would allow the system to be 
more stable, while taking the advantage of the increases in q values. The solubility 
would also be improved owing to the extra acid groups.
2.3: Nomenclature for hex-acid cycien systems
The lUPAC nomenclature produces extremely long names for the ligands studied in 
this project; therefore abbreviations will be used from this point onwards, based upon 
the system seen in Parker et al. in 2001. This uses the generic name of the acid 
groups as the first letter, followed by the generic core name. Thus, if the ligand has 
three adipic acid pendant arms it would be aDOSA (20); if the acid pendant arms 
were malonic acid it would be represented as mDOSA (31); and sDOSA (32) for 
succinic acid pendant arms. The fourth pendant arm is expressed before the DOSA
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nomenclature, e.g. a butene-based arm attached to gD03A (79) would be expressed 
as butene-gD03A (106) (Figure 2.3.1).
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Figure 2.3.1: Examples o f different compounds based on D03A
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2.4.1: Synthesis of a malonic acid-armed cycien, mDOSA (31)
The first di-acid chosen was malonic acid (80); with a carbon chain length of 3 it is 
the shortest possible chain length that allows for modification for attachment to the 
cycien. This is in contrast to oxalic acid (81), which has only the carbonyl carbons, 
and thus no position for possible attachment to the cycien (Figure 2.4.1.1).
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Figure 2.4.1.1: Structures o f oxalic acid (8^) and malonic acid (80)
Malonic acid (80) is not directly suitable as a ligand, owing to its ease of 
decarboxylation to form an acetic acid group (84)®® via the decomposition of (82) to 
give the enolate (83), which converts to the mono-acid (84) by addition of a proton 
(Figure 2.3.1.2).
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Figure 2.4.1.2: Decarboxylation o f malonic acid compounds
The decarboxylation may be reduced by the addition of a methyl group to the central 
carbon; this improves the stability of the compound (85) (Figure 2.4.1.3).
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Figure 2.4.1.3: Structure o f proposed methylated malonic acid group to
prevent decarboxylation
The redesigned target molecule (8 6 ) can be prepared from three main reagents: the 
cycien (9), the haloalkene 4-bromobut-1-ene (78), and the di-acid 2-(bromomethyl)- 
2-methylmalonic acid (89). The formation of the ligand arm occurs in several steps. 
The 2-(bromomethyl)-2-methylmalonic acid (89) is formed from the di-alcohol 2 - 
(bromomethyl)-2-methylpropane-1,3-diol (90) by the oxidation of the primary alcohol 
group to a carboxylic acid, which is in turn synthesised from the oxetane 3-methyl-3- 
oxetanemethanol (91) by a ring-opening reaction. The 2 -(bromomethyl)-2 - 
methylmalonic acid (89) would need to be protected using a suitable ester protection 
group before the reaction with the cycien ring (Figure 2.3.1.4).
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Figure 2.4.1.4: Retrosynthetic analysis o f compound (86J
The first synthetic step in the synthesis of (8 8 ) is the ring-opening reaction of 3- 
methyl-3-oxetanemethanol (91) to form 2-(bromomethyl)-2-methyipropane-1,3-diol 
(90), catalysed by 40% hydrobromic acid added dropwise over one hour before
91
being heated to 90 °C for 16 hours (Figure 2.4.1.5). The reaction was cooled to 4 °C, 
at which temperature the product crystallises out of solution. The crystals were taken 
up into DCM and dried over magnesium sulfate, giving rise to a white solid product 
with a yield of 59%. The and ^^0 NMR spectra correspond to the literature
values.89
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Figure 2.4.1.5: Mechanism for the formation o f 2-(bromomethyi)-2~
methyipropane-1,3-diol (BO)
Primary alcohols can be oxidised to form carboxylic acids by several strong oxidising 
agents. The oxidation of 2-(bromomethyl)-2-methylpropane-1,3-diol (90) occurs in 
two steps, of which the first is the oxidation of the alcohol groups to the 
corresponding aldehyde groups. The aldehyde is then oxidised to form the carboxylic 
acid. The oxidation is carried out using Jones’ reagent; a solution of chromic acid 
and sulfuric acid, which is added to a solution of the di-alcohol dissolved in 
acetone.®® Since the reaction is highly exothermic, the Jones’ reagent is added 
dropwise over a period of one hour. After this addition, the reaction is stirred for 16 
hours at room temperature (Figure 2.4.1.6).
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Figure 2.4.1.6: Formation of2-(bromomethyi)~2-methyimaionic acid fB9J from 2- 
(bromomethyi)~2~methyipropan-1,3-dioi (90) via Jones’ reagent in acetone
The reaction mixture was then poured into methanol (100 ml) and stirred for 30 
minutes in order to quench the remaining Cr '^  ^to Cr^. The reaction changes colour 
from red to green during the quenching, owing to the reduction of the Cr®^  to Cr^ .^ 
Methanol and acetone are removed using reduced pressure and the acid is
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extracted from the aqueous layer using chloroform (2 x 50 ml) and diethyl ether (4 x 
200 ml). The combined organic phase is dried and the solvent removed using 
reduced pressure. The reaction gives yields greater than 46%. The and NMR 
spectra matched the published data, and gave a MP of 128.1 °C compared to the 
literature value of 126.5 °C.
The next step is the protection of the carboxylic acids by the formation of esters with 
a suitable protection group. Methanol was used in the first attempt, to form dimethyl 
2-(bromomethyl)-2-methylmalonate (96) (Figure 2.4.1.7).
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Figure 2.4.1.7: Formation o f ester-protected 2-(bromomethyi)‘2‘methyimalonic
acid
The reaction produced a monomethyl ester, 2-(methoxycarbonyl)-3-bromo-2- 
methylpropanoic acid (114), after 24 hours and showed no sign of the diester 
product by LCMS analyses. The reaction of the dicarboxylic acid with ethanol under 
the same conditions produced a trace amount of diethyl 2 -(bromomethyl)-2 - 
methylmalonate (112), in a yield of less than 2% (Figure 2.4.1.8)
94
-o OH
Br
97
Figure 2.4.1.8: Structure of2-(methoxycarbonyi)-3-bromo-2-methyipropanoic
acid (97)
With no trace of the intermediate monomethyl ester compound (97) and the starting 
material, it was proposed that the starting material was being lost though 
decarboxylation of 2-(bromomethyl)-2-methylmalonic acid (89) to form 2- 
methylpropanoic acid (99). The decarboxylation also presented a major problem for 
the stability of the mD03A-La complex, as any loss of a ligand arm would 
destabilise the complex®®' (Figure 2.3.1.9).
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Figure 2.4.1.9: Proposed mechanism for the decarboxyiation of2- 
(bromomethyi)-2-methylmaionic acid (89)
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2.5.1 : Synthesis of a succinic acid substituted cycien (9), butene-sD03A
Since the synthesis of mDOSA (8 6 ) was not feasible, an alternative molecule was 
proposed utilising succinic acid as the di-acid arm instead of malonic acid. Succinic 
acid (100), with its additional CH2 , would prevent the decarboxylation step from 
occurring (Figure 2.5.1).
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Figure 2.5.1.1: Structure o f succinic acid (100)
The amount of cross-binding occurring should be lower than with the glutaric-based 
gDOSA (25), owing to the increased ring strain induced by the smaller ring system 
formed. The target molecule sDOSA (32) could be split into three reagent molecules; 
the core of the molecule was as before, cycien (9); the ligand arms would be succinic 
acid (100); and the linking arm would be a haloalkene such as 4-bromobut-1-ene 
(78) (Figure 2.5.1.2 ).
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Figure 2.5.1.2: Retrosynthetic analysis o f butene-sD03A (101)
91
2.5.2: Synthesis of butene-sD03A-(ethyl) (101)
As described in earlier routes, there are two possible pathways for the synthesis of 
butene-sD03A-(ethyl) (101). Route C (figure 2.5.2.1) was the 1+3 route, while Route 
D (figure 2.5.2.1) was the 3+1 route. The first step in Route C (1+3) was the 
selective alkylation of the cycien molecule with 4-bromobut-1-ene (78), to form 
compound (106). The direct alkylation of cycien with 4-bromobut-1-ene (78) would 
result in multiple alkylation of the cycien (9), and so protection groups are needed to 
prevent that from occurring. The second step, after deprotection of the remaining 
nitrogens, was the alkylation of the three remaining nitrogen atoms with the diethyl 2- 
bromosuccinate (103) to give the ethyl-protected butene-sD03A-(ethyl) (101) (Figure 
2.4.2.1).
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Figure 2.5.2.1: Routes C (1+3) and D (3+1) for the synthesises o f butene-sD03A
(101)
The first step in Route D (3+1) was the alkylation of the cycien with diethyl 2- 
bromosuccinate (103) to give sD03A-(ethyl) (107). The second was the alkylation of 
sD03A-(ethyl) (107) using 4-bromobut-1-ene (78) to give butene-sD03A-(ethyl)
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(101). The key for this route was the prevention of over-alkylation to yield sD04A- 
(ethyl) (110), or under-alkylation to yield sDOIA-(ethyl) (108) and sD02A-(ethyl) 
(109) (Figure 2.5.2.2). As the possible compounds have similar chemical properties, 
owing to the presence of amines and ethyl esters, they would need to be carefully 
separated using chromatographic methods.
h^ v_ 7^h
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Figure 2.S.2.2: The four possible products from the reaction o f cycien (52) with
diethyl 2-bromosuccinate (103)
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2.5.3: Synthesis of butene-sD03A-(ethyl) (101) by Route C (1+3)
The first step in the synthesis of the target molecule was the alkylation reaction 
between 4-bromobut-1-ene (78) and cycien (9) to give the monosubstituted cycien 1- 
but-3-en-1 -yl-1,4,7,10-tetraazacyclododecane (106) (Figure 2.5.3.1).
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Figure 2.5.3.1: Formation o f the mono-alkene cycien, 1~buU3‘en-1~yi-1,4,7,10-
tetraazacyclododecane flOSJ
4-bromobut-1-ene (78), dissolved in acetonitrile, was added to the cycien (9) as a 
cooled solution (-10 °C), dropwise over 4 hours. The reaction was monitored by 
LCMS, which showed the formation of the monoalkene cycien (106), but with 
significant amounts of the di-alkene and tri-alkene substituted cyclens as seen by 
LCMS. Unfortunately it was not possible to separate these compounds, owing to 
their close Rf values (MeOH (5%) CHCI3 (95%) Silica).
To overcome the over-alkylation, a protected cycien methodology was sought. The 
first protected cycien was triformylcyclen (74) from section 2.2.3, which was then 
reacted in anhydrous acetonitrile with a large excess of 4-bromobut-1-ene (78) using 
potassium carbonate as the base. The reaction was monitored using LCMS and was 
shown to reach completion after 72 hours. The solid residues were removed by
101
filtration and the solvent and the remaining 4-bromobut-1-ene (78) were removed 
using reduced pressure, yielding an oil (Figure 2.5.3.2).
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Figure 2.S.3.2: Formation o f 10-but~3-en~1~yF1,4,7,10-tetraazacyclododecane-
1,4,7-tricarbaldehyde f111J.
During the alkylation step one of the formyl groups was lost, leading to the formation 
of a di-alkene cycien (112) (Figure 2.5.3.3).as characterised by LCMS which showed 
both products (111) and (112) at 311.31 [M(lll)'"^] and respectively 337.51 
[M(112)^"]. This loss of the formyl group was from hydrolysis caused by the base in 
the reaction. The separation of these two alkenes on alumina, eluting with DOM 
(90%) and MeOH (10%), was unsuccessful, producing a product in a yield of 19% 
which, by LCMS, was shown to be a mixture of compounds (111) and (112) 311.21 
[M (1 1 ir”], 337.61 [M(112f^].
o=^
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2.S.3.3: Side product o f the aikyiation reaction
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Owing to the problems with the triformylcyclen, an alternative protection method was 
attempted. The tri-protected cycien, octahydro-5H-2a,4a,7,9a- 
tetraazacycloocta[1,2,3-cd]pentalene (113) has been reported as having been used 
in a number of syntheses for the formation of monosubstituted cyclens.^^’ The 
advantage of this substrate was that the protecting group can be removed using 
aqueous acid or alkaline solutions, but it was stable in anhydrous conditions.
Octahydro-5H-2a,4a,7,9a-tetraazacycloocta[1,2,3-cd]pentalene (113) was 
synthesised from cycien (9) and N,N-dimethylformamidedimethlyacetal (DMF-DMA) 
(114) in refluxing toluene. The solvent, along with by-products and excess reagents, 
was removed using reduced pressure to give a white, crystalline solid in a yield of 
86% (Figure 2.5.3.4).
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Figure 2.S.3.4: Reaction o f cycien (9) and DMF-DMA (113j
The product was confirmed by using both and NMR spectroscopy and 
comparison with the published data.® ’^ The protecting group fixes the structure in 
one plane, forming a rigid system of 5- and 8-membered rings. This structure 
presents the lone pair of the unprotected amine to the outside of the ring system. 
The 4-bromo-but-1-ene (78) will undergo reaction with the lone pair of the protected
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cycien (113) to give the monosubstituted cycien 7-but-3-en-1 -yloctahydro-5H- 
2a,4a,7,9a-tetraazacycloocta[1,2,3-cd]pentalene (115). To prevent the 4-bromobut-
1-ene (78) from undergoing decomposition, the reaction must be kept at a low 
temperature for the first 3 hours, after which the temperature was slowly raised to 25 
°C. The product was purified by flash-column chromatography, using neutral alumina 
as the stationary phase to avoid deprotection of the cycien and subsequent binding 
of the deprotected cycien to the stationary phase. The chromatography column was 
eluted using a mixture of 97% chloroform with 3% methanol yielding 30% product, 
which was shown to be pure by a single LCMS ion peak at 237.18 [M(115)'^^] and 
the integration of the NMR spectra which showed the correct number of protons 
for the alkene and the cycien. (Figure 2.S.3.5).
78 113 115
Figure 2.5.3.S: Reaction o f tricyclic amine (^^3) with 4-bromobut~1-ene (78)
The deprotection of the tricyclic alkene system (115) occurs in two steps. The first 
step was the hydrolysis of the protecting group to give the monoformamide 7-but-3- 
en-1-yl-1,4,7,10-tetraazacyclododecane-1-carbaldehyde (121). The second
hydrolysis step was the removal of the formyl group to give the monoalkene-armed 
cycien 1 -but-3-en-1 -yl-1,4,7,10-tetraazacyclododecane (106). The first hydrolysis 
was performed by refluxing the protected product in a solution of water and methanol 
(Figure 2.5.3.6).
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Figure 2.5.3.6: Reaction mechanism for the deprotection o f compound (121).
This ring-opening step was highly regioselective for the formation of the 1,7-isomer 
(121), with only a trace of the 1,4 (122) isomer. The isomers were identified in the 
reaction product by ^H-^H-COSY and ^H-^^C-COSY NMR spectroscopy, where the 
differences in the symmetries of the CH2 groups of the cycien were observed.®"  ^ In
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particular, in the ^^C-NMR the 1,4 (122) compound would have 9 carbon 
environments, whereas the 1,7 (121) compound would have 13 carbon 
environments. The formation of the bicyclic intermediate (117) was possibly 
prevented by the strain induced by the CH group adjacent to the N-4 and N-10 
nitrogens. The hydrolysis of the five-membered ring in (118) would be expected to 
give both of the isomers (121) and (122), after carbonyl formation in the last step. 
The possible mechanism by which the 1,7(121) isomer was obtained as the main 
product could involve the addition of a water molecule to the cation (119), since the 
protonation of the N-10 nitrogen was more favourable than that of the N-7 nitrogen, 
owing to the interaction with N-1; the interactions with N-7 and N-4 are less 
favourable owing to N-4 being protonated.®^
The removal of the formyl group may be carried out with either weakly acidic or basic 
conditions. As the use of an acid was inconvenient, owing to the loss of the alkene 
group in the presence of strong acids, the reaction was performed under basic 
conditions. The first alkali used was potassium hydroxide. The crude material was 
dissolved in methanol and added to potassium hydroxide (0.2M solution) and 
refluxed for 24 hours, after which the pH of the reaction was then carefully lowered to 
pH 7.00 using hydrochloric acid. The solvent was removed using reduced pressure 
to yield a white solid. The product was extracted using a biphasic method with 
dichloromethane and water; the organic layer was separated to yield a clear, yellow 
oil. The NMR analysis showed that the reaction was incomplete and consisted as a 
mixture of the N-4 and N-7 formyl isomers together with the monosubstituted cycien 
(106) and cycien (9). Presumably the addition of hydrochloric acid caused the 
decomposition of the alkene-cyclen (106), giving back the cycien (9) starting 
material.
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The second base attempted was ammonium hydroxide, which had the advantage of 
being volatile, allowing its removal by reduced pressure and thus limiting the need 
for acid neutralisation of any excess base. 7-but-3-en-1-yl-1,4,7,10- 
tetraazacyclododecane-1-carbaldehyde (121) was dissolved in 2% ammonia solution 
and heated to 105 °C in a sealed tube. The solvent was removed using reduced 
pressure to give a yellow transparent oil in a yield of 64% (Figure 2.5.3.7). The 
compound (106) was characterised by NMR spectra which showed the correct 
integration and peak pattern, NMR spectra showed that the carbonyl had been 
removed and that there was only 4 carbon environments on the cycien. The LCMS 
showed single ion peak at (227.24 [M(106)'" ]^), while the FTIR showed the absence 
of the carbonyl peak at 1980 cm'^.
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Figure 2.5.3J: Hydrolysis o f ( \2 \ )  to form 1~but-3-en“1-yl-1,4J,10~ 
tetraazacyclododecane (106)
2.5.4: Synthesis of diethyl 2-bromosuccinate (103)
The next step in the reaction with 1 -but-3-en-1 -yl-1,4,7,10-tetraazacyclododecane 
(106) was the addition of the succinate groups, to form butene-sD03A-(ethyl) (101). 
This was achieved using 2-bromo-succinic acid. As the acid groups would cause 
problems with the hydrosilylation reaction later, they would have to be protected as
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ethyl esters to give diethyl 2-bromosuccinate. Diethyl 2-bromosuccinate (103) was 
formed by the estérification of 2-bromo-succinic acid (104) in ethanol, with sulfuric 
acid as the catalyst. This reaction produced the diethyl ester, diethyl 2- 
bromosuccinate (103), in yields of greater than 89%. The diethyl 2-bromosuccinate 
(103) was then stored under argon and molecular sieves (type 3A) to remove any 
residual water. The diethyl 2-bromosuccinate (103) was confirmed by and 
NMR spectra, both of which showed the presence of the ethyl groups, while the 
NMR spectra also showed the down field shift of the carbonyl from 177ppm to 
169ppm corresponding to the formation of the ethyl ester group. The FTIR showed a 
stretch at 1739 cm'  ^ which corresponds to the carbonyl of the ethyl ester group and 
LCMS which showed two ion peaks the first at 253 [M(103)^"] which corresponds to 
the target molecule with a second at 174 [M(103) -  Br^"] which shows the target 
molecule with the loss of the bromide due to ionization conditions of the LCMS. 
(Figure 2.5.4.1).
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Figure 2.5.4.1: Synthesis of diethyl 2~bromosuccinate (103).
2.5.5: Synthesis of butene-sD03A-(ethyl) (101) from 1 -but-3-en-1 -yl-1,4,7,10- 
tetraazacyclododecane (106)
The final step in this (1+3) strategy was the formation of butene-sD03A-(ethyl) (101). 
The 1-but-3-en-1-yl-1,4,7,10-tetraazacyclododecane (106) was dissolved in
108
anhydrous acetonitrile, along with potassium carbonate. To this solution, excess 
diethyl 2-bromosuccinate (103) in anhydrous acetonitrile was added dropwise over 
several hours. The reaction was then heated to reflux for 48 hours (Figure 2.5.5.1).
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Figure 2.5.5.1: Synthesis o f butene-sD03A-(ethyl) (^0^)
LCMS analysis showed that the compound had formed small amounts of the 
trisubstituted cycien (123), along with large amounts of the disubstituted species 
(124), this was seen as two ion peaks at 571.32 [M(123)^"], 398.12 [M(124)"^"]. The 
NMR could not distinguish between compounds (123) and (124). There was no 
evidence of the target molecule, and modification by increasing the amount of diethyl
2-bromosuccinate (103) and/or reaction time did not improve the reaction.
The failure of the reaction could have been due to two factors. The first factor could 
have been due to the increasing amount of steric hindrance with every diester arm 
attached, because of the size of the diethyl succinate group (Figure 2.5.5.2). The 
second was that there was the possibility of the diethyl 2-bromosuccinate (103) 
undergoing an elimination reaction forming an alkene with the elimination of HBr. 
This elimination of HBr to form the corresponding alkene was not reported in similar
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work by Parker^® were the dimethyl 2-bromoglutamate and dimethyl 2-bromoadipate 
were reacted with cycien to form gD03A (25) and aD03A (26)
123 124
Figure 2.5.S.2: By-products from the formation o f butene-sD03A-(ethyl) (101)
2.6.1 : Route D (3+1) for the synthesis of butene-sD03A-(ethyl) (101)
Since the incomplete alkylation of (106) produced compounds (123) and (124), the 
alternative Route D (3+1) was investigated. The first step investigated was based on 
the synthesis of gD03A (25), where dimethyl 2-bromoglutamate was reacted with 
cycien (9).®® In this case dimethyl 2-bromoglutamate was replaced with diethyl 2- 
bromosuccinate (103) (Figure 2.6.1.1).
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Figure 2.6,1.1: The 3+1 route for the formation o f butene-sBD03A-(ethyl) ('lOI)
Cycien (9) dissolved in anhydrous acetonitrile was reacted with diethyl 2- 
bromosuccinate (103) (3.1 eq) in the presence of potassium carbonate (3.4 eq). As 
this reaction was exothermic, the diethyl 2-bromosuccinate (103) was added in small 
aliquots of 0.5 ml and kept at -15  °C using a refrigerant bath consisting of crushed 
ice, industrial methylated spirits (IMS) and sodium chloride. The reaction was then 
left to stir under argon for 24 hours, while the refrigerant bath was allowed to warm 
up to room temperature over time. After this step samples were tested by LCMS,
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which showed that the reaction did not go to completion, as only sDOIA-(ethyl) (108) 
and a trace of sD02A-(ethyl) (109) could be identified.
To force the reaction in the direction of the desired product, another volume of 
diethyl 2-bromosuccinate (103) (1.3 eq) was used in the reaction, which was stirred 
for a further 24 hours. The reaction mixture was then filtered and the solvent was 
removed using reduced pressure. The crude product was shown by LCMS to consist 
of mainly sD02A-(ethyl) (109), with a trace of sD03A-(ethyl) (107). The products, 
sD02A-(ethyl) (109) and sD03A-(ethyl) (107), run at similar Rf values of 0.15 and 
0.20 (MeOH (5%), CHCI3  (95%)), which makes TLC monitoring of the reaction of 
limited use. The properties of the possible products are shown in Table 2.6.1.1.
.Compound Mass
Cycien 172.17 173.17
sDOIA-(ethyl) (108) 344.24 345.24
sD02A-(ethyl) (109) 516.32 517.32
sD03A-(ethyl) (107) 688.39 689.39
sD04A-(ethyl) (110) 860.46 861.46
Diethyl 2-bromosuccinate (103) 252 174.08
Table 2.6.1.1: The [MT^] ions o f the starting material and the products of 
formation o f sD03A-(ethyl) (* = [M-BrJ*^  ^ion)
While the conditions of the LCMS were kept as gentle as possible (i.e. low voltage), 
to stop any fragmentation of the molecules, the diethyl 2-bromosuccinate (103)
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appeared as the [M(103)-Brf^ ion, owing to electron impact-induced halogen 
elimination of the bromide ion.®^ ’ It should be noted that the percentage values 
measured by LCMS are qualitative, owing to the ease of ionisation of the compound. 
Both sD02A-(ethyl) (109) and especially sDOSA-(ethyl) (107) can stick to the 
ionisation cone of the mass spectrometer for a substantial amount of time, and can 
distort the results of following measurements. This was compensated for by allowing 
a suitable time between runs and the use of base-line subtraction from the ion peak 
in the recording of the spectra. The crude reaction was chromatographed on silica 
eluted with chloroform (95%) and methanol (5%), producing sDOSA-(ethyl) (107) in 
2.25% yield, as shown by spectra where the integration of the ethyl groups was in 
proportion to the protons in the cycien / succinic groups at 1.21 ppm (H18, t, 4.7 Hz) 
and 2.52-2.91 (H22, m) respectively. The ^^ C NMR spectra showed the presence of 
the carbonyl carbons at 170.94 ppm and 171.29 ppm and the secondary carbon 
attached to the amine at 60.70 ppm. The FTIR which showed stretches associated 
with both with the ethyl ester (1737 cm"^ ) and amine (1464 cm" )^. The LCMS showed 
the product at 689.37 [M(107)+"] and 728.37 [M(107)+
To increase the yield, the number of equivalents of diethyl 2-bromosuccinate (103) 
was increased from 4.2 to 6.2 equivalents relative to cycien (9). The reaction 
conditions were the same as before. The reaction was monitored over a period of 72 
hours by LCMS and was refluxed until there was no presence of sDOIA-(ethyl) 
(108) signal and the signal for sD02A-(ethyl) (109) on the LCMS has been reduced 
as much as possible when compared to the sD03A-(ethyl) (107) signal. While this 
was not an accurate method of determining reaction product percentages, it was a 
good indication of the progress of the reaction. The reaction mixture was centrifuged
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to compact the solids into a pellet, allowing the solvent layer to be decanted. The 
solvent was then removed using reduced pressure, yielding an oil that contained 
sD02A-(ethyl) (109), sDOSA-(ethyl) (107), and diethyl 2-bromosuccinate (103) 
(LCMS analysis). This reaction method was used as a “universal method” for the 
syntheses of sDOSA-(ethyl) (107), which was used to produce the crude product for 
the following purification methods.
The first method of purification, taken from the literature, was based on biphasic 
solvent separation, by which the isolation of gDOSA-(methyl) was performed.®® The 
crude product was taken up into DCM and then washed with water to remove the 
excess diethyl 2-bromosuccinate (103), sDOIA-(ethyl) (108) and any remaining 
potassium carbonate and cycien (9). While the water removed the sDOIA-(ethyl) 
(108), it did not completely remove the sD02A-(ethyl) (109), as shown by LCMS. 
The resulting product was then chromatographed on silica gel using a mixture of 
DCM 70% and THF 30%, changing to DCM 66.5%, THF 30%, MeOH 3% and 
ammonium solution (33% strength) 0.5% as the eluent. This process separated the 
two compounds, but only by a small amount, as they eluted at virtually the same time 
from the column. The reaction gave yields of less than 1.1% of sD03A-(ethyl) (107). 
As this compound would be needed for several further steps, this was not a feasible 
method of purification of the compound. The second purification method attempted 
involved column chromatography. Several solvent systems were investigated for the 
separation of the crude reaction product, along with different stationary phases 
(Table 2.6.1.2). The solvent strength was calculated using Equation 2.6.1.1 and 
Table 2.6.1.3.
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Purification
method
Solvent
1
Solvent
2
Solvent
3
Solvent 4 Yield of 
sDOSA- 
Ethyl)
Solid
Phase
Solvent
strength
1 DCM
66.5%
THF 30
%
MeOH
3%
Ammonia
0.5%
1.10% Silica 0.48
2 DCM
95%
MeOH
5%
3.70% silica 0.44
3 DCM
95%
MeOH
5%
Mixture Alumina 0.44
4 DCM
70%
THF
30%
Mixture Alumina 0.46
5 DCM
99%
MeOH
1%
5.60% Alumina 0.42
Table 2.6.1.2: Results from comparative purification techniques
{solventA%{strengthy) +  {solventB%{strengtJi))
ÎÔÔ
=  eluant _  strength
Equation 2.6.1.1
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Solvent Strength
Methanol 0.95
Ethanol 0.88
Propan-2ol 0.82
Acetonitrile 0.65
Ethyl Acetate 0.58
THF 0.57
Acetone 0.56
DCM 0.42
Chloroform 0.40
Diethyl Ether 0.38
Toluene 0.29
Hexane 0.01
Table 2.6.1.3: Relative solvent strength based on polarity
The most effective solvent system for elution was a mixture composed of DCM 99% 
and MeOH 1%, using alumina as the stationary phase. This gave yields of around 
5.5%, with minimum contamination of sD02A-(ethyl) (109). The main obstacle was 
the excess diethyl 2-bromosuccinate (103) acting as a co-solvent in the 
chromatography column. The co-solvent effect was seen as an increase in the 
polarity of the solvent, which decreased the retention times. This was shown by co- 
spotting samples of the purified sample with and without the diethyl 2- 
bromosuccinate (103), which showed a marked difference in the Rf values. The
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samples with diethyl 2-bromosuccinate (103) gave an Rf of 0.55, while the sample 
without diethyl 2-bromosuccinate (103) gave an Rf of 0.32 (CDCI3 99%, MeOH 1%).
2.7.1 ; A study of the reaction between cycien and diethyl 2-bromosuccinate
The crude reaction product was produced using the “universal method" mentioned in 
Section 2.6.1 to see if an elimination reaction was occurring in the reaction for the 
formation of sD03A-(ethyl). The TLCs of the reaction crude were rerun using glass- 
backed plates to which was bound Si-60 (Si-60 refers to the average size of the 
silica particles as 60 pm, this was comparable to the silica used in the column 
chromatography, where as the TLC media used in the previous TLC was a polymer 
backed with a silica gel partial size of 25 pm. With the closer partial of the TLC plates 
to that of the silica gel of the column chromatography, better models of the 
purification system could be produced and thus refine the chromatography 
technique. As the plates contain no fluorescent indicator, so were developed using a 
potassium permanganate spray. The plates were previously washed with the 
solvents used in the elution of the plates. This gives a plate which has a closer 
match of Rf values to that of the actual chromatography column under the same 
conditions.
A range of solvent combinations was explored. The aim was to adjust the polarity of 
the solvent so that the Rf of the target compound was 0 .2 0 , while the non-desired 
compounds were less than Rf 0.10 or greater than Rf 0.30. This led to an ideal eluent 
of DCM 95% and EtOH 5%. The chromatography columns used in the subsequent 
study were Sep-Pak columns containing 25 grams of Si-60 in a 60 ml syringe body. 
Sep-Pak was a pre-packaged, disposable chromatography cartridges supplied by
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Waters (Milford, Massachusetts, USA) which have consistency between each 
cartridge. The column was primed using vacuum and eluting solvent, then 200 ml of 
eluting solvent was passed though the Sep-Pak to fully saturate the eluent. The Sep- 
Pak was then loaded with 500 mg of the crude oil and the solvent passed through, 
collecting the eluent in 20 ml fractions. The fractions were examined using a 
combination of TLC and LCMS. This method successfully separated the crude 
extract, giving a pure sample at Rf 0.19 for sDOSA-(ethyl) (107). The diethyl 2- 
bromosuccinate (103) was seen at Rf 0.91, while at Rf 0.55 a new compound was 
found. The new compound was diethyl maleate (126), which was confirmed by NMR, 
LCMS and FTIR analysis. The formation of the diethyl maleate (126) from diethyl 2- 
bromosuccinate (103) was confirmed by an experiment in which diethyl 2- 
bromosuccinate (103) was heated in the presence of potassium carbonate at 60 °C 
for 72 hours. This conversion was achieved with a yield of 87%.
2.8.1: Method for improving yields of the reaction between diethyl 2- 
bromosuccinate (103) and cycien (9)
One possible method of improving yields would be to change the base (potassium 
carbonate) to a more reactive, such as caesium carbonate. The increase in reactivity 
by the use of caesium carbonate stems from two main factors. The first was the 
lower ion pairing of caesium carbonate compared to potassium carbonate, due to 
caesium having a lower charge density because of its increased cationic radius while 
retaining the same charge. This allows greater accessibility of the ion to the reaction. 
The second effect was that caesium carbonate was more soluble in acetonitrile than 
was potassium carbonate, allowing for a greater number of ions to be available. ®®
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Caesium carbonate has been used in several cycien (9) -based reactions once the 
cycien (9) had already undergone substitution.®®’ The caesium carbonate
reactions were first performed in the same manner as those of the potassium 
carbonate reactions. The diethyl 2-bromosuccinate (103) was dissolved in 
acetonitrile and added dropwise over a period of two hours. LCMS showed that the 
main products of the reaction were as expected: sD02A-(ethyl) (109) and sDOSA- 
(ethyl) (107). The crude extract was chromatographed on alumina using DCM (99%) 
and MeOH (1%) as the eluent. The product was isolated in a yield of 5.6% and 
characterised by ^H, NMR and FTIR spectroscopy which were identical to the 
spectra for sD03A-(ethyl) (107) produced by using potassium carbonate as the base 
with in the reaction. The LCMS showed the product at 689.38 [M(107)^"].
Careful monitoring of the reaction by LCMS gave an indication that the reaction had 
not gone to completion. Since the cycien (9) was soluble in the diethyl 2- 
bromosuccinate (103) the reaction was attempted using solvent free conditions, as a 
way of increasing the concentration. As the addition of the caesium carbonate was 
highly exothermic, the reactions were kept at low temperature in an ice/salt/IMS 
bath. The cycien (9) was dissolved in 6.9 eq of diethyl 2-bromosuccinate (103), along 
with 4.8 equivalents of caesium carbonate. The reaction was heated at 60 °C for 24 
hours. The LCMS suggested that the reaction had gone to completion, with no sign 
of sDOIA-(ethyl) (108) and sD02A-(ethyl) (109) present. The reaction mixture was 
taken up into DCM and the solids removed. Since the LCMS showed that the only 
compounds in the crude product were sD03A-(ethyl) (107) and excess diethyl 2- 
bromosuccinate (103), the crude product was washed with water, which removed the 
majority of the diethyl 2-bromosuccinate (103) from the organic layer. The organic
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layer was washed with water to yield 6.6% of sDOSA-(ethyl) (107), with only a trace 
of diethyl 2-bromosuccinate (103). While a small amount of sDOSA-(ethyl) (107) 
would be expected to be lost in the water layer during the purification, its yield was 
still too low. The reaction was repeated with 9.6 eq of diethyl 2-bromosuccinate (103) 
with 5 eq of caesium carbonate. After 10 minutes the LCMS showed that the reaction 
contained a mixture of cycien (9), diethyl 2-bromosuccinate (103) and both sD01A- 
(ethyl) (108) and sD02A-(ethyl) (109), but no sDOSA-(ethyl) (107). The reaction was 
then stirred for 48 hours at room temperature, after which the LCMS showed that the 
reaction contained sD02A-(ethyl) (109) along with traces of sDOIA-(ethyl) (108) and 
sDOSA-(ethyl) (107). As the LCMS results suggested that the sD03A-(ethyl) (107) 
had been produced only in trace amounts, the reaction was heated for another 48 
hours at 60 °C. The LCMS showed that this reaction had produced mainly sD03A- 
(ethyl) (107), with only a trace of sD02A-(ethyl) (109). Critically, there was no sign of 
diethyl 2-bromosuccinate (103) being present. The reaction mixture was dissolved in 
DCM and the solids removed by centrifuge. The sample was split into two aliquots. 
The first sample undenvent column chromatography on silica with elution with DCM 
(95%) and MeOH (5%), to yield a pure sample of sD03A-(ethyl) (107) (1.1%), 
characterised by ^H and ®^C NMR, FTIR spectroscopy and LCMS data which 
matched the known spectras for sD03A-(ethyl) (107). The solvent from the second 
sample was removed and the sample purified using high-vacuum distillation. At 60 
°C a white solid formed on the side of the condenser. No other products were 
extracted from the oil, as it had decomposed giving a viscous black oil.
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2.8.2; Synthesis of (E)-3-(ethoxycarbonyl)acrylic acid (125)
The white solid obtained via the high-vacuum distillation was shown to be (E)-3- 
(ethoxycarbonyl)acrylic acid (125) by and NMR and FTIR spectroscopy, and 
had a melting point (MP) of 68 °C based on the literature values of 66-70  
The MP of the cis (Z) isomer was 180 The formation of the acrylic acid (125)
could occur in two possible steps (Figure 2.8.2.1). The first step involves the 
formation of diethyl maleate (126) by the elimination of HBr, as with the side reaction 
seen with potassium carbonate in section 2.7.1. The second step involves the 
hydrolysis of diethyl maleate (126), with the alkene undergoing rearrangement to the 
(E) isomer, the acrylic acid (125).
126
Br
103 125
OH
o
Figure 2.8.2. f :  Reaction path for the synthesis o f (E)-3'(ethoxycarbonyl)acrylic
acid (i25)
This pathway was confirmed by the reaction of diethyl 2-bromosuccinate (103) with 
caesium carbonate. Upon addition of the diethyl 2-bromosuccinate (103) to the 
carbonate, the reaction released a large amount of heat and HBr gas. The gas was 
identified by the use of wet pH indicators. LCMS and NMR spectroscopy showed 
that (E)-3-(ethoxycarbonyl)acrylic acid (125) had been formed, and the sample had
121
the strong smell associated with acrylic acids. The reaction was then heated to 60 °C 
for 1 hour, giving a mixture of diethyl 2-bromosuccinate (103) and (E)-3- 
(ethoxycarbonyl)acrylic acid (125), as shown by the spectra which showed 
protons at 7.66ppm with C-C coupling as associated with the trans isomer at 15.70 
Hz. The NMR spectra showed that there were six different carbon environments 
present at 14.05, 61.60, 132.54, 135.84, 164.65, 170.21 ppm. The (E)-3- 
(ethoxycarbonyl)acrylic acid (125) was removed using vacuum distillation. The 
corresponding (Z) isomer, (Z)-3-(ethoxycarbonyl)acrylic acid (127), was not found in 
the sample. This was supported by the literature, which shows that the hydrolysis of 
diethyl 2-bromosuccinamate (103) produces fumaric acid (129), owing to the (E) 
isomer being more stable^(Figure 2.8.2.2).
o o o
OH 'o .OH
127
(Z)-3-(ethoxycarbonyl)acrylic acid 
(Maleic acid monoethyl ester)
O
125
(E)-3-(ethoxycarbonyi)acrylic acid 
(Fumaric acid monoethyl ester)
O
HO OH
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maleic acid
O
HO
129
.OH
O
fumaric acid
Figure 2.8.2 2; Structures of the two isomers o f the monoethyl acrylic acids
and the free acids
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2.9.1: Conclusion
There are two main problems presented with the use of diethyl 2-bromosuccinate 
(103) as a starting material in the formation of sD03A-(ethyl) (107). The first was the 
elimination of the bromide to form the alkene, with diethyl maleate (126) as a 
significant product from the reaction of diethyl 2-bromosuccinate (103) when in the 
presence of potassium carbonate, and with the formation of (E)-3- 
(ethoxycarbonyl)acrylic acid (125), when diethyl 2-bromosuccinate (103) was in the 
presence of caesium carbonate (Figure 2.9.1.1). The second problem with diethyl 2- 
bromosuccinate (103) was that it changes the Rf values of the reaction products. 
This causes both sD02A-(ethyl) (108) and sD03A-(ethyl) (107) to be eluted from the 
chromatography column at the same time reducing the usable yield of sD03A-(ethyl) 
(107).
103
P o ta s s iu m  c a rb o n a te C a e s iu m  c a rb o n a te
126
O H
125
Figure 2.9.1.1: Products o f the reaction ofdiethyi 2-bromosuccinate C103j with 
potassium carbonate and caesium carbonate, producing diethyl maleate f126J 
and (E)-3-(ethoxycarbonyl) acrylic acid (125)
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The alkene formed from diethyl 2-bromosuccinate (103) was by an E2 elimination 
pathway, which was favoured by secondary halides in the presence of a strong 
baseJ°^ The base attacks the neighbouring hydrogen to the bromide on the diethyl 
2-bromosuccinate (103) (Figure 2.9.1.2). This E2 elimination occurs in competition 
with Sn2 addition reaction between the diethyl 2-bromosuccinate (103) and the 
cycien (9). In this case the elimination was faster than the substitution reaction. This 
indicates that the reaction was going down an alternative pathway to that of the 
substitution reaction between the diethyl 2-bromosuccinate (103) and cycien (9).
B:0
103
130 126
Figure 2.9.1.2: Mechanism o f the E2 reaction ofdiethyi 2-bromosuccinate (103) 
with a strong base to form diethyl fumarate (130) and diethyl maleate (126)
With the alkene produced by the elimination reaction between diethyl 2- 
bromosuccinate and the base being adjacent to two electron withdrawing groups 
makes it acceptable to react with the amine of the cycien (9). This was due to the 
carbonyl groups stabilising the formation of the carbanion making the alkene formed 
(diethyl maleate (126) or diethyl fumarate (130)) an excellent nucleophile. This leads 
to an alternative synthetic pathway for the formation of sDOSA-(ethyl) (107) though
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the use of the Michael addition of diethyl maleate (126) or diethyl fumarate (130) with 
cyclen (9)
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2.10.1: Synthesis of sD03A-(ethyl) (107) via Michael addition with diethyl 
maleate (126) and diethyl fumarate (130)
The Michael addition reaction has been traditionally performed in protic solvents, 
with a catalytic amount of alkali®®. The Michael addition requires a nucleophile 
acceptor and a nucleophilic donor. A nucleophile acceptor could be a,p-unsaturated 
carbonyl compound, or a ester, nitrile, amide or nitro compound.
In this case the Michael acceptor was the alkene in the diethyl maleate (126) or 
diethyl fumarate (130). These are excellent Michael acceptors, owing to the electron- 
withdrawing effect of both carbonyl groups. The Michael donor was the lone pair on 
the nitrogen of the cyclen (9) (Figure 2.10.1.1). Several methods have been reported 
for the reaction of a 1-2 alkene with a cyclen, giving a range of products from 
monosubstituted to tetra-substituted cyclens. °^®'^ °^ There have also been several 
reports of the reaction of diethyl maleate with secondary amines such as 
diethylamine.^^^
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Figure 2.10.1.1: Mechanism for the Michael addition o f diethyl 2- 
bromosuccinate f126J with cyclen (B) for the formation ofsDOIA-(ethyl) flOBJ
The reactions were run under identical conditions using acetonitrile as the solvent 
and potassium carbonate as the base. The alkene was added in a ratio of 5.4 eq to 
that of cyclen. Both reactions yielded sD03A-(ethyl) (107), as has been reported in 
the l i terature.There was no difference between the two alkenes in terms of 
reaction yields.
The use of the alkenes diethyl maleate (126) and diethyl fumarate (130) has a 
marked effect on the Rf values in the chromatography of the crude reaction product. 
In the reaction using diethyl maleate (126) and diethyl fumarate (130) the Rf
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difference between sD02A-(ethyl) (109) and sD03A-(ethyl) (107) was greater than 
when diethyl 2-bromosuccinate (103) was used. This was due to the co-solvent 
effect noted earlier.
The main synthesis of sD03A-(ethyl) (107) was scaled up to 3g of cyclen (9) 
allowing for the synthesis of greater amount of product. This was performed in 
acetonitrile with 3.3 eq of potassium carbonate and 14 eq of diethyl maleate (126) in 
acetonitrile. The reaction was heated to 80 °C for 72 hours. The chromatography 
protocol had to be modified to make purification of the crude oil possible. Since the 
amount of the crude material to be loaded onto the column was too large, direct 
addition of the oil to the column was not feasible, owing to uneven band separation 
occurring during the loading of the product. This was prevented by adsorbing the 
crude product onto the silica before addition to the column, by dissolving the crude 
oil in DCM and then adding silica (10 g of silica per 1 g of crude). The solvent was 
then removed, using reduced pressure, to yield a sticky powder. The powder was 
added to the top of the column and compacted in the same manner as before. After 
the compaction a layer of sand (3 cm) was placed on the top to prevent movement of 
the silica during the addition of the eluent. This methodology replicates the benefits 
of the Sep-Pak columns, by reducing air/solvent pockets within the chromatography 
bed to allow for a greater resolution within the column and thus better separation. 
The column was then eluted with a mixture of DCM 95%, EtOH 5%. The sD03A- 
(ethyl) (107) was found at Rf 0.20, giving a yield of over 35%. The product was 
confirmed by HRMS predicted 711.3787 [M(107)+Na^"], found 711.3792 
[M(107)+Na^"], The FTIR and the and ^^0 NMR spectra matched the spectra of
the known sD03A-(ethyl) (107) samples.
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2.11.1: Synthesis of butene-sD03A-(ethy[) (101) from sD03A-(ethyl) (107)
The final step in the synthesis of butene-sD03A-(ethyl) (101) was the reaction of 
sD03A-(ethyl) (107) with 4-bromobut-1-ene (78) via the remaining amine group of 
the cyclen, in a nucleophilic reaction. The reaction was performed in anhydrous 
acetonitrile, with potassium carbonate as the base. The main problem was stopping 
the 4-bromobut-1-ene (78) from reacting with itself, and this was achieved by 
lowering the temperature of the reaction to around -15  °C using an ice/salt/IMS bath, 
before the addition of the 4-bromobut-1-ene (78). The reaction was then allowed to 
warm up slowly to room temperature over a period of several hours. The solid was 
removed from the reaction by filtration, and the solvent and excess of 4-bromobut-1- 
ene (78) were removed using reduced pressure. The crude product was identified 
using LCMS and then passed through a silica chromatographic column using DCM 
95 % and EtOH 5% as eluent, giving an oil in a yield of greater than 75%. It was 
noticed in the LCMS of the crude reaction that the butene-sD03A-(ethyl) (101) 
underwent a Menshutkin reaction, where the tertiary amine was converted to the 
quaternary ammonium salt (132).®® This effect was seen mainly in reactions that 
contained a large excess of 4-bromobut-1 -ene (78). This by-product was removed on 
work-up using chromatography (Figure 2.11.1.1).
The^H NMR spectra showed the presence of the protons of the alkene at 4.93 and 
5.71 ppm and the integration fitted the proposed structure. The ®^C NMR spectra 
confirmed the presence of the alkene at 115.31 ppm and 137.09 ppm and the 
spectra also showed the N-CH carbon of the succinate groups. The HRMS 
calculated 743.4437 [M(101)^"], found 743.4445 [M(IOI)"^"], the FTIR showed the 
presence of a stretch associated with the alkene at 2982 cm '\ the ethyl ester at 
1723 cm'  ^ and the amine at 1461 cm"\
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Figure 2.11.1.1: Formation o f butene-sD03A~(ethyl) (101) and a quaternary
ammonium compound (1Z2)
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2.11.2: Synthesis of pentene-sD03A-(ethyl) (133) from sD03A-(ethyl)
(107)
An alternative linker arm, was based on 5-bromopent-1-ene (134) and was also 
synthesised to form pentene-sD03A-(ethyl) (133). The reaction was performed in 
anhydrous acetonitrile, to which potassium carbonate and sDOSA-(ethyl) (107) were 
added. The temperature of the reaction was adjusted to -15  °C using an ice/salt/IMS 
bath, before the addition of the 5-bromopent-1 -ene (134). The reaction was then 
warmed up slowly to room temperature over a period of several hours. The solid was 
then removed from the solvent along with any excess 5-bromopent-1 -ene (134). The 
crude product was passed through a silica chromatographic column using DCM 95% 
and EtOH 5% as eluent, giving a yield of 62%. (Figure 2.11.2.1). The target 
compound was identified by using NMR which showed the alkene at 4.92 ppm 
and 5.72 ppm, and the integration fitted the predicted structure. The ^^0 NMR 
showed the alkene at 115.30 ppm and 137.11 ppm and showed the presence of the 
extra carbon environment when compared to butene-sD03A-(ethyl) (101). The FTIR 
showed the alkene at 2981 cm"^  the ethyl ester at 1728 cm'  ^ and the amine at 1448 
cm"\ The HRMS showed an ion at 757.4590 [M(133)^"j which matched the 
predicted ion of 757.4593 [M(133)^"j.
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Figure 2.11.2.1: Formation o f pentene-sD03A-(ethyl) (1ZZ)
2.12: Conclusion
Following the successful synthesis of sDOSA-(ethyl) (107), butene-sD03A-(ethyl) 
(101) and pentene-sDOSA-(ethyl) (133), they can be employed in the preparation of 
lanthanide complexes in one of two ways. The first was hydrolysis to form the 
associated carboxylic acids of the ethyl esters; these are sDOSA (32), butene- 
sDOSA (105) and pentene-sD03A (135). These compounds would then be 
complexed with Gd^  ^ and Eu^ .^ The second approach was to react the alkene- 
sD03A-(ethyl)’s with the silicon cages as in Chapter 3. These compounds would 
then be hydrolysed and complexed with Gd^ "^  and Eu^ "".
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2.13.1: Hydrolysis of sD03A-(ethyl) (107), butene-sD03A-(ethyl) (101) to 
give the acids sD03A and butene-sD03A
The final step in the synthesis of butene-sDOSA (105) and sDOSA (32) was the 
hydrolysis of butene-sDOSA-(ethyl) (101) and sD03A-(ethyl) (107). The reaction was 
monitored using a combination of LCMS and and ^^ C NMR techniques. The NMR 
integration and position of the NMR signals for the protons attached to carbon [1], 
relative to the protons attached to carbons [5] and [8 ], can be used to measure the 
progress of the hydrolysis reaction (Figure 2.13.1.1).
The integration of the proton attached to carbon [1 ] was used as a standard, as it 
was present in both the ester and acid compounds, whereas the integration of the 
protons attached to carbons [8 ] and [5] will vary with the number of ester groups in 
the molecule and these are seen at 1.18 ppm on the NMR spectra. The chemical 
shift of the proton attached to carbon [1 ] depends on the shielding produced by the 
different carbonyl groups on carbons [6 ] and [3]. When both of the carbonyls are 
ethyl esters, the chemical shift of the protons attached to carbon [1] was at 4.1 ppm; 
while when the carbonyls [6 ] and [3] are carboxyl ic acids the shift goes upfield to 3.8 
ppm.
o
Figure 2.13.1: Structure (136), showing the numbering o f the carbon atoms in 
the ligand~arm section o f sD03A“(ethyl) (107)
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Alternatively, when the carbonyl [6 ] was an ethyl ester and the carbonyl [3] was a 
carboxyl ic acid, the chemical shift moves downfield to 4.13 ppm. When the carbonyl 
[6 ] was an acid and the carbonyl [3] was an ethyl ester, the peak shifts upfield to 
3.78 ppm. This variability of chemical shift makes it possible to monitor which of the 
ester groups are being removed during the reaction, by measuring the integration 
between the peaks as well as their ppm.
2.13.2: Acid-catalysed hydrolysis of sD03A-(ethyl) (107)
The reaction was performed in D2O, as then it was possible to monitor the reaction 
by NMR spectroscopy without the need for purification. The hydrolysis was 
performed using DCI in D2O to reduce the HOD signal in the NMR. The reaction was 
heated at 90 °C in a sealed tube to prevent the loss of DCI over the 18-hour reaction 
time, after which the NMR spectra showed the presence of the ester groups. The 
heating was continued for another 18 hours until the ester peaks were no longer 
present. The DCI was removed using reduced pressure and the D2O removed by 
freeze-drying. The solid was then dissolved in water and freeze-dried. This step 
removed all traces of DCI and replaced the deuterium on the carboxyl ic acid groups 
with protons. The NMR spectra showed that the protons at 1.18 ppm had been 
removed indicating that the ester groups had been removed. The proton associated 
with position [1] had been shifted from 4,1 ppm to 3.5ppm. LCMS spectra showed 
that during the hydrolysis one of the succinic acid arms had been removed 231.35 
[1/2M(138)-NaCr”l, 403.69 [M(138) 439.97 [M(109)Cr^]. The product was the
only one from the reaction and was identified as the chloride salt, with yields of 92%. 
The structure of sD02A has two possible regioisomers: the 1,4-sD02A (137), with
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Cz and D2 symmetry, and the 1,7-sD02A (138), with D2 symmetry. The synthesised 
product was shown to have 1,7 substitution. This conclusion was based on the 
NMR of the carbon environments of the cyclen ring. The 1,7-sD02A (138) has two 
carbon environments, whereas the 1,4-sD02A (137) has 4 carbon environments 
(Figure 2.13.2.1).
HOHO
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KIH > HN
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OH OHOH
HO
1-4-SD02A (137)1-7-SD02A (138)
Figure 2.13.2.1: The C2-D2 symmetry o f 1J~sD02A (138j and D2 symmetry of
1A-SD02A (^^^)
This suggests that the sDOSA (32) was decomposing via an elimination mechanism, 
whereby the leaving group of the protonated nitrogen leads to the formation of the 
formate. The fumarie acid was seen in the NMR spectrum of the crude reaction 
product at 7 ppm (Figure 2.13.2.2).
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Figure 2.13.2.2: The decomposition ofsD 03A  (32) to form sD02A (i3B) and
fumaric acid f129j.
As the hydrochloric acid-catalysed hydrolysis formed sD02A (138) from sDOSA- 
(ethyl) (107), an alternative, weaker acid was investigated. Formic acid was chosen 
for its high volatility. It was first dissolved in a small amount of ethanol, to assist the 
solubility of the ester in the acid solution. Because of the low boiling point of the 
formic acid, the reaction was performed in a sealed tube, heated to 90 °C for 24 
hours. The water and the formic acid were removed by lyophilisation, freezing the 
sample in liquid nitrogen and placing under vacuum. To remove all traces of formic 
acid from the sample the lyophilisation was repeated by dissolving the sample in 
ultra-pure water and repeating the lyophilisation step three times. The resulting solid 
was then dissolved in D2O. The NMR spectra showed that the deprotection of the 
ester was incomplete, and increasing the time for the hydrolysis did not lead to 
further hydrolysis.
The hydrolysis of butene-sDOSA-(ethyl) (101) was attempted using formic acid in 
parallel with the hydrolysis of sD03A-(ethyl) (107). The butene-sD03A-(ethyl) (101) 
was dissolved in 1.4M formic acid solution, and heated for a period of 48 hours at 60 
°C. However, the NMR spectra showed that no hydrolysis had occurred, so the
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reaction was heated to 70 °C for a further 24 hours. The NMR spectra showed 
that two of the ester groups had been hydrolysed to form the corresponding 
carboxylic acids (139) and (140). This was confirmed by the reduction in the 
integration of the CH3 signal in the NMR corresponding to the ester group. The 
loss of the ester group was also seen in the NMR, by the appearance of a third 
peak corresponding to a carboxylic acid group (Figure 2.13.2.3).
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Figure 2.13.2.3: Probable structures of the products from the hydrolysis of
butene-sD03A-(ethyl) flO lj
Stronger conditions were tested, in which butene-sD03A-(ethyl) (101) was dissolved 
in 2.2M formic acid and heated to 80 °C for 48 hours. The mass spectrum of the 
resulting product showed a mixture of products. These were identified as sD02A- 
(ethyl) (109), butene-sD02A-(ethyl) (123) and butene-sD03A (105), with the butene- 
sD02A-(ethyl) (123) being the major compound. The reaction showed two types of 
decomposition; the first was the loss of a succinate arm to give butene-sD02A- 
(ethyl) (123), in the same manner as the HCI hydrolysis of sD03A-(ethyl) (107). The
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second form of decomposition was the loss of the butene arm to produce sD03A- 
(ethyl) (107), which then decomposed to give sD02A-(ethyl) (109).
Since this decomposition occurred in the hydrolysis of both sD03A-(ethyl) (107) and 
butene-sD03A-(ethyl) (101) to produce the corresponding sD02A compounds, and 
also because decomposition via the loss of the alkene was seen in the formic acid 
hydrolysis reaction of desBD03A, an alternative route for the hydrolysis of sD03A- 
(ethyl) (107) and butene-sD03A-(ethyl) (101) was sought.
2.13.3: Base-catalysed hydrolysis of sD03A-(ethyl) (107) to form sD03A (32)
The next method of hydrolysis was a base-catalysed reaction. The main problems 
with the use of a base such as potassium hydroxide, sodium hydroxide or lithium 
hydroxide involve the removal of the excess base and the removal of the inorganic 
salts formed in the reaction, owing to the high polarity of the target molecule and its 
high solubility in water. There are several methods for removing the salts and the 
excess hydroxide, which will be discussed later.
The first attempt at the alkaline hydrolysis employed 1M sodium hydroxide. One 
problem that arose in the monitoring of the reaction via LCMS was that ion 
suppression occurred in the LCMS due to the presence of the metal ions, since they 
are charged and present in high numbers. These metal ions swamp the detector, 
reducing its ability to detect high molecular masses. When this ion-suppression 
effect was combined with the multiply charged states of the compounds, it makes 
analysis of the reaction mixture virtually impossible using this technique. One 
solution was to perform the trial reactions in D2O in the same manner as the DCI
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reaction. This allowed a small sample of the reaction mixture to be removed and 
analysed using NMR. The reaction was performed in a sealed, screw-topped 
tube, to limit deuterium exchange with water in the atmosphere. The analysis 
showed that no reaction took place over a period of 1.5 hours at room temperature. 
This was shown as before, based on the integration of the protons attached to 
carbon [1] relative to those attached to carbon atoms [8 ] and [5]. The temperature of 
the reaction was increased to 80 °C and maintained for 24 hours. After this the 
reaction was cooled and a sample was removed and analysed via NMR 
spectroscopy, which showed the loss of the protons due to the cleavage of the ethyl 
ester groups.
2.14.1: Purification of sD03A (32) by ion-exchange chromatography
Cyclen-based compounds will form stable complexes with sodium and will 
temporarily complex both lithium and potassium. These metal ions need to be 
removed owing to the competitive binding with the gadolinium at the complexation 
stage. The sDOSA (32) has the ability to be separated on both cation and anion 
resins, depending on the pH, because the compound has a secondary amine, which 
when protonated (141) will interact with the cation-exchange resin, while the 
carboxylic acid groups (142) can interact with the anion-exchange resin (Figure 
2.14.1.1).
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Figure 2.14.1.1: The charged ion sites for ion exchange
2.14.2: Cation-exchange chromatography of sD03A (32)
Cationic ion-exchange chromatography was performed using Dowex SOW x 8, a 
strong sulfonic acid-based exchange resin. The resin was used in the H'^  form. The 
sDOSA (32) and sodium hydroxide solution were passed slowly though the ion- 
exchange column. The pH was monitored after every 5 ml of eluent, showing a 
decrease in the pH of the eluent from pH 6 to pH 3. This confirmed the absorption of 
the sodium cation and the sDOSA (32). The pH decrease was due to the release of 
H"^  ions from the ion-exchange resin.
After the pH of the eluent stabilised, showing complete absorption of the ions, the 
column was eluted with a solution of ammonia (2%) at a rate of 4 ml per minute. 
Ammonia solution was used since the resin has a higher affinity for Na  ^ than for 
N H /, thus allowing the elution of the hex-acid as the ammonium salts while the Na^ 
ions remain on the r e s i n . T h e  pH then rose over time, showing a step increase, 
and then stabilising at pH 11. At this point the sDOSA (32) was eluted off the ion-
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exchange chromatography column. The negative ion LCMS showed the presence of 
the sD03A (32) as the diammonium salt. The positive spectra showed no trace of 
sodium ions. The water and ammonia were removed using lyophilisation. and ^^0 
NMR data showed that the sample contained both sD03A (32) and sD02A (138).
2.14.3: Anion-exchange chromatography of sD03A (32)
Since sD02A (138) was formed from sD03A (32) while undergoing ion-exchange 
chromatography, owing to the highly acidic conditions on the surface of the resins, 
an alternative to the cation-exchange resin was employed: an anion-exchange resin. 
With anion-exchange resins the lower the selectivity of the counter ion, the more 
readily it exchanges with an ion of similar charge.
As anion-exchange chromatography relies on the flushing of the metal ion frorh the 
resin bed, it was possible to use Li^  ions. The advantage of LiOH was that it was a 
“milder” base than NaOH and KOH and leads to less decarboxylation. The sD03A- 
(ethyl) (107) was dissolved in a small volume of 1M LiOH, and heated in a sealed 
tube at 90 °C for 38 hours. The LCMS showed complete removal of the ester arms, 
with no production of sD02A (138). The resin used was analytical grade Bio-Rad 
AG1 A4I, which was a quaternary ammonium-based resin. The resin was prepared 
in the OH" form, as the sD03A (32) would bind to the resin and the LT ion would be 
carried through with the eluent. The reaction solution of sD03A (32) and LiOH was 
added to the resin column and eluted with water until the pH was stabilised, showing 
the complete elution of the LiOH. The column was then eluted with a gradient of 
formic acid (1M) in water (3.3% increase in 1M formic acid per minute verse water).
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and the pH was monitored every 5 ml. The product was eluted at pH 2.75 and 
monitored by LCMS. The fractions containing the product were then lyophilised, 
retaken up into water and lyophilised again. This process was repeated three times 
to remove any trace of the formic acid. The LCMS confirmed the presence of the 
sD03A (32) ion, and the H^ and ^^ C NMR spectra showed that the ester had been 
hydrolysed to the acid, by the loss of the protons of the ethyl ester at 1.18 ppm, and 
the change in ppm of the proton at [1] from 4.1 ppm to 3.83 ppm on the ^H NMR 
spectrum. The ^^ C NMR showed the change in ppm of the carbonyls from 170.93 
and 171.46 to 174.9 and 177.3 ppm. The HRMS showed the target ion at 521.2088 
[M(32)+"], with the predicted ion at 521.2089 [M(32)+"j.
2.14.4: Conclusion
The acid-catalysed hydrolysis was unsuccessful owing to the decomposition of the 
alkene and of the succinate groups. The base-catalysed hydrolysis of sD03A-(ethyl) 
(107) was successful and did not induce the decomposition that occurred with the 
acid-catalysed process. The cationic ion exchange proved problematic, with 
decomposition occurring during the eluting phase of the chromatography. This was 
circumvented by changing the solid-phase ion-exchange resin type to an anionic 
form; thus allowing the elution of the desired product with decomposition. The formic 
acid used in the elution meant that the butene-sD03A (105) could not be purified 
without decomposition of the alkene occurring.
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Chapter 3.0: Silicon-cyclen chemistry
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3.1: Catalysts used in hydrosilylation reactions.
The next stage in the synthesis was the attachment of the substituted cyclen to the 
silicon cage via the alkene arm. This reaction between the alkene and the Si-H was 
performed using a platinum catalyst. There are two main types of catalyst for the 
formation of S i-0  bonds via hydrosilylation, both based on Pt species. The first 
investigated was Speier’s catalyst, a solution of chloroplatinic acid (H2 PtCl6) (143) in 
propan-2-ol (144), which was used with reactions involving TqHq (33) cages; while 
the second catalyst, known as Karstedt’s catalyst (145), was commonly used in 
reactions involving QglVIs" (38), although Speier’s may also be used with the 
Q8Ms”.[58, 111, 112]
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Figure 3.1.1: Active site in Karstedfs catalyst
There are two possible products from the reaction between the alkene and the 
silsesquioxane, depending on whether the hydrosilylation proceeds via a- or p- 
addition. In general most reactions go via a-addition with a trace of p-addition; the 
degree of p-addition depends upon the functionality of the alkene. In the case of 
butene-sBDOSA-(ethyl) the effect should be minimised, as the bulk steric effect of 
the cyclen system should hinder the formation of P-addition products [1].
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The active Speier’s catalyst (143) was formed by the reduction of Pt '^  ^ by the 
propan-2-ol (144) to give Pt^ "^  as PtCU^" (146) and propan-2-one (147). The PtCl/" 
(146) then binds with the alkene (148), displacing one of the chlorides and forming 
the complex (149). This complex then undergoes an oxidative addition with a silane 
(150) to form a Pt^ ’''^  complex (151). This forms an intermediate complex (152), where 
the alkene was reduced. The complex then reacts with another alkene (148) 
molecule to give the Pt^ "^  complex (149), whilst producing the target molecule (153) ( 
Figure 3.1.2).
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Figure 3.1.2: Catalytic reaction mechanism for Speier’s catalyst
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3.2: Reaction of pentene-sD03A-(ethyl) with TgHg
3.2.1: Formation of TgHs
The first cage investigated was the silsesquioxane [HSiOsds (33), referred to as 
TsHs. TgHg (33) was synthesised by the bi-phasic hydrolysis of trichlorosilane (154), 
yielding a white crystalline solid with a yield of up to 12%. The compound was 
confirmed by the ®^Si NMR peak at -84.44 ppm. The Si-H stretch in the FTIR was at 
2169 cm"\ These characteristic peaks are useful as a method of monitoring the 
reaction, as alternative methods, such as LCMS, are not suitable for these 
compounds owing to their poor ionisation ability. The size of the molecule will be 
close to the detection limits of the available equipment (Figure 3.2.1.1).
HSi 0 — SiH
ÇI 9  H / °  OI--------------------------------- HSi----0 - j—SI I
C! SiH I HSi—1-0— SiH
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154 33
Figure 3.2.1.1: Formation o f TbHq (ZZ) from trichlorosilane
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3.2.2: Model reaction of N,N-diethylbut-3-en-1-amine and TgHg
The first reactions to be performed on the TgHg (33) were reactions with the model 
ligand N,N-diethylbut-3-en-1-amine (156). This allowed the testing of the catalyst and 
the methodology. The model ligand N,N-diethylbut-3-en-1-amine (156) was 
synthesised from 4-bromobut-1-ene (78) and diethylamine (155) in anhydrous 
acetonitrile at 60 °C for 48 hours. The product was confirmed by and NMR, 
which showed the loss of the proton signal for the CH2-B r group at 3.34 ppm. The 
FTIR and LCMS also confirmed the target product (Figure 3.2.2.1).
NH + \
155 78 156
Figure 3.2.2.1: Synthesis o f N,N-diethylbut-3~en~1-amine (156)
N,N-diethylbut-3-en-1-amine (156) was then reacted with both TgHg (33) and QgMs  ^
(38) in anhydrous toluene, using Speier’s catalyst. Owing to the sensitivity of the 
reaction to water, the reactions were performed in a sealed, screw-top tube flushed 
with argon. The reactions were worked up by centrifugation to remove any solids 
formed in the reaction. The solvent was then removed and the crude product taken 
up in CDCI3 , leaving an insoluble residue (Figure 3.2.2.2).
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Figure 3.2.2.2: Hydrosilylation reaction o f N,N-diethylbut~3~en-1-amine C156j 
with TbHb (ZZ) and OgMg  ^f38j via Speier’s catalyst.
The NMR of the reaction mixture from TgHg (33) showed that the signal had 
shifted downfield from -84.44 ppm to -66.0 ppm, in accordance with other alkyl TgS 
with a extracted yield of 8mg, 85%. The and NMR showed that the alkene
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had been removed by loss of the NMR signal at 4.98 and 5.73 ppm and signals in 
the NMR at 115.95ppm and 135.42ppm.
The NMR spectra of the reaction mixture from the OsMs" complex (158) are more 
complex than those from the TsHs complex (157), owing to the presence of two 
environments for the silicon (highlighted in red and purple). The ®^Si NMR shows a 
shift upfield from -O.TBppm to - 1 1.31 ppm upon hydrosilylation of the HSi(CH3 )2  with 
the alkene. The chemical shift of the second silicon environment, the quaternary 
silicon (marked in purple), was shifted upfield from -107.79 ppm to -109.58 ppm. 
This shift was thought to be due to the N,N-diethylbut-3-an-1 -amine group causing 
more shielding of the silicon (Figure 3.2.2.3). The reaction yielded 50mg of 
recoverable product.
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Figure 3.2.2.3: The different NMR environments and their NMR signai ppm for 
QsMs^  (^59) and Q8M8~diethylbut~3~an-1-amine f IB O j .
3.2.3: Reaction of butene-sD03A-(ethyl) (101) with TgHs (33)
As had been demonstrated in the model reaction, the prevention of water from 
entering the system was paramount. The reactions were performed in two types of 
reaction vessel. The first was a screw-topped reaction tube that was flushed with
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argon and sealed with polytetrafluoroethylene (PTFE) tape. The second involved the 
use of a Schlenk line. All the glassware used in the hydrosilylation reactions was 
dried in an oven at 90 °C for a minimum of 3 hours, and cooled to room temperature 
in vacuum desiccators.
Butene-sD03A-(ethyl) (101) and TsHg (33) were combined with the Speier’s catalyst 
and the reaction was heated to 80 °C for 24 hours; following that the product was 
dissolved in chloroform, which was then passed though an activated charcoal plug to 
remove the platinum from the reaction. The pooled eluent formed a mixture of 
solution and gel. The gel was extracted from the liquid by centrifugation. The liquid 
layer was decanted and the solvent was removed using reduced pressure, yielding a 
mixture of oil and solid. The mixture was dissolved in CDCI3 and centrifuged to 
remove the insoluble gel. The sample was then analysed (Figure 3.2.3.1).
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Figure 3.2.3.1: Reaction of butene-sD03A-(ethyi) (101) with TgHg (33)
The NMR of the original liquid layer showed that the alkene of the butene-sDOSA- 
(ethyl) (101) was still present and had not undergone the hydrosilylation reaction. 
The NMR also confirmed the presence of the alkene. The ®^Si NMR showed only 
the glass of the NMR tube. The gels from the first separation and the CDCI3  
extraction were dried under high vacuum, yielding small, spherical particles. Under 
the microscope (x 1 0 0 ) the particles were seen to be translucent and green in colour, 
with a glassy appearance.
Owing to the formation of the gel during filtration through activated charcoal, the 
reaction was repeated without the platinum-removal step. The reaction was set up as 
before. After being stirred at 80 °C for 24 hours, the reaction formed a gel within the 
reaction tube. The reaction was extracted using chloroform, which formed a 
precipitate. The precipitate was separated from the solution by centrifuge, yielding a 
gel, while the solution was decanted and the solvent removed using reduced 
pressure to yield a viscous oil, which was then taken up into CDCI3 . We attempted to 
dissolve the gel in hexane. The gel did not dissolve in hexane, but it formed a white 
solid, which when subjected to high vacuum to remove any residual solvent 
produced a glassy-looking product. NMR of the CDCb-soluble product showed 
that the sample was butene-sD03A-(ethyl) (101), while % i  NMR gave a signal at 
-21.49 ppm, which was characteristic of a PDMS (Figure 3.2.3.2). This signal was 
characteristic of silicone grease. However, all the glassware had been washed with 
hexane at all stages of the reactions involving the cages and the formation of 
pentene-sD03A-(ethyl) (133), in order to remove any residual grease, and the joints
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within the glassware were sealed with PTFE tape. The ®^Si NMR needed a large 
number of scans to be able to detect the signal with no T or Q silicon’s being visible 
in the ®^Si NMR spectra. This indicates that the silsesquioxane was undergoing 
hydrolysis of the silsesquioxane cage instead of the hydrosilylation reaction. This 
resulted in an insoluble polymer formed from the cage, while the un reacted alkene- 
sD03A-(ethyl) went into solution.
R— Si— O— Si— O —Si— R
Figure 3.2.S.2: The silicon environment corresponding to -21.4 ppm
The formation of the gel in the second reaction suggested the presence of water in 
the starting materials. The butene-sD03A-(ethyl) (101) with the six ester groups and 
the four amines was very hydrophilic and absorbs water readily. Owing to the range 
of chemical functional groups in the butene-sDOSA-(ethyl) (101), the most effective 
method for drying was the use of molecular sieves. Because of the viscous nature of 
butene-sD03A-(ethyl) (101), a solvent would have to be used. Toluene was chosen 
for its high boiling point, its lack of reactivity to hydrosilylation reactions^® and its non­
polar properties, reducing water absorption from exposure to the air. The two pore 
sizes ideal for removal of water are 3 A and 4 A, with 4 A being preferred for non­
polar solvents. The molecular sieve was activated at 300 °C for 12 hours, cooled 
under vacuum and kept under argon. The butene-sD03A-(ethyl) (101) was dissolved 
in toluene, to which the sieve was added and kept under argon for 24 hours, after 
which the solution was decanted onto a fresh sieve and kept for another 24 hours
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under argon and sealed with a suba seal. The solution was then taken directly from 
the flask via syringe and used immediately in the reaction with TsHs (33) to avoid 
moisture absorption. The reaction was heated to 80 °C for 48 hours, after which the 
solvents were removed using reduced pressure to yield the crude product. The crude 
product was shown by TLC (DCM 95%, EtOH 5%) to be a mixture of two products. 
The spot at Rf 0.56 co-spotted with butene-sD03A-(ethyl) (101), while the second 
spot remained on the base line, and was the polymerised gel. The crude product 
was extracted first with CDCI3 , which left a residual gel that was dissolved in 
CeDsCDs to leave only a small amount of insoluble material. The and % i  NMR 
spectra of the chloroform-soluble component, by comparison with the NMR of the 
starting alkene, showed the product to be a mixture of mainly butene-sDOSA-(ethyl) 
(101) and butane-sDOSA-(ethyl) (162) (Figure 3.2.3.3). The CeDsCDs fraction 
showed butene-sD03A-(ethyl) (101) in the NMR spectra. The ®^Si NMR showed 
the silicone grease at -21.40ppm. The spectra also showed two other peaks at - 
111.06 and -116.14 ppm. These two peaks correspond to quaternary silicon atoms. 
With the presence of the alkene on the amine indicate that the presence of this 
silicon compound was minimal.
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Figure 3.2.3.3: Structure of butane-sD03A~(ethyl) (162)
The formation of butane-sD03A-(ethyI) (162) was a result of the alkene reacting with 
the TgHg via hydrosilylation, then decomposing to the alkane. There was a trace 
NMR signal in both the and NMRs at 0.04 ppm, and 0.94 ppm respectively. 
These peaks correspond to Si-CHn bond formation, and are likely to be due to the 
grease.
3.2.4: Reaction of butene-sD03A-(ethyi) (101) with QgiVIg" (38) via 
Speier’s catalyst
Owing to the TgHg (33) readily undergoing hydrolysis, an alternative cage was 
investigated. Octakis(dimethylsilyloxy)silsesquioxane (QgMg") (38) was less likely to 
undergo hydrolysis because of the lower reactivity of the SiH(Me2)(0 R) when 
compared to SiH(0 R)3^^ .
The first QgMg" (38) reaction to form the QgM8-butane-sD03A-(ethyl) (163) was 
performed in toluene in which butene-sD03A-(ethyl) (101) was dissolved, along with 
QsMg" (38) to which Speier’s catalyst had been added. The reaction was heated to 
80 °C for 65 hours, while being monitored by FTIR looking at the Si-H stretch at 
1694 cm"\ The reaction was passed though an activated charcoal plug and the 
solvent was removed using reduced pressure to give a clear gum. The product was 
taken up into C6 D5CD3 , leaving a residual gum-like product that formed a glassy 
product upon vacuum drying (Figure 3.2.4.1).
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Figure 3.2.4.1: Reaction of butene-sD03A~(ethyl) (101j with QsMs  ^(38J
The NMR showed that the cage had decomposed, with the major peak 
appearing at -21.47 ppm, and no sign of the peak for the SiH(CH3 )2  group at -0 .78  
ppm. The ®^Si NMR did show very small trace peaks, which were just above the
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background noise, at -1.10 and -11.23 ppm, corresponding to the formation of an 
Si-C bond. Since it appeared that the hydrolysis of QglVIg" (38) occurred during the 
reaction, an alternative method to the drying of butene-sD03A-(ethyl) (101) over 
molecular sieve was investigated: namely, a Dean-Stark-based azeotropic 
distillation. The butene-sD03A-(ethyl) (101) (400 mg) was dissolved into 38 ml of 
toluene, and the drying process was run for 4 hours, with 12 ml of solvent being 
removed. From this stock solution a 5 ml aliquot was taken and used in the 
experiment as before, with the Speier’s catalyst and OsMg" (38). The reaction 
produced a yellow gel, which on analysis by ^H, and ®^Si NMR showed the same 
decomposition products as before in the TgHs with the and NMR spectra 
showed the reaction product to be a mixture of butane-sD03A-(ethyl) (162) and 
butene-sD03A-(ethyl) (101), and the FTIR showed the loss of the Si-H stretch at 
2144 cm'  ^ .
3.2.5: Reactions of pentene-sD03A-(ethyl) (194) with QglVIg" (38) via Karstedt’s 
catalyst
Since it seemed the decomposition of the OgMg" (38) cages occurred with the 
Speier’s catalyst, the alternative Pt-based Karstedt’s catalyst (145) was investigated. 
The benefit of Karstedt’s catalyst was that it was dissolved in toluene, which, unlike 
the 2-propanol used as a solvent in the Speier’s catalyst, should not rapidly absorb 
water and thus catalyse the decomposition of the cages.
An alternative to butene-sD03A-(ethyl) (101), pentene-sD03A-(ethyl) (133), was 
employed. The pentene-sD03A-(ethyl) (133) was dissolved in toluene and dried over 
4 A molecular sieve for 48 hours, as before. The reaction was catalysed using 
Karstedt’s catalyst and heated to 80 °C for 18 hours. After the solvent had been
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removed the residual platinum was removed by take-up of the crude product in 
dichloromethane. This was followed by refluxing the solution with activated charcoal, 
which was then removed using gravity filtration. The and NMR suggested a 
mixture of products, including pentane-sD03A-(ethyl) (133), was confirmed by the 
absence of the alkene signals. The ®^Si NMR had a major peak at -21.49 ppm, but 
no peak corresponding to HSi(CH3)2 . The signal arising from the Q S i-O -Si group 
had also disappeared, suggesting that QgMs" (38) had undergone the same form of 
hydrolysis as the TqHq (33).
The only other possible source of water was the catalysts. To see if that was causing 
the hydrolysis of the cage, the following test reaction was performed. The TsHs (33) 
and Speier’s catalyst were combined in anhydrous toluene, and heated to 80 °C for 
48 hours. The solvents were removed to yield a white solid, which was shown by 
and ®^Si NMR and FTIR to be the un reacted TsHs (33) cage.
This showed that the hydrolysis must arise from water in the butene/pentene- 
sD03A-(ethyl) (101)/(133). There must be bound water within the sD03A-(ethyl) 
structure or the amines of the cyclen, which was responsible for the hydrolysis seen 
in the cage reactions. This form of decomposition has been observed with primary, 
secondary and simple tertiary amines, where the decomposition was relatively rapid 
in wet solvents but much slower in anhydrous systems.^ '^^ "^  As the decomposition of 
both cages still occurred even after the appropriate alkene-sD03A-(ethyl) had been 
dried, this suggests that the decomposition was catalysed by the amine groups of 
the cyclen. The earlier reaction with N,N-diethylbut-3-en-1-amine showed no 
decomposition of the TsHg (33) and OsMs" (38) cages. This suggests that the tertiary 
amines of the alkene-sD03A-(ethyl) have no role in the decomposition. The only
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possibility left was that the alkene-sD03A-(ethyl) undergoes an elimination reaction 
with the platinum catalyst, forming a secondary amine by the loss of one of the 
succinate groups, and it was this amine group that catalyses the hydrolysis reaction.
3.3: Investigation into the stability of pentene-sD03A-(ethyl) (133) in the 
presence of a platinum catalyst
The platinum catalyst itself could have been causing the decomposition of the 
alkene-sD03A-(ethyl), producing a fumarate or maleate and, importantly, a 
secondary amine, which would catalyse the hydrolysis of the cage in the presence of 
water. The stability of the pentene-sD03A-(ethyl) (133) in the presence of the 
platinum catalyst was investigated by dissolving pentene-sD03A-(ethyl) (133) in 
CDCI3 to which the catalyst had been added, and warming to 80 °C for 48 hours. 
Both Speier’s and Karstedt’s catalysts were used.
The analysis of the reaction of pentene-sD03A-(ethyl) (133) with the Speier’s 
catalyst by and NMR showed that a mixture of pentene-sD03A-(ethyl) (133), 
propan-2-ol (144) and a trace amount of (Z)-3-(ethoxycarbonyl)acrylic acid (127) had 
been formed. The strongest evidence was obtained from the NMR. The carbonyl 
of the ethyl ester of the (E/Z)-3-(ethoxycarbonyl)acrylic acid (125/127) occurs at a 
characteristic position of around 164 ppm. In the reaction mixture the signal was 
between 175 and 178 ppm, suggesting the loss of an ethyl group from the pentene- 
sD03A-(ethyl) (133).
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The reaction of pentene-sD03A-(ethyl) (133) with Karstedt’s catalyst showed the 
formation of (Z)-3-(ethoxycarbonyi)acrylic acid (127), using both and NMR 
spectroscopy. The formation of the acrylic acid arises from the decomposition of the 
pentene-sD03A-(ethyl) (133), forming pentene-sD02A-(ethyl) (164) (Figure 3.3.1).
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Figure 3.3.1: Decomposition o f pentene-sD03A-(ethyl) (13Z) to pentene-
sD02A-(ethyl) (164).
This suggests that in the hydrosilylation reaction a secondary amine was formed, 
which catalyses the hydrolysis of the siloxane cage with extraneous water. It has 
been reported that both maleate and fumarate inhibit Karstedt’s catalyst by binding 
to the platinum, thus preventing h y d r o s i l y l a t i o n . T h u s  the corresponding acids
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are formed in the decomposition reaction, leading to the inhibition of the catalyst by 
the alkene bonds next to carboxyl functional groups (Figure 3.3.2).
o
165
Figure 3.3.2: Complex (^65) formed during the inhibition o f Karstedt’s catalyst
by fumarate^^^
3.4: Alternative route to the formation of Q8(pentene-sD03A-(ethyl))8
Clearly the direct hydrosilylation between the silsesquioxane cages and pentene- 
sD03A-(ethyl) (133) failed because of the decomposition of pentene-sD03A-(ethyl) 
(133) by the platinum catalyst. The most logical approach to preventing the 
decomposition was to remove the step where both the cyclen and platinum are 
present together. This was achieved by the hydrosilylation reaction being performed 
before the introduction of the sD03A-(ethyl) (107) group.
The hydrosilylation reaction of QsMs  ^ (38) with 5-bromopent-1-ene (134) was 
performed to give Qe-(1-bromopentane)8 (166), which could then be reacted with 
sD03A-(ethyl) (107) to give the target ligand. The first step was performed in toluene 
to which QsMs  ^ (38) and 20 eq of 5-bromopent-1-ene (134) were added. Speier’s
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catalyst was used for this reaction (Figure 3.4.1). The reaction yielded the product 
with a yield of 84%, as shown by ^H, and ®^Si NMR spectroscopy. The ®^Si NMR 
gave two peaks at -11.32 ppm and -109.5 ppm, which was a result similar to the 
reaction product from N,N-diethylbut-3-en-1-amine (156) and QsMs" (38).
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Figure 3.4.1: Formation o f Q8M8(1-bromobutane)s (166)
The second step was performed in acetonitrile along with potassium carbonate, in 
the same manner as the synthesis of butene-sD03A-(ethyl) (101) (Figure 3.4.2). The 
solids were removed from the reaction and the solvent by filtration to give a yellow 
solid after evaporation of the solvent. The product was extracted from the solid by 
DCM to give an oily product. The NMR showed the loss of the CH2-B r group, 
indicating that the intended reaction had taken place. The ®^Si NMR, however, 
showed that a side reaction had occurred and the product had been decomposed, 
as before, giving a signal at -21.40 ppm. There was also a trace peak of an
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unknown compound at -97.21 ppm. This decomposition was most likely due to the 
secondary amine catalysing the hydrolysis of the silicon cage, as before.
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Figure 3.4.2: Formation of Q8(pentane~sD03A~(ethyl))8 (187)
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3.5: Mechanism for the decomposition of silsesquioxane cages
The main cause of the decomposition and polymerisation of the silsesquioxane 
cages was side reactions that occur when pentene-sDOSA-(ethyl) (133) reacts with 
the cages. It was noted earlier that NMR suggested the alkene had been removed by 
the hydrosilylation reaction (red arrow) with the silsesquioxane cage, showing that 
the intended reaction had worked. The problems occurred when the pentene- 
sDOSA-(ethyl) (133) reacted with the platinum catalyst and formed pentene-sD02A- 
(ethyl) (164) and an acrylic acid (Figure 3.5.1.).
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Figure 3.5.1: The different reactions o f pentene-sDOSA-(ethyi)
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The pentene-sD02A-(ethyl) (164) can decompose both TsHs (33) and QsMs  ^ (38) in 
the same fashion. There are three ways in which the Q8M8^(33) can decompose. 
The first was the removal of the SiH(CH3 )2  group by the pentene-sD02A-(ethyl), 
producing an Si-OH group on the cage, which then undergoes a siloxane bond- 
forming reaction with another 08^8^ to form an Si-0-Si(CH3)2- bond. The pentene- 
sDOSA-(ethyl) (164) was re-formed by the reaction of the intermediate (169) with 
water, generating the silanol (171). The silanol produced would then react with the 
08^8" forming (173) (Figures 3.5.2 and 3.5.3).
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Figure 3.5.2: Decomposition ofQSMS^ (35) by pentene‘SD02A~(ethyi) (164).
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Figure 3.5.3: Reaction o f QsMa  ^(38) with compound (170)
The alternative reaction for the Si-OH group, for example compound (170), was to 
react with another unit of pentene-sD02A-(ethyl) (164), producing a larger
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compound which in turn reacts with OslVIs" (38), (174) leading to the incompletely 
condensed silsesquioxane (175)^^’^^  (Figure 3.5.4). This would then decompose into 
penetene-sD02A-(ethyl) (164) and the linked cages (176). This would lead to an 
increases in the presence of -21 ppm in the ®^Si NMR and importantly it would 
continue to polymerise to form the insoluble gels seen in the reactions.
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Figure 3.5.4: Linking o f an incompieteiy condensed siisesquioxane (175) with
Q8M8^ (38)
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The TsHs (33) cage may undergo similar decomposition reactions to QglVIs" (38). The 
first reaction was the opening of the cage by reaction with pentene-sD02A-(ethyl) 
(164), forming an intermediate compound (176), which then reacts with another TsHs 
(33) or an incompletely condensed silsesquioxane (177) to give the polymerised 
product (178) (Figure 3.5.5).
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Figure 3.5.5: Decomposition ofT8H8 (33) via pentene-sD02A‘ (ethyi) f164)
These reactions can continue occurring with catalytic amounts of pentene-sD02A- 
(ethyl) (164) in the presence of water, until the relative silsesquioxane cage has been 
fully polymerised. The sDOSA-(ethyl) (107) and pentene-sDOSA-(ethyl) (133) are 
too hygroscopic for the hydrosilylation reactions. Several methods were utilised in 
the drying of the reactions and of the starting materials. The drying of the catalyst did 
not make any difference, in that the reactions still produced the gel. This points to the
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cyclen as the source of the water, such that the hygroscopic properties of the cyclen 
were greater than those of the physical drying methods used. It was the presence of 
this water that, along with the decomposed sD03A-(ethyl) (107), created the 
conditions for the decomposition. The hydrolysis of the cages competes with the 
hydrosilylation reaction, and the resulting mixture of hydrolysed and hydrosilylated 
cages forms the insoluble gel seen in the reaction. It was this insolubility that led to 
its absences in the ®^Si NMR leaving only the signal at -21 ppm, which arose from a 
trace of the silicon grease used within the laboratory as a general lubricant and 
sealant of gas-tight joints. It might also have been present in the NMR probe.
This was evident in the TsHs hydrosilylation reactions from the presence of 
(RO)2Si(CH3)2 , which gave the signal at ®^Si NMR -21 ppm that should not have 
been formed from the TsHs. The QsMs  ^ (38) was different, in that it was possible to 
form the H0Si(CH3)20H by decomposition of the outer silicon groups (Figure 3.5.6).
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Figure 3.5.6: Formation o f -(0-Si(CH3)2-0)n- fISOJ by the hydroiysis o f QsMsH
170
The water that leads to the hydrolysis of the silicon cages was prevented from being 
removed by hydrogen bonding to the sD03A-(ethyl) (107) via the carbonyl functional 
groups, and also the amines. As the sD03A (32) forms a cage-like structure, it 
effectively traps the water, preventing the drying agents from capturing it. This film of 
water surrounding the sD03A-(ethyl) (107) leads to the hydrolysis of the Si-N bonds, 
which are highly labile in the presence of water, and thus regenerates the secondary 
amine, allowing the cyclen to catalyse the decomposition of the cages. The route 
with the Tg and Qg cages had to be abandoned because of this hydrolysis, as it was 
not possible to fully dry the sD03A-(ethyl) (107) or pentene-sD03A-(ethyl) (133) and 
thus prevent the hydrolysis of the TgHg (33) and OgMg" (38) from occurring.
3.6: Reaction of butene-sD03A>(ethyl) (133) with simpie siioxanes and 
siianes
Since the hydrolysis of the cages occurred in the reactions of both pentene-sD03A- 
(ethyl) (133) and butene-sD03A-(ethyl) (101), alternative silicon compounds were 
investigated. Three different substrates were chosen: 1,1,3,3,5,5-hexamethyl- 
trisiloxane (182) was used as a model for the siloxane QgMg" cages; triethoxysilane 
(181) was chosen as a model for Tg and to see whether the decomposition affected 
only the S i-O -Si bonds. The final compound looked at was triethylsilane (183), 
which contains no S i-0  bonds and so should not be susceptible to aqueous 
decomposition (Figure 3.6.1).
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Figure 3.6.1: Structure o f triethoxysiiane f181j, 1,1,3,3^5,5-hexamethyF 
trisiloxane (162) and triethyisiiane (163)
The first simple siloxane investigated was triethoxysilane (181), which was reacted 
with butene-sDOSA-(ethyl) (101) in toluene using Speier’s catalyst. The reaction was 
run in the same manner as for the TgHg (33) and QgMg" (38) cages. The reaction 
produced a large amount of insoluble material, which was removed from the reaction 
sample. The product was extracted from the solvent by reduced pressure and 
dissolved in CDCIg. The FTIR of the product showed that the Si-H stretch had 
disappeared, indicating that the hydrosilylation reaction had occurred. The ^H and 
NMR spectra showed a mixture of butane-sD03A-(ethyl) (162) and butene- 
sD03A-(ethyl) (101). The ®^Si NMR gave only a small signal at -21.38 ppm, showing 
that all the triethoxysilane (181) was bound up in the gel formation, as the ®^Si NMR 
signal corresponded to the silicon grease found in the earlier reactions. The majority 
of the starting material had decomposed during the reaction, forming the insoluble 
residue in the same manner as in the cage experiments.
The experiment was repeated using 1,1,3,3,5,5-hexamethyl-trisiloxane (182) under 
the same conditions. As with the other reactions, an insoluble residue was formed. 
The soluble product showed two peaks in the ®^Si NMR spectra: a major peak at 
-21.46 ppm, suggesting decomposition, and a second peak at -7 .79 ppm. The ®^Si
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NMR of 1,1,3,3,5,5-hexamethyl-trisiloxane (182) had peaks at -6.20 and -17.30  
ppm. The -7.79 ppm peak in the reaction mixture shows that the hydrosilylation 
reaction had occurred to some extent, although at a lower rate than the 
decomposition reaction. The decomposition product would be a linear polymer. The 
1,1,3,3,5,5-hexamethyl-trisiloxane would first be hydrolysed to the silanol (184), 
which then reacts with another 1,1,3,3,5,5-hexamethyl-trisiloxane (182) to give 
1,1,3,3,5,5,7,7,9,9,11,11 -dodecamethylhexasiloxane (185), which in turn could then 
react further forming longer chain lengths (Figure 3.6.2).
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Figure 3.6.2: Decomposition o f 1,1,3,3,5,5-hexamethyi-trisiloxane (162) to form 
1,1,3,3,5,5,7,7,9,9,11,11-dodecamethyihexasiloxane (165).
The final test compound was triethylsilane (183), which was unlike the other test 
compounds; it was a silane and does not possess an S i-0  bond that can be 
hydrolysed. The reaction was run under the same conditions as before, and yielded 
a soluble clear gum. The loss of the Si-H stretch at 2101 cm"^  in the FTIR confirmed 
complete hydrosilylation. The ^H and NMR showed the formation of a new Si-C  
bond giving peaks at 1.09 ppm and 5.18 ppm respectively (Figure 3.6.3). With this 
success of the hydrosilylation reaction between triethylsilane and pentene-sD03A 
(133) to give compound (186), the target molecule could be redesigned around a 
silane core instead of a siloxane core.
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Figure 3.6.3: Structure oftriethylsilane-butane-sD03A’(ethyl) (186j
3.7.1 : Use of dimethylsilanen-benzenes as the scaffold for the attachment 
of pentene-sD03A-(ethyi) via hydrosilylation
The new core was based on a silane-substituted benzene. Three different 
substituted benzenes were chosen for the experiments. These were the 
monosubstituted aromatic (pentane-sD03A-(ethyl))dimethyl(phenyl)siiane (187), the 
disubstituted aromatic 1,4-bis((pentane-sD03A(ethyi))dimethylsilyl)benzene (218), 
and the tri-substituted aromatic 1,3,5-tris((pentane-sD03A(ethyl))dimethylsilyl) 
benzene (289) (Figure 3.7.1.1).
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Figure 3.7.1.1: Structure o f the new core sD03A-(ethyl) systems
The new core molecules would allow the formation of a series of three contrast 
agents. The aim was to show the effect on the relaxivity of the addition of extra 
groups, by the increase in mass and any interactions between the sD03A systems, 
such as the cross-binding as described in Section 1.7.1.
There are two methodologies for the formation of the (pentane-sD03A-(ethyl)- 
(dimethylsilyl))benzene (187). Route H  was a one-step reaction involving a direct 
hydrosilylation reaction between dimethylphenylsilane (190) and pentene-sD03A- 
(ethyl) (133), using Speier’s catalyst. While this was the same as the routes used 
earlier, it failed owing to the presence of water that induced the hydrolysis of the
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cage. It was repeated with the aryl silanes to see if it was only the hydrolysis that 
was causing the problems. The second Route, /, was a two-step reaction, in which 
the first step was the hydrosilylation reaction between dimethylphenylsilane (190) 
and 5-bromopent-1-ene (134) to give (5-bromopentyl)(dimethylphenyl)silane (191). 
That was then reacted with DOSA-(ethyl) to give the target molecule, (199) (Figure 
3.7.1.2).
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Figure 3.7.1.2: Two routes for the synthesis of (pentane-sD03A~(ethyl)-
(dimethylsilyl)benzene (iS7)
Both dimethylsilylbenzene (190) and 1,4,bis-(dimethylsilyl)benzene (192) were 
purchased from Aldrich, and the 1,3,5,tris-(dimethylsilyl)benzene (193) was
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synthesised using a Grignard reaction between 1,3,5-tribromobezene (194) and 
dimethylchlorosilane using magnesium, with a yield of around 35%. The compound 
was characterised by NMR which showed the Me protons at 0.24 ppm. The 
protons on the silicon atoms at 4.34ppm and the aromatic protons at 7.63 ppm. The 
structure was also confirmed by the NMR as three proton environments at -3.72, 
136.75 and 140.52 ppm. The ®^Si NMR spectra showed only one peak at -15.99ppm. 
(Figure 3.7.1.3).
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Figure 3.7.1.3: Synthesis o f 1,3,5,trh(dimethylsilyl)benzene (193j
3.7.2: Synthesis of ((pentane-sD03A(ethyl))dimethyisilyl)n- benzene via Route 
H
The first route investigated was Route H, used in the formation of 1,4-bis((pentane- 
sD03A(ethyl))dimethylsilyl)benzene (188) and 1,3,5-tris((pentane-sD03A(ethyl)) 
dimethylsilyl)benzene (189). The first core used was 1,3,5,tri-(dimethylsilyl)benzene 
(193). The pentene-sD03A-(ethyl) (133) was dissolved in toluene, to which Speier’s 
catalyst was added along with 1,3,5-tri-(dimethylsilyl) benzene (193), and the mixture 
was heated to 80 °C for 72 hours. The solvent was removed and the crude product 
was taken up into DCM and refluxed with activated charcoal for 30 minutes to 
remove the platinum (Figure 3.7.2.1). The ^H, and ®^Si NMR spectra of the crude 
product showed that a mixture of products had formed, including some 
polydimethylsiloxane, as shown by a peak at -21.49 ppm in the ®^Si NMR. The
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crude product was split into two fractions. The first fraction was chromatographed on 
silica and eluted with DCM and acetone (92%: 8%), which failed to yield a product; 
the second fraction was vacuum distilled.
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Figure 3.7.2.1: Reaction of pentene-sD03A-(ethyl) (^ZZ) with 1,3,5,tri~
(dimethylsilyi)benzene (19Z)
The distillation of the product was not successful, as the products had such a high 
boiling temperature that they condensed and stayed in the condenser and on the 
thermometer. These were extracted and analysed. The thermometer fraction showed 
a single product with a peak at 5.37 ppm in the ®^Si NMR. The and NMR 
spectra showed the presence of a trace of alkene and, interestingly, there was no 
characteristic signal of the cyclen. The product from the condenser also showed 
similar NMR spectra, but with a ®^Si NMR signal at 5.71 ppm.
The reaction of pentene-sDOSA-(ethyl) (133) with 1,4-bis(dimethylsilyl)benzene 
(192) was run in parallel with the previous reaction under the same conditions. The 
®^Si NMR showed three signals at 5.22, 5.00, and -0.86 ppm. The NMRs 
showed that there was evidence of beta-addition, although as a minor product, with 
the alpha-addition product being in the majority. The presence of beta-addition was 
seen in the NMR at 21.28ppm as a CH3 group which was not present in the 
alpha addition pathway. The TLC of the crude product showed that it was a mixture 
of three different products. As a result of the unsuccessful separation of the tris- 
siloxane reaction mixture, further purification of the bis compound was not attempted 
(Figure S.7.2.2).
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Figure 3.7.2.2: Reaction o f pentene-sD03A-(ethyl) (A3Z) with 1,4- 
bis(dimethylsilyl)benzene (192J
With several different signals being seen in the ®^Si NMR spectra, it was proposed 
that a secondary side reaction was occurring that was different from the hydrolysis 
seen with the silsesquioxane cages.
The formation of an alkene by the reaction of the platinum catalyst with pentene- 
sD03A-(ethyl) (133) was noted earlier. This alkene could react with the silane 
forming the new compound. Such a compound was noticed in the reaction product
180
extracted from the distillation of the product of the reaction between pentene-sDOSA- 
(ethyl) (133) and 1,3,5,tri-(dimethylsilyl)benzene (193). To see whether or not these 
reactions were occurring, a model reaction was used.
3.8: Modelling of side reactions between pentene-sD03A-(ethyi) and 
dimethyisiiylbenzene noticed in Route H
1,4-bis(dimethylsilyl)benzene (192) was reacted in toluene with diethyl maleate 
(127) using Speier’s catalyst, under the same conditions as in the previous reactions. 
The reaction gave a gum with a yield of 68%. The ®^Si NMR of the reaction mixture 
showed a mixture of 8 different signals, some of which matched the ®^Si NMR 
signals of the reaction mixture from 1,4-bis(dimethylsilyl)benzene (192) with 
pentene-sD03A-(ethyl) (133) (Figure 3.8.1).The accurate mass spectrum (HRMS) of 
the crude material showed that the target molecule 1,4-bis(diethylsuccinate- 
dimethylsilyl)benzene (197) was present in the reaction as a major constituent.
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Figure 3.8.1: Reaction o f diethyl maleate (128) and 1,4- 
bis(dimethylsilyl)benzene (192) via Speier’s catalyst, producing 
bis(succinate)dimethyl phenylsilane (198)
To discover whether the succinate was reacting with the silane, a second model 
compound, diethyl 2-(diethylamino)succinate (197), was synthesised from 
diethylamine (155) and diethyl fumarate (130) under the same conditions as for the 
formation of sDOSA-(ethyl) (107) (Figure 3.8.2). The compound was purified on silica 
and eluted with DCM: EtOH (96:4), then identified using NMR spectra which 
showed the loss of the alkene of the diethyl fumarate (130) and the presence of the 
Et groups of the diethyl amine (155). The HRMS, gave the calculated ion mass at 
246.1700 [M(197)^"], and found the ion mass at 246.1697 [M(197)^"]. The reaction 
yielded the reaction product at 17.6%.
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Figure 3.8.2: Synthesis o f diethyl 2-(diethyiamino)succinate (^97) from diethyl
fumarate 30) and diethyl amine 55)
Diethyl 2-(diethylamino)succinate (197) was reacted with dimethylphenylsilane (190) 
in toluene using Speier’s catalyst. After the platinum had been removed the reaction 
give a viscous oil, which was taken up into CDCI3 leaving a large proportion of 
product as an insoluble gum. The loss of the Si-H stretch in the FTIR showed that 
the reaction had taken place. The ®^Si NMR showed two signals, with a major peak 
at 5.91 ppm and a minor one at 5.18 ppm.
The ^^ Si NMR signals obtained from the reaction of 1,4,bis-(dimethyl)benzene (192) / 
1,3,5,tris-(dimethylsilyl)benzene (193) with pentene-sD03A-(ethyl) (133) are different 
from the ®^Si NMR signals from the reaction of diethyl fumarate (130) and 
bis(dimethylsilyl)benzene (192), pointing to the occurrence of several different side 
reactions. These are the reaction with the diethyl fumarate formed by the reaction of 
pentene-sD03A-(ethyl) (133), the hydrosilylation reaction with pentene-sD02A- 
(ethyl) (164), and the hydrosilylation reaction with the carbonyls of the succinate 
groups on the pentene-sD03A-(ethyl) (133). It was the reaction with the succinate
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groups on the cyclen that caused the polymerisation of the silicon cages in the 
earlier reactions.
3.9.1 : The synthesis of ((pentane-sD03A(ethyl))dimethylsilyl)n- benzene 
via Route I
Owing to the decomposition seen in Route H, an alternative Route I was 
investigated. This alternative route had the advantage of avoiding the decomposition 
of the pentene-sD03A-(ethyl) (133) by the platinum, by having the hydrosilylation 
reaction between the silane and the alkene occurring before the sD03A-(ethyl) (107) 
group was attached. The first step was the formation of (5- 
bromopentyl)dimethyl(phenyl)silane (191) by the hydrosilylation reaction between 
neat dimethylphenyl silane (190) and an excess of 5-bromopent-1-ene (134), using 
Speier’s catalyst (Figure 3.9.1).
Br.
'Si
Speiers
134 190
'Si'
191
Figure 3.9.1: Synthesis of(5-bromopentyi)dimethyi(phenyi)siiane (191)
The reaction was heated to 60 °C for 34 hours, after which the Speier’s catalyst was 
removed using activated charcoal and DCM, as in the previous reaction. The excess
184
5-bromopent-1-ene (134) was removed by reduced pressure (50 mbar) at 40 °C by 
placing the sample under high vacuum for 48 hours. The product was confirmed by 
^H, and NMR, which showed the loss of the alkene and the formation of the new 
Si-C bond. The loss of the Si-H was seen in the FTIR and in the ®^Si NMR, which 
gave a signal at -2.65 ppm. The formation of both 1,4-bis((5- 
bromopentyl)dimethylsilyl)benzene (198) and 1,3,5-tris((5-bromopentyl)
dimethylsilyl)benzene (199) was achieved using the same reaction conditions, 
involving 1,4,bis-(dimethylsilyl)benzene (192) and 1,3,5,tri-(dimethylsilyl) benzene 
(193), respectively (Figure 3.9.2). These products were also confirmed by ^H, 
and ^^ Si NMR and FTIR -  see Table 3.9.1.
Si
198 Br 199
Br
Figure 3.9.2: Structures of 1,4~bis((5-bromopentyl)dimethylsllyl)benzene f198J 
and 1,3,5-tris((5-bromopentyl)dimethylsilyl)benzene (199j.
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Compound Yield NMR
(5-bromopentyl)dimethyl(phenyl)silane (191) 59.0% -2.65
1,4-bis((5-bromopentyl)dimethylsilyl)benzene (198) 62.3% - 2 .6 6
1,3,5-tris((5-bromopentyl)dimethylsilyl)benzene (199) 54.1% -2.59
Table 3.9.1: Results o f the reactions between 5-bromopent~1~ene (134) and 
dimethylsllyl benzene (190), 1,4,blS”(dlmethylsllyl)benzene (192) or 1,3,5-trh
(dlmethylsllyl)benzene (193)
The second step was the attachment of the sD03A-(ethyl) (107) to (5- 
bromopentyl)dimethyl(phenyl)silane (190), to form (pentane-sD03A-(ethyl)) 
dimethyl(phenyl)silane (187) (Figure 3.9.3). The reaction was performed in 
deuterated acetonitrile with potassium carbonate as the base. The use of the 
deuterated solvent for the reaction allowed the monitoring of the reaction via 
NMR, monitoring the protons adjacent to the bromide. This was needed as the size 
of the molecules made monitoring of the reaction by LCMS less useful, owing to the 
detection limits and the ionisation abilities of the compounds as mentioned earlier.
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Figure 3.9.3: Synthesis of(pentane-sD03A’(ethyl))dimethyl(phenyl)siiane (^S7)
The reaction was heated to 60 °C for 48 hours, by which time the NMR signal for 
CH2-B r had disappeared. After the solids and solvent had been removed from the 
reaction, the crude product was chromatographed on silica and eluted with DCM in a 
gradient from 100% to 95% in relation to EtOH. The pentane-sDOSA- 
(ethyl))dimethyl(phenyl)silane (187) was characterised by ^H, ^^ 0 and ®^Si NMR 
spectra and by FTIR and HRMS.
187
The bis (228) and tris (229) reactions followed a similar protocol, but needed a 
slightly different solvent gradient of 100% to 70% during column chromatography, 
owing to the increased mass of the product increasing the retention times. The 
reactions gave yields of around 40%, and the compounds were characterised by ^H, 
and ®^Si NMR, as well as FTIR and HRMS. The ®^Si NMR showed a slight 
downfield shift for the products of about 0.1 ppm. This may have been due to a 
decrease in the shielding of the Si nuclei, as a result of the molecule becoming more 
linear because of the repulsion of the sDOSA groups (Table 3.9.2; Figure 3.9.4, 
Figure 3.9.5).
Compound Yield ....
NMR
(pentane-sD03A-(ethyl))dimethyI(phenyl)silane (187) 40.5% -2.75
1,4-bis((pentane-sD03A(ethyl))dimethylsilyl)benzene (188) 41.5% -2.85
1,3,5-tris((pentane-sD03A(ethyl))dimethylsilyl)benzene
(189)
43.0% -2.83
Table 3.9.2: Results of the reaction between(5~bromopentyl) 
dlmethyl(phenyl)sllane (190), 1,4~bls((5-bromopentyl)dlmethylsllyl)benzene 
(198) and 1,3,5-trls((5-bromopentyl)dlmethylsllyl)benzene and sD03A-(ethyl)
(199)
188
188
Figure 3.9.4: Structure o f 1,4'‘bis((pentane-sD03A(ethyl))dimethylsilyl)benzene
(188;
Q
o
189
Figure 3.9.5: Structure of 1,3,5-trls((pentane‘
sD03A(ethyl))dlmethylsilyl)benzene (i 99)
3.10: Hydrolysis of the ethyl ester protecting groups on the ((pentane- 
sD03A(ethyi))dimethyisilyi)n-benzene
The final step was the removal of the ester protection groups from the ethyl esters. 
The hydrolysis was achieved by dissolving the ester in 1M LiOH and heating to 100 
°C for 24 hours (Figure 3.10.1). The reaction was worked up by ion-exchange 
chromatography using a Bio-Rad AGI A41 resin in the HO' form, with a bed volume 
of 500 cm .^
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Si-----
HO' HO
LiOH HO
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Figure 3.10.1: Hydrolysis of(pentane‘‘SD03A-(ethyl))dimethyl(phenyl)silane 
(i97) to give (pentane-sD03A)dimethyl(phenyl)silane (200)
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The LiOH reaction solution was injected at the top of the column and was washed 
though with ultra-pure water, after which the product was eluted using formic acid 
(1M). The fractions were collected and worked up using lyophilisation. The products 
were identified using H^ NMR, FTIR and CHN analyses; the results are shown in 
Table 3.10.1. See Figure 3.10.2 for structures of products.
Compound Yield
(pentane-sD03A-)dimethyl(phenyl)silane (200) 32.0%
1,4-bis((pentane-sD03A)dimethylsilyl)benzene (2 0 1 ) 46.0%
1,3,5-tris((pentane-sD03A)dimethylsilyl)benzene (202) 17.6%
Table 3.10.1: Reaction yields o f the hydrolysis o f compounds (187), (188)
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HO.OH
HO'HO' HO
OHHO
OH .OH.OH
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H O ^ ^  HO
Figure 3.10.2: Structures o f 1,4-bis((pentane-sD03A)dimethylsilyl)benzene 
(2 0 y  and 1j3,5‘ tris((pentane-sD03A)dimethylsilyl)benzene (202).
The presence of the Si groups was identified by the presence of the Si-CHa groups 
and the protons on the aromatic ring in the 'H NMR. The yield of 1 ,3 ,5 -tris((pentane- 
sD03A)dimethylsilyl)benzene (2 0 2 ) was low owing to the formation of a gum during 
the hydrolysis step of the reaction. This gum was removed and the sample was 
purified as normal.
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This research has shown that there are several issues that needed to be resolved 
with the formation of cyclen-silicon compounds. The first issue was the 
decomposition of the pentene-sD03A-(ethyl) (133) by the platinum catalyst. This 
produced several difficulties owing to the formation of the secondary amine, which 
would have decomposed the cages. There was also the side reaction of the diethyl 
fumarate undergoing a hydrosilylation reaction with the siloxane/silane. The second 
issue was the reaction of the Si-H with the carbonyls of the succinate groups on the 
cyclen. In the cage-based reactions, the reaction between the Si-H and succinates 
on the cyclen would play a major part in the formation of the gel that caused the 
problems with the silsesquioxane cages. This was due to the sD03A-(ethyl) (107) 
having multiple succinates, allowing a high amount of cross-linking, and it was that, 
together with hydrolysis by the cyclen bound water, that was causing the gel 
formation.
These two issues showed that direct hydrosilylation with the alkene-sD03A-(ethyl) 
was not possible, owing to the reaction with the succinate groups. This was 
circumvented when the 5-bromobutene was reacted with the silane and QglVIg" 
forming the terminal brominated compounds. These terminal bromide compounds 
were then reacted with sD03A-(ethyl) (107). While the benzene-based silanes were 
successful, the QsMs^-based brominated compound failed, and was hydrolysed 
because the secondary amine in the sD03A-(ethyl) and the associated water 
catalysed the decomposition of the OglVIs", forming the gel product. The benzene- 
based silicon-cyclen compounds were then successfully hydrolysed by a functional- 
group interconversion of the ethyl ester to the carboxylic acid. The final stage would
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be the complexation of the silicon-cyclen compounds with gadolinium to investigate 
their efficacy as contrast agents.
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Chapter 4.0: Complexation and luminescence and relaxivity studies 
of lanthanide complexes of (13), (101), (107), (138), (141), (200), (201), 
(202).
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4.1: Complexation of the sD03A-(ethyl)-ligands and the aD03A-ligands 
with Gd *^ and
The complexation of the ligands with the lanthanides may be grouped into two 
sections. The first group was the ligands, sD03A-(ethyl) (107) and butene-sD03A- 
(ethyl) (101). The second group was the ligands, sD03A (32), DOTA (13), (pentane- 
sD03A-)dimethyl(phenyl)silane (200), 4-bis((pentane-sD03A) dimethylsilyl)benzene 
(201) and 1,1,3,5-tris((pentane-sD03A) dimethyl silyl)benzene (202).
The products from both complexation methods were characterised by a combination 
of FTIR, CHN analysis and the measurements of the q number and the relaxivity, 
which showed a marked difference between complexed and non-complexed 
lanthanides.
Ester-protected cyclen derivatives, such as sD03A-(ethyl) (107) and pentene- 
sD03A-(ethyl) (133), were dissolved in ethanol; to the solutions the desired 
lanthanide -  gadolinium or europium -  was added as the chloride salt (GdCb or 
EuCb). The reactions were refluxed under argon for 48 hours. For each lanthanide 
reaction, the cooled reaction solution was then added to diethyl ether, producing a 
precipitate that was collected. The product was then purified by dissolving the solid 
in methanol, and resuspending the precipitate with the addition of the diethyl ether. 
The solids were extracted, and dried under vacuum.
The ligands that possess carboxylic acid groups, such as sD03A (32), (pentane- 
sD03A-)dimethyl(phenyl)silane (200) and DOTA (13) were complexed with the 
lanthanides in water, using the oxides GdaOs and EU2O3 . The pH of the solution was
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adjusted to pH 8  and the samples heated to 80 °C for 48 hours. The solution was 
then filtered through a 5 pm PTFE filter, and the filtrate lyophilized to yield a white 
powder (Table 4.1.1).
Complex Lanthanide Yield
Butene-sD03A-(ethyl)-Gd (203) GdCb 25%
Butene-sD03A-(ethyl)-Eu (204) EuCb 25%
sD03A-(ethyl)-Gd (205) GdCb 46%
sD03A-(ethyl)-Eu (206) EuCb 75%
sD03A-Gd (207) Gd2 0 3 79%
sD03A-Eu (208) EU2O3 82%
sD02A-Gd (209) Gd203 38%
SD02A-EU (210) EU2O3 6 8 %
DOTA-Gd (2 ) Gd2Û3 96%
DOTA-Eu (211) EU2O3 96%
(pentane-sD03A-)dimethyl(phenyl)silane-Gd (212) Gd203 73%
(pentane-sD03A-)dimethyl(phenyl)silane-Eu (213) EU2O3 83%
1,4-bis((pentane-sD03A)dimethylsilyl)benzene-Gd2 (214) Gd2 0 3 83%
1,4-bis((pentane-sD03A)dimethylsilyl)benzene-Eu2 (215) EU2O3 80%
1,3,5-tris((pentane-sD03A)dimethylsilyl)benzene-Gd3 (216) Gd203 79%
1,3,5-tris((pentane-sD03A)dimethylsilyl)benzene-Eu3 (217) EU2O3 81%
Table 4.1.1: Ligands complexed, with the lanthanide used and the yield o f
products
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4.2.1: Luminescent studies of sD03A-(ethyl)-Eu-based complexes, 
sD03A-Eu-based complexes and the organosilicon Eu^  ^complexes
From the luminescence of the complexes described in section 4.1, information about 
the physical properties of the complexes, such as the hydration number and their 
symmetry in solution, could be obtained.
The Gd^  ^ complexes are not suitable for investigation by luminescence 
spectroscopy, although the large band gap between the ground state and the lowest 
excited state of Gd^  ^will produce fluorescent spectra when excited at 274 nm, with 
emission in the UV band at 311 nm^ ®^. The main purpose of the luminescence 
studies was to calculate the water coordination number (q) from the difference in the 
excited state lifetime of the complex in H2O and in D2O. The problem was that Gd^  ^
does not undergo quenching by OH and CD oscillation, so it would not be possible to 
calculate the water coordination number using luminescence. The water coordination 
number may be found by using an alternative lanthanide, Eu^ ,^ in the place of Gd^ .^ 
Eu^ '^  was adjacent to Gd^ "" in the periodic table, and has similar physical 
characteristics to Gd^  ^ -  such as size and charge density. It also forms the same 
coordinating complex as that of Gd^  ^and, importantly, the excited state of Eu^  ^was 
quenched by OH and OD oscillators. The spectral details obtained from the emission 
spectrum of Eu^  ^ provide information about the structural symmetry by examination 
of the peak splitting and intensity ratios in the different AJ bands.
The spectra obtained for Eu^  ^ complexes are intense, sharp and well defined; they 
are due to f- f  transitions between the same 4 f  configurations that are effectively
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shielded from the environment by the 5s^5p® orbitals, owing to the small radial 
extension of the 4f orbital.
When the was excited at 394 nm the electrons are excited from the F^o energy 
level to that of the ®Dj energy level (Figure 4.2.1.1). The emissions from the long- 
lived (®Do / ^Fj) levels are observed in the Eu^ "^  spectra as ^Fi = 590 nm, ^F2 = 615 
nm, and = 698 nm, corresponding to the strong emission AJ bands 1, 2 and 4 
respectively. The actual emission values can shift slightly owing to the nephelauxtic 
effect the ligands have upon the Eu^  ^ion as the effective positive charge on the Eu 
has decreased due to change in the ligands.^^® Bands ^Foand F^s are evident only in 
some compounds, at 570 nm and 650 nm respectively.^^®
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Figure: 4.2.1.1: Energy levels o f Eu^* below 30 000
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4.2.2: Results and analysis of the emission spectra for the Eu *^ 
complexes
The emission spectra for the complexes were taken between 550nm and 750 
nm, with excitation at 395 nm. The spectrum was split into five AJ bands: AJ = 0, 
577-581 nm; AJ = 1, 585-600 nm; AJ = 2, 611-624 nm; AJ = 3, 640-655 nm; and 
AJ = 4, 680-710 nm. These bands have been noted on the spectra in graphs 4.2.2.1 
to 4.2.2.7. The bands of the emission spectrum show details of the symmetry, or 
lack of it, for the complex in which the Eu^ "" was bound. The AJ bands 1, 2 and 3 
show sensitivity towards the degree of symmetries.
The AJ = 0 band was normally weak, because it was “forbidden” by the selection 
rules.^^  ^ The emission intensity seen for this magnetic dipole transition was due to 
band mixing of the electric dipole transitions though interaction with the ligand field or 
the vibrational states. For example DOTA has C4 symmetry and shows an intense 
AJ = 0 transition / band. (Figure 4.2.2.1).
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Graph 4.2.2.1: Emission spectrum of DOTA~Eu (3)
The intensity of the AJ = 0 band was related to the symmetry of the complex and 
increases in complexes with Cn or Cnv symmetry. As the AJ = 0, was non­
degenerate therefore If there are two or more peaks present in the spectrum at AJ = 
0 , then it shows that there was more than one complex site for the Eu^  ^ in the 
solution.
The intensity of the AJ = 1 region varies from one coordination environment to 
another, with the number of peaks within the region relating to the different isomers 
of the complex present in the solution and to the degree of symmetry. For example, 
a complex with C3- or C4-axis symmetry would lead to two peaks in the band, while a 
compound with no symmetry in the axis would produce three peaks. Complexes 
such as DOTA-Eu (3) which C4 symmetry display 3 peaks with the third peak arising
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from the presence of a minor isomer.^This isomer mixture was not observed for 
septadentic complexes as they are a mixture of isomers. These details of the 
spectrum allow analysis of the binding and symmetry of the molecule to be 
determined (Table 4.2.2.1).
AJ À range 
(nm)
Intensity Notes
0 577-581 Variable / weak Intensity increases with symmetry by J-mixing.
1 585-600 Strong Always present splitting, dependent on symmetry. 
Three transmissions for low-symmetry complexes; two 
transmissions for those with C3 or C4 symmetry.
2 611-624 Strong / very 
strong
Hypersensitive; increases when there was a loss of 
symmetry.
3 640-655 Very weak Always weak.
4 680-710 Medium / strong Sensitive to Eu coordination symmetry and donor atom 
type.
Table 4.2.2.1: Characteristic properties o f europium emission spectrum 116
The AJ = 2 band was determined by the complexation site's symmetry, and 
increases in intensity as the symmetry was reduced. The number of peaks found for 
this band was also linked to the symmetry, such that a complex with limited 
symmetry has a greater number of signals than one with a high amount of symmetry.
To confirm the technique and to act as a reference compound the first compound we 
examined was DOTA-Eu. The spectrum obtained (Graph 4.2.2.2) was sharp and 
well defined, and matched the published data.^^® The AJ = 0 band was intense, 
because of the high amount of symmetry in the molecule, and because the ratio 
between different isomers was low. The splitting of the AJ = 1 band was 
characteristic of a compound with C4 symmetry. This symmetry also influences the 
AJ = 2 band, which was reduced in intensity when compared to the AJ = 1 band. The
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AJ = 4 was sensitive to the coordination environment of the Eu^ '" within the complex, 
and was identical to that given by the literature data.^ ^®
The AJ bands 0 and 1 for the emission spectrum for sD03A-Eu (208) (Graph 
4.2.2.2) are low in intensity, which was indicative of a complex with low symmetry. 
This was also seen in the AJ = 2 band, which has a greater intensity due to the 
limited symmetry of the complex. This was expected, as sD03A-Eu has symmetry 
only in the Ci symmetry in the symmetry axis which was expected for a tri­
substituted cyclen.
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Graph 4.2.2 2; Emission spectrum ofsD03A-Eu  (208j
The emission spectrum for sD03.A-(ethyl)-Eu (206) (Graph 4.2.2.3) was somewhat 
similar to that of sD03A-Eu (208) (Graph 4.2.2.2). The main difference was on the 
AJ = 2 band, where the sD03A-(ethyl)-Eu (208) has only one peak, whereas the 
sD03A-Eu (208) has two. This was due to the resolution of the spectrum as the peak 
was stepped, caused by the hypersensitivity of the band to changes in the groups
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binding to the emitting closer together than the sD03A-Eu does. That was due 
to the change in the coordinating ligands -  in the case of sD03A-(ethyl) (206) 
complexing by the carbonyl group of the ester, and complexing by the carboxylic 
acid in the case of sD03A-Eu (208).
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Graph 4.2.2.3: Emission spectrum of sD03A-(ethyl)-Eu (2QS)
The spectra for the organosilicon complexes (pentane-sD03A-)dimethyl 
(phenyl)silane-Eu (213) (Graph 4.2.2.4), 1,4-bis((pentane-sD03A)dimethylsilyl) 
benzene-Eu2 (215) (Graph 4.2.2.S) and 1,3,5-tris((pentane-sD03A)dimethylsilyl) 
benzene-Eus (217) (Graph 4.2.2.6) are all similar in their peak pattern and are a 
close match to the sD03A-Eu spectrum. This too was expected as there was 
unlikely to be coupling between the complexes. It also suggests there is no cross 
binding occurring. The AJ = 2 band shows a strong signal, indicating that the 
molecules have reduced symmetry; that was confirmed by the AJ = 1 band, which 
has three transmissions, indicative of low symmetry.
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Graph 4.2.2A: Emission spectrum of Ph~(Sh(Me)2-pentene-sD03A-Eu) (213)
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Graph 4.2.2.S: Emission spectrum of Ph-(Si-(Me)3-pentene-sD03A-Eu)2 (216)
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Graph 4.2.2.Ô: Emission spectrum of Ph-(Si~(Me)3‘pentene‘SD03A-Eu)3 (217)
4.3.1 : Determination of the water coordination number (q) for the 
complexes
The hydration number for the europium complexes was calculated from the decay- 
rate constant of the excitation state, which was found by measuring the intensity of 
the phosphorescence emission of the complex solution in both H2O and D2O. The 
difference in the quenching between the two solvents was by a factor of 200, which 
was seen in the lifetimes of the luminescence/^^
To measure the luminescence, the solution undergoes excitation by a short pulse of 
light at 395 nm for 40 ms; after a delay ranging from 0.1 ms to 5 ms (increments of 
0.2) the intensity of the phosphorescence was measured through a window of 0.1 
ms. The observed wavelength used for all the complexes was the A =J2 at 615 nm.
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which was an intense peak in the emission spectrum, and was often used for these 
types of complexes.[18, 56, 117, 118, 121]
4.3.2: Calculation of the water hydration number for the Eu^*-complexed 
ligands
The water coordination number (q) was obtained from Equation 4.3.2.1 in
which A was an empirical constant based on the sensitivity of the lanthanide to 
quenching (Eu^  ^ = 1.11 water molecules ms, Tb^ '" = 4.2 water molecules ms), kxn 
was the combined values of the oscillators in the first coordination sphere, which can 
shorten the Eu^  ^excited-state lifetimes by varying degrees.
Q = A{K:p )-Q % o) -^ xh\ Equation 4.3.2.1
These oscillators have exchangeable hydrogens, such as alcohols and amines, in 
which the oxygen or nitrogen was directly coordinated to the metal ion.^ ^^  The 
constant can be calculated using Equation 4.3.2.2.
■ ^ XH P c^M ~^ y^ NH Equation 4.3.2 2
where non was the number of alcoholic 0 -H  oscillators, /7/vh was the number of 
amine N-H oscillators and a?o=ca/h  was the number of amide carboxylic oxygen 
oscillators. The values for these are averages, calculated by Horrocks et al. as (3 = 
0.44 ms“\  V = 0.99 ms"' and 5 = 0.075 ms"\^^^ While p, y, and 5 are related to the 
first coordination sphere, the a value was the quenching of the excited state Eu^  ^by 
the second coordination sphere water molecules. This gives an average value of 
0.31 ms"\
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The equation was then rewritten, taking into account the functional groups on the 
complexes being measured, to give Equation 4.3.23:
,q (^ o ) Equation 4.3 2.3 122
4.3.3: Results and analysis of the water coordination numbers of the Eu 
complexes
3+
The results from Equation 4 .3 .23 and the oscillator values are presented in Table 
4.3.3.1. The methodology for the calculations was validated by the analyses of 
DOTA-Eu (211). The values obtained for DOTA-Eu are consistent with the published 
values, where the average was 1.22 (+ /- 0.5)^®. It should be noted that there was 
some uncertainty with such reported estimates with an experimental error in the rate 
of between +/-10% and +/-20%.®^’ The solutions of the complexes were made at 
1 mg per ml of ultra-pure water.
Complex k n /) ko^o qper
Gd
q AT
Butene-sD03A-(ethyl)-Eu (204) 3.457 1.81 1.49 1.49
sD03A-(ethyl)-Eu (206) 3.423 0.78 1.5 1.5
sD03A-Eu (208) 4.563 1.75 1.68 1.68
sD02A-Eu (210) 6.549 0.564 4.11 4.11
DOTA-Eu (211) 1.93 0.443 1.31 1.31
(pentane-sD03A-)dimethyl(phenyl)silane-Eu (213) 1.758 0.78 0.75 0.75
1,4-bis((pentane-sD03A)dimethylsilyl)benzene-Eu2 (215) 1.95 0.769 0.97 1.94
1,3,5-tris((pentane-sD03A)dimethylsilyl)benzene-Eu3 (217) 1.894 0.772 0.9 2.7
Table 4.3.3.1; Lifetime data for Eu^* complexes to calculate q values
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The q values of the silicon-sD03A-Eu compounds are lower than that of sD03A-Eu 
alone. This was most likely caused by two effects. In compound (213) the benzene 
ring maybe blocking a potential binding site for the water. By the benzene ring 
binding to the Eu^  ^through an electrostatic bond. This would increase the number of 
coordinating ligands and thus reduce the number of sites to which the water can 
bind.
The second was that the q values are sensitive to the distance of the coordinating 
water to the europium. This increasing distance reduces the energy-transfer 
efficiency, which was manifested as a reduction in the q value.^^® The distancing of 
the water molecules could happen as a result of the way in which the succinic acid 
forms a cage around the Eu^ ,^ thus reducing the ability of the water to get close to 
the Eu^ "^ . This effect could also explain why the results for sD03A-Eu (208), butene- 
sD03A-(ethyl) (204) and sD03A-(ethyl) (206) are lower than the expected q = 2 
value predicted.
The predicted q value of sD02A-Eu was q = 3, as the number of ligands binding to 
the Eu^  ^was six, with four from the amines and two from the succinic acid donors. 
The observed value for sD02A-Eu (210) was q = 4.2; the difference between the two 
values for q was greater than the expected error of 20%.
Décomplexation of the unstable hexadentate complex would explain discrepancies 
in the predicted and experimental results. The décomplexation may be seen in the 
lifetimes of sD02A-Eu (210) in water, and hence the q values. The solution was 
measured three times over a total period of 3 hours. The variation in the q value over 
time indicates that the complex was undergoing some
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decomplexation/recomplexation. This instability can be seen in the comparison of q 
values for sD03A-Eu over time, which shows little variation between the q values 
(Table 4.3.3.2). This slight décomplexation has been noted in other hexadentate 
lanthanide ligands/^'^’
SD02A-EU sD03A-Eu
Run number
kn^o kojo
q No
kn^o ko^o
q
No
1 6.43 0.56 3.79 4.56 1.75 1.67
2 6.48 0.56 4.14 4.58 1.76 1.69
3 6.74 0.56 4.32 4.55 1.75 1.67
Table 4.3.3.2: Kh2o and Kd20 values forsD02A-Eu (210) andsD03A-Eu (208)
4.4.1 : Relaxivity measurements of the complexes
The relaxation experiments were performed on a Minispec mq60 pulsed time-domain 
NMR analyzer (Bruker, Massachusetts, USA), with a fixed field of 60 MHz and a 
magnetic strength of 1.4 Tesla such that for the Ti measurements could be 
undertaken near the field of 1.5 T used in clinical MRI systems. The samples were 
prepared in standard NMR tubes containing 1 ml of the sample. The temperature of 
the samples was controlled via an external Circulator HAAKE Phoenix II P1-C35P 
(Thermo electron Corporation) to an accuracy of 0.01 °C.
The samples were measured three times at 25 °C, and were prepared in buffered 
solution of 10 mmol MOPS (3-(N-Morpholino) propanesulfonic acid) and adjusted to 
pH 7.4. The buffer was used to keep the experimental conditions identical and allow
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the comparison to published data. MOPS was chosen because it has a minimum 
interaction with gadolinium, compared to phosphate-based buffers that bind to 
gadolinium.^® The signal intensity was measured over a period of time by the use of 
a set of 20 pulse sequences, which varied by the length of time after the pulse before 
the measurements are taken. The slope of the graph gives the Ti time for a given 
sample. The Ti data used was an average of three stable results. The average Ti 
times gained were then plotted as the 1/Ti time (in ms) versus concentration (in 
mmol). The relaxivity (ripmM"  ^ s“ )^ was obtained by calculation of the linear 
regression trend line (Graph 4.4.1). The equation of the line was then used for the 
calculation of the relaxivity. The of the linear regression trend line was used to 
check the validity of the results. We only used data that gave a linear regression line 
with a (R  ^) that was greater than 0.99.
Plot of 1/T^  against concentration for 
1,4-bis((pentane-sD03A)dimethylsilyl)benzene-Gd2 (214)
0 .010 -
0.008 -
0.006 -
0.004-
0.002 -
0.000 -
1 20 3 b4
mMol
Graph 4.4.1: Example o f the plot o f 1/Ti against concentration for 1,4- 
bis((pentane-sD03A)dimethylsilyl)benzene-Gcl2(214)
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Graph 4.4.1: Example o f the plot o f I/T 1 against concentration for 1,4- 
bis((pentane-sD03A)dimethylsilyl)benzene-Gd2 (214)
4.4.2: Relaxation results for the synthesised Gd®* complexes
GdCIs and DOTA-Gd (3) were used as standards to validate the complexation 
method, analytical technique and calculation methodologies. The results for the 
DOTA-Gd were performed at both 25 °C and 20 °C, giving relaxation times of 4.3 
rip/mM"''s"  ^ and 3.6 rip/mM"”'s"^  respectively, corresponding to known literature 
values.^®’ ^  The relaxivity values of sD03A-Gd (207) and sD03A-(ethyl)-Gd (205) 
were measured, giving 6.4 rip/mM'^s"  ^ and 12.6 rip/mM"^s"  ^ respectively, while the q 
values stayed relatively similar at g = 1.68 and g = 1.50 (corresponding to acceptable 
experimental error). The drop in relaxivity suggests the occurrence of cross-binding 
as was seen in (D. Parker et al)^ ® (section 1.6.6). Although the luminescence studies 
did not suggest this was an issue. This was possibly due to the increased 
concentrations used in the relaxation studies might influence the degree of cross­
binding.
When the relaxivity of sD03A-Gd (207) was compared to the relaxivity of GdaD03A  
(7) (13.8 rip/mM“ s^"^ ) and GdgD03A (8) (6.2 rip/mM"''s"^), there was an important 
suggestion that the cross-binding effect of the succinic acid groups was 
approximately the same as that of glutaric acids. The slight increase in the g number 
and the relaxivity of sD03A-Gd shows that the effect was less pronounced than that 
of the GdgD03A (Table 4.3.2.1).
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Complex riD/ml\/r^s~^
GdCI3 8.6
Butene-sD03A-(ethyl)-Gd (203) 5.7
sD03A-(ethyl)-Gd (205) 12.6
sD03A-Gd (207) 6.4
sD02A-Gd (209) 5.1
DOTA-Gd (3) 4.3
(pentane-sD03A-)dimethyl(phenyl)silane-Gd (212) 4.8
1,4-bis((pentane-sD03A)dimethylsilyl)benzene-Gd2
(214)
4.5
1,3,5-tris((pentane-sD03A)dimethylsilyl)benzene-Gd3
(216)
13.1
Table 4.4.2.1: Results o f relaxation measurements
Complex q
[GdaD03A] (218) 12.3a (13.8)(3 2.2
[GdgD03A] (219) 5.4a (6.2)p 1.2
[GdaDOTA] (7) 7.6a (8.9)p 1.0
[GdgDOTA] (8) 7.3 a(9.0)p 1.1
[Gd-D03A] (220) 6.0a 4.8y 1.8
[Gd-DOTA] (3) 4.2a 3.5y 1.0
Table 4.4.2.3: Table o f comparative complexes 
Note: a  20 MHz, 25 °C; p 65.3 MHz, 25 °C, pH 7.2 y 20 °C, 40MHz
The relaxivity of (pentane-sD03A-)dimethyl(phenyl)silane-Gd (212), with a value of 
4.8 rip/ mM"^s"\ was substantially lower than the one corresponding to sD03A-Gd
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(207). This was due to the low q value of (pentane-sD03A-) dimethyl(phenyl)silane- 
Gd (212) seen while analysing the europium complexes. It can also be noticed in the 
comparison between Ph-(pentane-sD03A-)dimethyl(phenyl)silane-Gd (212) and 
DOTA-Gd (3) (q = 1), which has similar relaxation values, as well as number of 
coordinated waters. While the relaxivity for (pentane-sD03A- 
)dimethyl(phenyl)silane-Gd (212) and 1,4-bis((pentane-sD03A)dimethylsilyl) 
benzene-Gd2 (214) are similar, at 4.8 rip/ mM"^s“^and 4.5 rip/ mlVI'^s"Respectively, 
1,3,5-tris((pentane-sD03A)dimethylsilyl)benzene-Gd3 (216) shows a marked 
difference, with a relaxivity of 13.1 rip/ mM"R“\  This corresponds to cross-binding 
between the cyclen systems in the 1,3,5-tris((pentane-sD03A)dimethylsilyl)benzene- 
Gds (216), which locks the molecule in one position, thus reducing the internal 
oscillation between the cyclen groups and the aromatic ring and effectively changing 
the molecule from a branched oligomer to a barycentre. This means that the 
molecule has only the rotational coefficient to affect the relaxivity, which in turn 
increases the relaxivity from around 4.5 rip/ mM"R"Ro over 13 rip/ mM"^s“  ^ (Figure 
4.4.2.1). While the increase was a result of the cumulative effect of the gadolinium 
atoms, it shows the significant effect that the cross-binding has on stabilising the 
intermolecular movements. The cross-binding effect was not seen in the 
bis((pentane-sD03A)dimethylsilyl)benzene-Gd2 (214) complex, pointing to the 
gadolinium groups being at a comparatively long distance from each other and 
therefore being unable to cross-bind. This was reflected in the lower relaxivity of 4.5
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Figure 4.4.2.1: Possible configuration o f the cross-binding seen within 1,3,5- 
tris((pentane-sD03A)dimethyisiiyi)benzene-Gd3 (216)
4.5: Conclusion
Between sD03A-Eu (208) and sD03A-(ethyl)-Eu (206) there was a marked 
difference in how the cross-binding between the succinic acid groups affects the 
relaxivity. The series of dimethylsilyl-benzenes shows that it was possible to form 
lanthanide complexes from a cyclen ligand attached to a silicon core. It was 
important to note that sD03A (32) pendant groups will cross-bind with each other if 
they are in close proximity. If the attachment of the sD03A (32) to the silsesquioxane
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cages had occurred, then this cross-binding would have been a major part of the 
relaxivity, as the sD03A (32) pendant groups would have easily cross-linked, 
because their proximity to each other would have been close to that of the 1,3,5- 
tris((pentane-sD03A)dimethylsilyl) benzene-Gds complex (216).
The spectral data showed that the complexes were asymmetrical, as indicated by 
the fluorescence spectra of the individual compounds. This was expected, as the 
sD03A-Eu complex has only Ci symmetry (section 4.2.2). From the analysis of the 
luminescence emission spectra, it was possible to say that the complexes possess a 
mixture of different isomers of both [R] and [S]. That was to be expected, since there 
was no selective pressure during the addition of the maleate/fumarate to the cyclen 
to produce a predominant isomer. The q values of the compounds showed that the 
butene-sD03A-(ethyl)-Eu (204), sD03A-(ethyl)-Eu (206) and sD03A-Eu (208) have 
similar values, within experimental error. The organosilicon complexes (pentane- 
sD03A-)dimethyl(phenyl)silane-Eu (213), 1,4-bis((pentane-sD03A)dimethylsilyl)
benzene-Eu2 (215), and 1,3,5-tris((pentane-sD03A)dimethylsilyl)benzene-Eu3 (217) 
had similar q values to one another, with a value of q = 1 ; this was a noticeable 
difference from the non-organosilicon complexes. The critical difference was a result 
of cross-binding between the pendant groups.
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Chapter 5.0: Conclusion
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5.1: The formation of sD03A-(ethyl) (107) and sD 03A  (32)
The formation of sD03A-(ethyl) (107) and sD03A (32) gave several different 
problems, which were mainly due to the reactivity of the cyclen and the need to 
achieve an asymmetrical substituted pattern. There were two different routes to the 
formation of the substituted cyclens, the 1+3 and 3+1 routes. The first approach was 
the formation of pent-4-enoyl-D03A (61) via the 1+3 route, involving the linking arm 
based on pent-4-enoyl chloride (63). The pent-4-enoyl chloride (63) was reacted with 
cyclen, producing an over-alkylated product. The over-reaction was prevented by the 
use of protection groups. Two methods of protecting three of the cyclen's amines 
were tried. The first was di-ferf-butyldicarbonate (71), which gave tri-BOC-cyclen 
(72), and the second used 2,2,2-trichloroethane-1,1-diol (76) to give triformyl cyclen 
(74).
Both of the protection groups proved effective in preventing over-alkylation, but when 
the groups were removed the pent-4-enoyl arm was also removed if in the presence 
of weak base or acid. This ease of elimination of the carboxyl linker arm was a 
critical problem, as it meant it would be easily removed at later stages of the 
synthesis of the cage-cyclen complex, especially during the hydrolysis of the ester- 
protection groups.
This ease of decomposition meant that an alternative linking arm needed to be 
investigated, and so 4-bromo-butene (78) was looked at as a replacement for pent-4- 
enoyl chloride (63). The change in the linking arm presented a possible stability 
problem, because of the reduction of the number of ligands available for binding to 
the lanthanide from 8 to 7, due to the loss of the carbonyl on the but-3-enal. The loss
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of potential stability was compensated for by the use of di-acid arms, such as 
malonic acid (80) to give mD03A (95) and succinic acid (100) to produce sD03A  
(32). The synthesis of mD03A (95) failed, owing to the decarboxylation of 2- 
(bromomethyl)-2-methylmalonic acid (89) during the estérification of the acids. After 
that failure the alternative group sD03A, based on succinic acid (100) groups, was 
investigated. Again the 1+3 route was examined first, and the butene-cyclen 1-but-3- 
en-1 -yl-1,4,7,10-tetraazacyclododecane (106) was successfully synthesised by the 
reaction of 4-bromobutene (78) with the tricyclic protected cyclen, octahydro-5H- 
2a,4a,7,9a-tetraazacycloocta[1,2,3-cd]pentalene (113). This was then deprotected 
using a mild base to yield the butene-cyclen (106).
The next step was the reaction of 1-but-3-en-1-yl-1,4,7,10-tetraazacyclododecane 
(106) with diethyl 2-bromosuccinate (103), in an attempt to form butene-sD03A- 
(ethyl) (101). This approach failed to yield butene-sD03A-(ethyl) (101), but instead 
gave butene-sD02A-(ethyl) (123) and butene-sDOIA-(ethyl) (124). This was due to 
the steric hindrance caused by the attached arms, and the low reactivity of the 
secondary bromide. The approach to the synthesis was then changed to the (3+1) 
route, in which sD03A-(ethyl) (107) was synthesised first and then reacted with 4- 
bromobutene (78) to form butene-sD03A-(ethyl) (101). The synthesis of sD03A- 
(ethyl) (107) from cyclen (9) and diethyl 4-bromosuccinate (103) was problematic 
owing to poor separation from the reaction intermediates, mainly sD02A-(ethyl) 
(109), caused by the diethyl bromo-succinate (103) affecting the Rf values of the 
reaction products. This meant that they eluted together off the column over a wide 
range of solvent systems and solid-phase media. It was noted during the reaction 
with potassium carbonate that there was a side reaction occurring to the diethyl 2- 
bromosuccinate, which underwent elimination of the bromine to give the alkene
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diethyl maleate; that then went on to react with the cyclen. These discoveries led to 
the formation of sD03A-(ethyl) (107) by the Michael addition reaction between 
cyclen (9) and diethyl fumarate (130). By not using diethyl 2-bromosuccinate (103), it 
was possible to separate the reaction products with greater yields, as the difference 
between the Rf values of sD03A-(ethyl) (107) and sD02A-(ethyl) (109) was greater 
when not in the presence of diethyl 2-bromosuccinate (103). Following the 
successful synthesis of sD03A-(ethyl) (107), the next step was the formation of 
butene-sD03A-(ethyl) (101) and pentene-sD03A-(ethyl) (133) by reaction with 4- 
bromobutene (78) and 5-bromopentene (134), respectively.
The hydrolysis of the alkene-sD03A-(ethyl)s (101) and (133) showed that both the 
succinate and alkene arms were unstable in the presence of strong acids, such as 
HCI, and organic acids, such as formic acid, when heated. This led to the hydrolysis 
being performed using LiOH with ion-exchange chromatography to give the sD03A  
(32).
5.2: Silsesquioxane cage-based contrast agents
The evidence suggested that the pentene-sD03A-(ethyl) (133) was decomposing to 
give pentene-sD02A-(ethyl) (123), along with several side reactions involving the 
ester and the amine reacting with the Si-H, as shown by the various model 
reactions. It became apparent that the original syntheses involving siloxane cages 
could not succeed using the butene-/pentene-arm-based method for attachment to 
the cages.
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5.3: Siiylbenzene based contrast agents
The dimethylsilyl benzenes allowed for the attachment of the cyclen to the silicon 
core without side reactions involving the hydrolysis of the Si-H group and reaction 
with the ethyl ester. The measurements using the lanthanide complexes showed that 
the water coordination number was lower than that of the sD03A-Eu (208). This was 
most likely due to the water exchange rate being altered by the presence of the 
benzene group, and by some degree of cross-binding, seen in the difference 
between the Gd^  ^ complexes of sD03A (32) and the (pentene-sD03A) 
dimethyl(phenyl)silane-Eu (213) and 1,4-bis((pentene-sD03A)dimethylsilyl) 
benzene-Eu2 (215) silylbenzenes that had a reduction of relaxivity of around 26%. 
The effect of cross-binding was strongly evident in the 1,3,5-tris((pentene- 
sD03A)dimethylsilyl)benzene-Gd3 (217) complex, with a relaxivity nearly 280% 
greater than those of the (pentene-sD03A-)dimethyl(phenyl)silane-Eu (213) and 1,4- 
bis((pentene-sD03A)dimethylsilyl) benzene-Eu2 (215) complexes.
5.4: Further work on silsesquioxane-cyclen compounds
The decomposition problems associated with the silsesquioxanes could be 
overcome by the use of a two-part linking arm between the cage and the cyclen. This 
would allow the attachment of the alkene to the siloxane without the secondary 
reaction of the Si-H with the ester groups. This step would prevent the 
decomposition of the cages as seen in section 3.5, where the cage with bromo- 
alkane arms was decomposed by the secondary amine of the sD03A-(ethyl) (107).
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The main concern would be in choosing the type of reaction between the 
silsesquioxane cage linking arm and the cyclen linking arm. A suitable group would 
have to be stable around the Si-H groups to avoid unwanted reactions, for example 
the side reaction with carbonyl groups. This could be achieved by the formation of an 
ether bond. This particular bond could be formed by the reaction of a short alkane 
chain with a terminal bromide, from the reaction of TsHg (33) with bromoethene (221) 
using Speier’s catalyst, which produces a compound with eight terminal bromines 
(222). The product would then be reacted with an alcohol attached to the sDOSA- 
(ethyl) (107) unit. A suitable compound for the formation of the alcohol would be 
bromoethanol (223), giving ethanol-sD03A-(ethyl) (224) (Figure 5.4.1).
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Figure 5.4.1: Possible formation of sD03A-(ethyi)-T8 (225)
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The main obstacle with an ether linked arm was the amount of flexibility that it would 
acquire. While the length of the chain would be only one unit longer than that found 
in the Ts-pentane-sDOSA (225) molecules, the presence of the ether bond would act 
effectively as a ball joint. This would increase the anisotropic rotation around the 
linking arms, having the effect of lowering the relaxivity of the complex.
The hydrolysis of the cyclen-cage compound could present several problems, as the 
sD03A group was sensitive to acid, inducing the decomposition of the succinate 
groups, while the siloxane would be sensitive to an alkali-catalysed decomposition. 
One possible route around the problem would be to use enzymatic hydrolysis of the 
ester groups.
5.5: Further work on silylbenzene-based contrast agents
Further work on silylbenzene-based contrast agents could involve expanding the 
possibilities of silicon-based cores. This would be done by developing a sila 
substituted benzene suitable for the attachment of oligomers, peptides or proteins to 
develop targetable contrast agents. The new silicon-based core would have sites for 
both dimethylsilanes and for targeting groups. A bifunctional silicon core could be 
synthesised from 2,3,4,5,6-pentabromoanline (226) to give the silicon compound 
2,3,4,5,6-pentadimethylsilaneanailine (227) (Figure 5.5.1). This product could 
produce a compound in which the amine would allow the attachment of other groups.
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Figure 5.5.1: Formation o f the novel silylbenzene cores 2,3,4,5,6- 
pentadimethylsilaneanaline (227)
One result of using 2,3,4,5,6-pentabromobenzene as a core for a contrast agent 
would be that the five sD03A-Gd groups on the structure would cross-bind, as seen 
in the 1,3,5-tris((pentane-sD03A(ethyl))dimethylsilyl)benzene (207) complex. This 
would lead to a higher relaxivity than that of 1,3,5-tris((pentane-
sD03A(ethyl))dimethylsilyl)benzene (207). One possible problem with the proposed 
complexes was the number of sD03A-Gd (207) groups in close proximity to one 
another. The relaxed water molecule, when relaxed and released from the 
gadolinium, then was immediately attracted back into the neighbouring complex, 
which would have the effect of reducing the relaxivity of the complex.
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Chapter 6: Experimental Section
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6.1: Synthesis of 1 -pent-4-enoyl-1,4,7,10-tetraazacyclododecane (66)
Powdered A4 molecular sieve (30 g) was added to a solution of cyclen (9) (0.5 g, 
0.0029 mol) dissolved in anhydrous chloroform (100 ml). To this was added 4- 
pentenoylchloride (63) (0.3 g, 0.0025 mol, 0.3 ml). The reaction was stirred for 28 
hours. Thin Layer Chromatography (TLG) silica (Chloroform 90% methanol 10%) 
showed that the reaction could not be separated owing to the cyclen binding to the 
stationary phase seen by the Rf value of 0.01. The reaction produced a mixture of 1- 
, 2-, 3- and 4-armed cyclens, which were seen by LCMS.
LCMS (positive): 255.21 [IVI(6 6 )^"], 337.21 [IVI(6 8 )"^ "], 419.31 [M(69)^^], 501.33 
[M (70)^
6.2: Synthesis of 1,4,7,tetraaza-cyclodecane-1,4,7-tricarboxylic acid tri- 
fe/t-butyl ester (tri-Boc-cyclen) (72)
A solution of di-ferf-butyldicarbamate (71) (3.6 g, 0.030 mol) dissolved in chloroform 
(100 ml) was added dropwise to a solution of cyclen (9) (1.1 g, 0.00664 mol) and 
TEA (5.5 ml) dissolved in chloroform (120 ml). The reaction was stirred at room 
temperature for 18 hours. The solvent was removed using reduced pressure, and the 
resulting crude product was taken up into DCM (50 ml), and was washed first with 
0.5M HCI (1 X 50 ml) and then with water (2 x 50 ml). The organic layer was dried 
using magnesium sulphate, filtered and the solvent was removed using reduced 
pressure. The oil produced was then chromatographed on alumina eluting with 
chloroform (99%) methanol (1%).
Yield, 1 . 2 2  g, 40.3%, Rf 0.77 (CHCI3 99%, MeOH 1%-alumina)
’ H NMR (CDCI3): 1.45 (18H, s), 1.47 (9H, s), 2.81-2.89 (4H, m), 3.17-3.44 (8 H, m), 
3.54-3.72 (4H, m)
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FTIR (KBrdisk): 2977, 2935,1690, 1468, 1415,1366,1248,116,1103
NMR (CDCI3): 28.50 (CH3), 28.70 (CH3), 45.01 (CH2), 46.01 (CH3), 48.88 (CH2), 
49.12 (CH3), 49.49 (CH3), 49.90 (CH3), 50.52 (CH2), 51.01 (CH2), 79.20 (C), 155.43 
(C =0), 155.62 (C=0), 155.85 (C=0).
FTIR (KBrdisk): 3521,2977, 2121, 1691, 1464, 1418, 1368, 1272,1172,1101.
6.3: Synthesis of 1-pent-4-enoyi-4,7,10,tetraaza-cyclodecane-1,4,7- 
tricarboxylic acid tri-te/t-butyl ester (73), Scheme C
TriBOC cyclen (72) (0.33 g, 0.0007 mol) was dissolved in anhydrous chloroform (100 
ml), to which powdered A4 molecular sieve (30 g) was added. To the reaction 4- 
pentenoylchloride (63) (0.43 g, 0.0036 mol, 0.4 ml) was added. The reaction was 
stirred for 24 hours. The solids were removed using filtration, and the solvent was 
removed using reduced pressure. The crude product was columned on alumina, 
eluting with chloroform 95% and methanol 5%.
Yield 0.25 g, 0.00045mol, 64.4%
'H NMR (CDCI3): 1.39 (H 27, s), 2.32 (H 4, d, 2.5 Hz), 3.29-3.42 (H 16, t, 
18.5/20.3), 4.92 (H 2, t, 10.27 Hz), 5.76 (H 1, t, 3.48 Hz)
NMR (CDCI3): 28.42 (CH3 ), 49.54 (CH2 ), 50.32 (CHz), 51.38 (CH 2 ), 80.08 
(CH2=C), 80.34 (CH=C), 115.38 (O -C H 2 ), 137.28 (C = 0 ), 155.33 (0 -C ).
FTIR (NaCI thin film): 3521,2977,1761,2121, 1694, 1464, 1368,1270, 1175, 1110. 
LCMS (positive): 555.72 (M(70)*")
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6.4: Synthesis of 1-pent-4-enoyl-1,4,7,10-tetraazacyclododecane (66) 
from 1 -pent-4-enoyl-4,7,10-tetraaza-cyclodecane-1,4,7-tricarboxylic acid 
tri-ferf-butyl ester (73)
1“Pent-4-enoyl-4,7,10-tetraaza-cyclodecane-1,4,7-tricarboxylic acid tri-tert-butyl ester 
(70) (0.15 g, 0.00027 mol) was dissolved in acetonitrile (20 ml) to which 
trifluoroacetic acid (1  ml) was added, and the reaction was stirred at room 
temperature for 8  hours. After LCMS had shown incomplete hydrolysis, another 
amount of trifluoroacetic acid ( 2  ml) was added and the reaction stirred for another 
16 hours. The pH of the solution was adjusted to pH 7 by the addition of NaOH (1M). 
After 8  hours LCMS (positive); 355.26 [M^^ ] (semi-hydrolysed product), 455.31 [M^ ]^ 
(semi-hydrolysed product).
After 24 hours LCMS (positive): 173.19 [M(9)^^], 255.24 [M(6 6 )^ ]^ (target product, 
very small signal).
6.5: Synthesis of 1,4,7,10-tetraazacyclododecane-1,4,7-tricarbaldehyde 
(triformylcyclen) (74)
Cyclen (9) (10 mmol, 1.72 g) was dissolved in ethanol (15 ml) to which chloral 
hydrate (76) (60 mmol, 9.9 g) was added. The reaction was heated to 70 °C for 3 
hours. The solvent was then removed using reduced pressure to yield a clear oil. 
The crude product was then chromatographed on a silica column, eluting with DCM 
89.9%, MeOH10% and 0.1%.ammonia solution (35%) to yield a white solid. Yield 
2.02 g / 79%
'H NMR (CDCb); 2.84 (H4, t, 4.5 Hz), 3.09 (H4, t, 4.5 Hz), 3.22 (H8 , s), 8.06 (H3, s). 
NMR (CDCb): 43.61 (CH2), 47.89 (CH2), 45.32 (CH2), 162.71 (C= 0 ).
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FTIR (KBrdisk): 3298, 2942, 1669, 1648, 1451, 1408, 1286, 1221, 1155, 1095.
LCMS (positive): 257.39 (M(74)^").
6.6: Synthesis of 10-pent-4-enoyl-1,4,7,10-tetraazacyclododecane-1,4,7- 
tricarbaldeyde (75) version 1
Triformyl cyclen (74) (0.5 g, 0.0019 mol) was dissolved in chloroform (100 ml) to 
which 25 g of activated molecular sieve was added. The reaction was stirred for 10 
minutes, after which a solution of pent-4-enoyl chloride (63) (0.005 mol, 0.59 g, 0.62 
ml) in chloroform (50 ml) was added dropwise over 6  hours. The reaction was then 
stirred for another 48 hours, after which the solids were removed by filtration and the 
solvent was removed using reduced pressure.
The crude reaction product was chromatographed on silica, eluting with a mixture of 
DCM (90%) and MeOH (10%). 0.1 g was collected from the column. LCMS showed 
that the sample contained the target molecule, but also a large number of 
unidentifiable peaks.
LCMS (Positive): 270.59 [M?^ ]^, 302.59 [M?+"], 338.49 [M(75)^^], 371 [M?^"].
6.7: Synthesis of 10-pent-4-enoy 1-1,4,7,10-tetraazacyclododecane-1,4,7- 
tricarbaideyde (75), version 2
Triformyl cyclen (75) (1.5 g, 0.0058 mol) was dissolved in DCM (100 ml) to which 
potassium carbonate (1 g, 0.0072 mol) was added. To this reaction mixture pentyl-4- 
chloride (63) (1.06 g, 0.99 ml, 0.009 mol) was added and the reaction stirred at room 
temperature for 48 hours, after which TEA (4 ml) was added to the reaction and
230
stirred for 30 minutes. The solids were removed from the reaction using filtration, and 
the solvent was removed using reduced pressure. The crude product was then 
subjected to a high vacuum for 4 hours to remove any residual TEA.
The reaction crude was then taken up into acetone, causing TEA-Chloride to form a 
powder, which was removed using filtration. The solvent was then removed using 
reduced pressure, and the resulting crude product was chromatographed on silica, 
eluting with a mixture of DCM 90%: MeOH 10%: ammonia solution 0.1%.
The target molecule eluted at Rf 0.26.
Yield 0.71 g, 0.0021 mol, 35.7%
'H NMR (CDCb); 1.18 (H2, s). 1.23 (H2, t, 7.5 Hz), 2.38 (H8 , t, 6.7 Hz), 2.52 (H8 , t, 
6 . 6  Hz), 3.37 (H3, s,), 4.99 (H, d-d, 10.2 Hz), 5.78 (H2, d-d, HzC=C, 10.4 Hz),
^C NMR (CDCb): 28.3 (CHz), 33.2 (CHa), 59.3 (CHz), 68.0 (CH;), 115.9 (CHz), 135.8 
(CH), 162.7 (C=0), 171.9 (C=0).
LCMS (Positive): 339.41 [M(75)*"].
FTIR (thin-film NaCI): 3316, 2974,1715, 1666,1484, 1380,1330, 1274,1089,1054.
6.8: Synthesis of 1-pent-4-enoyl-1,4,7,10-tetraazacyclododecane (66)
10-pent-4-enoyl-1,4,7,10-tetraazacyclododecane-1,4,7-tricarbaldeyde (75) (0.71 g, 
0.00207 mol), was dissolved into 0.2M NaOH solution (10 ml) and heated to 70 °C 
for 72 hours. A 2 ml fraction of the reaction was removed and freeze-dried. The 
remaining solution was split into two fractions of 4 ml. Purification of the first fraction 
was attempted by bi-phasic extraction using chloroform (3 x 10 ml); the organic 
phase was combined and dried over magnesium sulfate. The solvent was removed 
using reduced pressure to yield zero products. The second 4 ml fraction was passed
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though a C18 reverse-phase chromatography column; analysis of the eluent showed 
that the product had washed through with the sodium hydroxide. The solution was 
then neutralised using HCI (0.2M), and the reaction was analysed by LCMS.
Crude reaction product LCMS (positive): 254.31 [M(6 6 )^"]. 282.48 [M(77)^"].
NMR of freeze-dried crude product
’H NMR (CDCb): 2.08 (H3, s)(g), 2.33 (H4 , m,)(c,d), 2.45 (H8 , m)(k ,j), 2 . 8 8  (H4, 
3.38 (H4, m)(e), 4.93 (H1, td, 10.0 Hz,)(a1), 5.02 (H I, t, 1.47,)(a2), 5.80 (H I,
m,)(5),
"C  NMR (CDCb): 29.38 (CH2)(C), 30.90 (CH2)(D), 33.12 (CH2), 115.22 (H2C =C H - 
}{A), 137.60 (H2C=CH-)(B), 171.21 (C=0)(£).
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6.8: Characterisation o f compound (66), proton (left) carbon (right)
FR (KBrdisk): 3435, 2964, 2921,2851, 2566, 1683, 1645, 1580, 1421 
Reverse-phase eluent LCMS (positive): 254.37 [M(6 6 ) 282.51 [M(77)"^].
Neutralisation product LCMS (positive): 171.41 [M(9)"^"], 254.32 [M(77)^"].
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6.9: Synthesis of 2-(bromomethyl)-2-methylpropane-1,3-diol (90)
Hydrobromic acid (40%, 28 g) was added dropwise to 3-methyl-3-oxetanemethanol 
(91) (0.1947 mol, 20.00 g) over one hour. The reaction was stirred at 90 °C for 16 
hours, and then cooled to 4 °C for 18 hours. The solution was filtered and the 
crystallised product collected. The resulting crystals were then filtered under vacuum 
and washed with ice water. The crystalline product was dissolved in DCM (100 ml) 
and dried over magnesium sulfate. The reaction was filtered and the solvent was 
removed, using reduced pressure, to yield a white solid.
Yield; 20.99 g, 0.11476 mol, 59%.
NMR (CD3OD): 1.17 (H3, s, -C H 3), 3.22 (H2, s, -CHg-Br), 3.47 (H4, s, CHg-OH). 
^^ C NMR (CD3OD): 15.6 (CH3), 35.8 (CHg-Br) 40.1 (C), 67.7 (CHg-OH).
LCMS (positive): 91.52 (1/2 M(90)^")
6.10: Synthesis of s-(bromomethyl)-2-methylmalonic acid (89)
2-(bromomethyl)-2-methylpropane-1,3,-diol (90) (0.0082g, 0.446mmol, 1.50 g) was 
dissolved in acetone (10 ml) and the reaction was cooled to -15  °C. To the reaction, 
Jones’ reagent* (25 ml) was added dropwise over 1 hour. The reaction was then 
stirred at room temperature for 16 hours, after which it was quenched with methanol 
(100 ml) and stirred for 30 minutes. The organic solvents were removed, using 
reduced pressure, to yield a dark green/black crude solid. The product was extracted 
using chloroform (2 x 50 ml) and diethyl ether (4 x 200 ml). The organic phases were
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combined and dried over magnesium sulfate, filtered and the solvent removed, using 
reduced pressure, to yield a white, crystalline solid.
Yield 0.81 g, 0.0038 mol, 46.8%
'H NMR (DzO): 1.78 (H3, s)(a), 3.64 (H2, s)(b)
NMR (D2 O): 18.21 (CH3)(/1), 24.28 (CH2 )(C), 65.42 (C)(8), 182.33 (C=0)(D)
O. a
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6.10: Characterisation o f compound (89), proton (ieft) carbon (right)
FTIR (KBrdisk): 3455, 2975, 1706, 1645, 1571, 1462, 1410, 1263,1172, 1043.
LCMS (positive): 51.75 (1/2M(89) "^").
MP 128.1 °C, Lit 126.5 °C
* Jones’ reagent: K2Cr20y (0.0335 mol, 9.86 g) was dissolved in conc. sulfuric acid (6 
ml) and diluted with ultra-pure water to make 50 ml of solution.
6.11: Synthesis of dimethyl 2-(bromomethyl)-2-methylmalonate (96)
2-(bromomethyl)-2-methylmalonic acid (89) (0.82 g) was dissolved in methanol (30 
ml) and sulphuric acid (4 drops). The reaction was then refluxed for 18 hours. The 
solvent was removed using reduced pressure, and the product taken up into DCM 
(100 ml) and dried over magnesium sulfate. The reaction was then filtered and the 
solvent removed, using reduced pressure, to give an oil consisting of (2- 
(methoxycarbonyl)-3-bromo-2-methylpropanoic acid (97).
LCMS (negative): 223.26 [M(97) "], 111.20 [1/2M(97)'"]
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6.12: Synthesis of diethyl 2-(bromomethyl)-2-methyinnalonate (95)
2-(bromomethyl)-2-methylmalonic acid (89) (1.47 g, 0.00696 mol) was dissolved in 
ethanol (100 ml) and sulfuric acid (4 drops) and heated to reflux for 24 hours. The 
solvent was removed using reduced pressure and the crude oil was taken up into 
DCM (50 ml) and dried over magnesium sulfate. The reaction was filtered and the 
solvent removed to give a red oil.
NMR (CDCb); 1.00 (H ,s). 1.07 (H ,s) 1.27 (H , t, 9.9Hz), 2.09 (H ,s),
'^C NMR (CDCb): 14.04 (CH3), 19.39 (CH3), 36.59 (CH2), 48.74 (CH2), 61.29 (CH2), 
65.95 (CH2), 173.12 (C=0 ).
FTIR (KBr disk): 3479 (C-OH), 2980, 2939, 2880, 1713, 1463, 1368, 1298, 1225, 
1175, 1114, 1047.
LCMS (negative): 125.22 [M(2-methylpropanoic acid)+K]
6.13: Synthesis of 1 -but-3-en-1 -yl-1,4,7,10-tetraazacyclododecane (106)
Cyclen (9) (0.5 g, 0.0058 mol) in acetonitrile (20 ml) was added to potassium 
carbonate (1.5 g, 0.011 mol). The reaction was then cooled to -18  °C (ice/salt/IMS). 
To the cooled reaction a precooled solution of 4-bromobut-1 -ene (78) (0.8 g, 0.40 ml, 
0.00597 mol) in anhydrous acetonitrile (30 ml) was added dropwise over 4 hours. 
The reaction was then allowed to warm up to room temperature and stirred for 24 
hours. The solid residual waste was removed using filtration. The solvent was then 
removed using reduced pressure.
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The crude was taken up into HCI (2M, 20 ml), the pH adjusted to 10, and then was 
extracted using chloroform (4 x 100 ml) and the organic component was dried using 
magnesium sulfate.
TLC -  silica (MeOH (5%) CHCI3 (955): Streak from Rf 0.0 to Rf 0.25.
LCMS (positive): 174.26 (M(9)+"), 227.31 (M(106)^"), 281.43 (bis-alkene cyclen),
335.49 (M^^)(tris-alkene cyclen).
FTIR (thin-film NaCI): 2963, 2876, 1672, 1487, 1464, 1384, 1253, 1153, 11067
6.14: Synthesis of 10-but-3-en-1-yl-1,4,7,10-tetraazacyciodo decane-1,4,7- 
tricarbaldehyde (111)
Under argon, triformylcyclen (74) (0.25 g, 0.00097 mol) was dissolved in acetonitrile 
(15 ml) to which potassium carbonate (0.67 g, 0.00485 mol, 5 eq) was added. To the 
reaction was added 4-bromobut-1-ene (78) (0.32 g, 0.0024 mol, 2.5 eq) and the 
reaction was stirred at room temperature for 72 hours. The solid residue was 
removed via filtration and the solvent by reduced pressure to yield an oil. The crude 
oil was then placed on high vacuum for 24 hours to yield a yellow oil. The crude 
product was chromatographed on alumina (neutral) DCM (95%), MeOH (5%).
Yield 0.16 g, 0.000516 mol, 19%
Crude product LCMS (positive): 311.31 [M(111)^"], 337.51 [M(112)^"j 
Chromatographed product LCMS (positive): 311.21 [M(lll)'"^], 337.61 [M(112)^"j. 
FTIR (KBrdisk): 3112, 2940, 2886, 2484, 1676, 1452, 1313, 1239.
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6.15: Synthesis of octahydro-5H-2a,4a,7,9a-tetraazacycloocta[1,2,3-
cdjpentaiene^^’ (113)
Under argon, cyclen (9) (2.58 g, 0.0148 mol) was dissolved in toluene (30 ml). To the 
solution was added N,N-dimethylformamidedimethlyacetal (114) (DMF-DMA) (2.32 
ml, 2.08 g, 0.0017455 mol), and the reaction was refluxed for 2 hours. It was then 
cooled and the solvent removed, using reduced pressure, to yield a clear oil.
Yield 86%, 2.38 g
’H NMR (CDCb): 2.23 (H1, s)(e), 2.81 (H16, m)(a,b), 4.63 (H1, s)(c) 
’®C NMR (CDCb): 45.73 (CHz)(/1), 53.01 (CH2)(6), 101.44 (CH)(C)
B
gHN
113
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6A5: Characterisation o f compound (113), proton (left) carbon (right) 
LCMS (positive): 183.15 [M(113)+"]
FTIR (thin-film NaCI): 3258, 2927, 1678, 1444, 1347, 1291, 1255, 1144, 1065.
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6.16: Synthesis of 7-but-3-en-1-yloctahydro-5/y-2a,4a,7,9a- 
tetraazacycloocta[1,2,3-cc/|penta!ene (115)
Under argon, octahydro-5/-/-2a,4a,7,9a-tetraazacycloocta[1,2,3-cc/|pentaIene (113) ( 
1.00 g, 0.00548 mol) was dissolved in anhydrous acetonitrile (25 ml) to which 
potassium carbonate (2.25 g, 0.0169 mol) was added. The reaction was cooled 
using an ice/salt/IMS bath. 4-bromobut-1-ene (78) (0.73 g, 0.0054 mol) was added 
and the reaction was allowed to warm up to room temperature over 18 hours. The 
solid residue was removed using filtration, and the solvent was removed using 
reduced pressure to yield a clear oil. The oil was then run though an alumina 
chromatograph column and eluted with CHCI3 97%, MeOH 3%.
Yield 0.39 g, 0.001650 mol, 30.1 %
'H NMR (CDCI3): 2.15 (H2. q, 6.95Hz)(c), 2.50-2.75 (HIS. multiple)(d,e,f,g), 4.70 (H, 
s,)(/}), 4.92 (H2, t, 8.79Hz)(a1,a2), 5.76 (H, d-q, 7.02 Hz-3.42 Hz){b)
NMR (CDCI3): 32.79 (ÇH2 )(C), 51.01 (CHsXD), 52.69 (CHaXD), 55.44 (CHaXE),
58.49 (£H2)(6), 97.97 (CH)(H), 115.12 (CHaX-A), 130.01 (CH)(B)
LCMS: 237.18 [M(115X"]
FTIR (thin-film NaCI): 3419, 3258, 2929, 1680, 1444, 1347,1291, 1257, 1150.
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6,16: Characterisation o f compound (116), proton (left) carbon (right)
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6.17: Synthesis of 7-but-3-en-1-yi-1,4,7,10-tetraazacyclododecane-1-
carbaidehyde (121)
7-but-3-en-1-yloctahydro-5H-2a,4a,7,9a-tetraazacycloocta[1,2,3-cc(|pentalene (115) 
(0.51 g, 0.00216 mol) was dissolved in a solution of methanol (90 ml) and water (30 
ml) and stirred overnight at room temperature. The solvents were removed using 
reduced pressure and the crude was taken up into DCM (50 ml) and dried over 
magnesium sulfate (20 g). The solution was filtered and the solvent removed using 
reduced pressure.
Yield: 0.42 g, 0.00164 mol, 76%
NMR (CDCI3): 2.13 (H2, t, 6 . 8  Hz)(c), 2.21-2.28 (H3, m)(g), 2.61 (H2, t, 6.93 
Hz)(cO, 2.66 (H8 , s)(e,0, 2.88 (H4, t, 6 . 6  Hz)(h), 3.12 (H4, t, 5.31 Hz)(/), 4.98 (H, t, 
8.35 Hz)(a1), 5.03 (H, t, 14.0 Hz)(a2), 5.67 (H, m)(5).
7-but-3-en-1 -yl-1,4,7,10-tetraazacyclododecane-1 -carbaldehyde (121 )
NMR (CDCb): 31.45 (CH2)(C), 43.64 (£H 2)(F), 45.29 (CH2)(G), 48.98 {ÇH2KH)
53.50 (CH2)(D), 55.90 (CH2)(£), 116.36 (£H 2)(/\), 136.20 (CH)(S), 164.31 (CH=0)(/).
4-but-3-en-1 -yl-1,4,7,10-tetraazacyclododecane-1 -carbaldehyde (122)
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NMR (CDCb): 31.45 (CH2)(C), 45.91 (CHz)(/), 47.51 (£H 2)(F), 50.20
(CH2)(6 ,H), 50.44 (CH2)(J) 51.25 (£H 2)(D), 55.90 (CH2)(£), 116.36 (H2C=)(A), 
136.20 (CH)(B), 164.31 (CH)(/W).
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6,17: Characterisation of compound (121), proton (left) carbon (right)and (122)
carbon (bottom)
LCMS (positive): 255.21 [M(121/122)^'^].
FTIR (thin-film NaCI plate): 3419, 3000, 2753, 2420, 1686, 1576, 1496, 1442, 1379, 
1291, 1254, 1171, 1116.
6.18:1 -but-3-en-1 -yl-1,4,7,10-tetraazacyclododecane (lOS)via potassium 
hydroxide
7-but-3-en-1-yl-1,4,7,10-tetraazacyclododecane-1-carbaldehyde (1 2 1 ) / 4-but-3-en- 
1 -yl-1,4,7,10-tetraazacyclododecane-1 -carbaldehyde (122) (0.40 g, 0.00156 mol) 
was dissolved in a solution of methanol (5 ml) and potassium hydroxide solution (0.2 
M, 10 ml). The reaction was refluxed for 24 hours. The reaction was cooled and the
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pH was adjusted to pH 7 using HCI (2 M). The solvents were removed using reduced 
pressure, after which the crude was taken up in DCM (50 ml) and centrifuged to 
remove the solid residue. Then it was dried over magnesium sulfate, filtered and the 
solvent removed using reduced pressure to yield a clear oil.
Yield: 0.21 g, 9.28 mmol, 59 %.
'H NMR (CDCb): 2.13 (H2, d-d, 6.7 Hz), 2.57 (H2, t, 7.0 Hz), 2.76 (H4, multiple), 
2.86 (H12, multiple), 4.94 (H2, t, 5.2), 5.73 (H I, multiple).
’^C NMR (CDCb): 31.62 (CH2-C H =C H 2), 44.75 (N-ÇH 2-C H 2-N ), 46.61 (N-CH 2-  
ÇH2-N ), 48.83 (O C-N-ÇH 2-C H 2) 50.92 (N-CH 2-C H 2-CH=CH 2), 54.12 (-CH 2- N -  
(CH2-R )-£ H 2-C H 2-N ), 116.44 (CH2-C H =C H 2), 135.99 (CH2-C H =C H 2), 169.07 (N - 
CH=0).
LCMS (positive): 227.35 [M(106)^"]
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6.19:1 -but-3-en-1 -yl-1,4,7,10-tetraazacyclododecane (106) via ammonium 
hydroxide
7-but-3-en-1-yl-1,4,7,10-tetraazacyclododecane-1-carbaldehyde (121) (0.42 g, 
0.00164 mol) was dissolved in ammonia solution ( 6  ml of 35% in 44 ml of water) and 
heated to 100 °C for 48h. The solvent was removed using reduced pressure. The 
crude product was taken up into water ( 1 0  ml) and was extracted with chloroform ( 2  
X 50 ml). The organic component was combined and dried using magnesium sulfate, 
filtered, and the solvent removed using reduced pressure.
Yield: 0.24 g, 0.00106 mol, 64.7 %
’ H NMR (CDCb): 2.12 (H2, d-d, 6 . 6  Hz), 2.58 (H2, t, 7.02 Hz), 2.76 (H4, d-m, 9.54 
Hz), 2.85 (H12, m), 4.93 (H2, t, 5.2), 5.73 (H I, m).
®^C NMR (CDCb): 31.60 (CH2-CH=CH 2), 44.85 (N-CH2-C H 2-N ), 46.60 (N-CH 2-  
ÇH2-N ), 50.90 (N-CH 2-C H 2-CH=CH 2), 53.78 (-CH 2-N -(C H 2-R )-C H 2-C H 2-N ),
116.42 (CH2-C H =C H 2), 136.58 (CH2-£H = C H 2)
FTIR (thin-film NaCI plate): 3075, 2879, 2780, 1657,1513,1446, 1351, 1296, 1218. 
LCMS (positive): 227.24 [M(106)*^]
6.20: Synthesis of diethyl 2-bromosucclnate (103)
2-Bromosuccinic acid (104) (3.5 g, 0.0177 mol) was dissolved in 1 0 0 % ethanol (25 
ml), to which sulfuric acid (conc., 0.5 ml) was added. The reaction was refluxed for 
24 hours under argon; it was then cooled, the solvent was removed using reduced 
pressure, and the crude oil was taken up into DCM (100 ml) and dried over 
magnesium sulfate (20 g). The solids were removed and then the solvent was
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removed using reduced pressure. The resulting oil was passed though an alumina 
plug (neutral, 10 g) and was stored over molecular sieve (3 A, 10% of weight).
Yield 4.01 g, 0.0159 mol, 89%.
NMR (CDCI3): 1.12 (H3, t, 7.14 Hz,)(a), 1.14 (H3, t, 7.16 Hz,)(/), 2.83 (H I, d-d, 
6.21 Hz)(c), 3.11 (H I, d-d, 8.97 Hz)(c), 4.05 (H2, q, 7.14 Hz)(6 ), 4.12 (H2, q, 7.15 
Hz) (e), 4.44 (H, d-d, 2.73 Hz, 6.06 Hz)(d).
NMR (CDCb): 13.48 (CH3)(/1), 13.71(CH3)(H), 38.22 (CH2)(D), 39.14 (£), 60.81 
(CH2)(G), 61.85 (CH2)(B), 168.63 (C)(F), 169.25 (£)(C).
FTIR (thin-film NaCI): 2985, 1739, 1364, 1301, 1257, 1170,1027.
LCMS (positive): 174 [M(103)- Br*"], 253 [M(103)*"j
103
a 103
6,20: Characterisation of compound (108), proton (left) carbon (right)
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6.21: Synthesis of butene-sD03A-(ethyl) (101) from 1-but-3-en-1-yl-
1,4,7,10-tetraazacyclododecane (106)
1-but-3-en-1-yl-1,4,7,10-tetraazacyclododecane (106) (0.67 g, 0.0029 mol) was 
dissolved in dry acetonitrile (20 ml) to which potassium carbonate (4 g, 0.0298 mol) 
was added. To this diethyl 2-bromosuccinate (103) (3.68 g, 0.0145 mol) was added 
dropwise. The reaction was heated to reflux for 78 hours, then cooled. The solid 
residues were removed using a centrifuge. The solvent was removed to yield an oil.
LCMS (positive): 571.32 [M(123)^"], 398.12 [M(124)^"].
6.22: Synthesis of sD03A-(ether) (107) from cycien (9)
1,4,7,10-tetraazacyclododecane (9) (0.5 g, 0.0029 mol) was dissolved in anhydrous 
acetonitrile (25 ml) to which potassium carbonate (1.35 g, 0.0098 mol) was added. 
The reaction was cooled to -15  °C in an ice/NaCI/IMS bath. Diethyl 2- 
bromosuccinate (103) (3.2 eq, 0.00896 mol, 2.26 g) was added in 0.5 ml aliquots 
every 5 minutes. The reaction was stirred at room temperature for 24 hours, after 
which another amount of diethyl 2-bromosuccinate (1.00 g, 0.0039 mol) was added 
and stirred for a further 24 hours. The reaction was then filtered, and the solvent was 
removed using reduced pressure to yield a clear oil.
Yield = (0.045 g) (0.000065 mol) (2.25%); this was chromatographed on silica eluted 
with chloroform (95%)/methanol (5%).
TLC -  mixture from column (silica, eluted with (MeOH 5%, CHCI3 95%) sD02A-ethyl 
(109) (Rf 0.15), sD03A-ethyl (107)(Rf 0.20)).
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LCMS (positive): 689.37 [M(107)^"], 728.37 [M(107)+
NMR (CDCb): 1.21 (H18, t, 4.7 Hz), 2.52-2.91 (H22, m), 3.63 (H3, q, 4.2 Hz), 
4.10(H 12,t, 7.5)
^^ C NMR (CDCb): 13.99 (CH3), 14.97 (CH3), 35.52 (CHg), 47.53 (CHz), 49.41 (CHg),
60.70 (CH), 63.40 (CH3). 170.94 (C=0), 171.29 (C=0)
FTIR (NaCI plate): 2985, 1737, 1464, 1368, 1301, 1170, 1027
6.23: Synthesis of sD03A-(ethyl) (107) from cyclen (9) -  universal 
method
1,4,7,10-tetraazacyclododecane (9) (0.50 g, 0.00285 mol) was dissolved in 
anhydrous acetonitrile (50 ml),. To this potassium carbonate (1.9 g, 0.0137 mol) was 
added. To the reaction a solution of diethyl 2-bromosuccinate (103) (4.50 g, 0.01775 
mol) in anhydrous acetonitrile (50 ml) was added dropwise over one hour. The 
reaction was stirred at room temperature for 18 hours, after which the mixture was 
refluxed for 72 hours. The reaction was cooled and the solids removed by centrifuge 
and the liquid decanted. The solvent was then removed using reduced pressure to 
yield a crude oil.
6.24: Purification method (1) -  biphasic separation: silica 
chromatography eluted with DCM (70%), THF (30%)
The crude from reaction 6.23 was taken up into DCM (10 ml) and washed with water
(3x10 ml); the organic was dried over magnesium sulfate and filtered. The solvent
was removed using reduced pressure. The resulting oil was then chromatographed
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on a silica column eluted with DCM 70%, THF 30%. The eluting solvent system was 
then slowly changed via a gradient to a system eluting with DCM 66.5%, THF 30%, 
MeOH 3%, 0.5% ammonia (33% in water). Two major products were extracted.
Product A: TLC (silica, DCM 66.5%, THF 30%, MeOH 3%, ammonia 0.5%) showed 
a streak between Rf 0.00 and Rf 0.40 
Yield 0.46 g, (mixture)
LCMS (positive): 689.23 [M(107)*’], 517.55 [M(109)*']
Product B: TLC (silica, DCM 66.5%, THF 30%, MeOH 3%, ammonia 0.5%) show/ed 
at Rf 0.35.
Yield 0.023 g, 1 .1 %,
LCMS = 689.24 [M(107)*"]
’H NMR (CDCia): 1.20 (H18, q, 4.77 Hz), 2.45-2.85 (H22, m), 3.75 (H3, q, 7.14 Hz),
4.10 (H12, d-t, 7.32 Hz).
’^C NMR (CDCia): 14.03 (CH3), 14.18 (CH3), 35.43 (CH2), 47.42 (CH2), 49.19 (CH2),
60.67 (CH), 61.24 (CH2), 61.97 (CH2), 170.96 (C=0 ), 171.24 (C=0).
FTIR (NaCI plate): 2986, 1732, 1461, 1370, 1303,1182,1025
6.25: Purification method (2) -  biphasic separation: siiica 
chromatography eluted with DCM 95%, MeOH 5%
The crude from reaction 6.23 was taken up into DCM (10 ml) and washed with water
(3x10 ml); the organic was dried over magnesium sulfate and filtered. The solvent
was removed using reduced pressure. The resulting product was chromatographed
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on a silica column eluted with a mixture of dichloromethane (95%) and methanol 
(5%). The column yielded three products: at Rf 0.12 (sD02A-(ethyl) (109)), at 0.34 
(sD03A-(ethyl) (107)) and at 0.73 diethyl 2-bromosuccinate (103) (obtained on silica 
TLC plates eluted with DCM (95%) MeOH (5%)).
LCMS crude: 172.75 [M(9)*"] , 210.78 [M(9)+K*"], 346.14 [M(108)*^], 385.10 
[M(108)+K*", 518.70 [M(109)*"], 556.10 [M(109)+K*"], 689.84 [M(107)*"], 728.74 
[M(107)+K*").
Fraction with Rf 0.34
Yield = 0.07 g, 0.0001013 mol, 3.7%
LCMS (positive): 689.32 [M(107)^"]
^H NMR (CDCb): 1.20 (H18, q, 3.1 Hz), 2.5-2.8 (H22, m), 3.77 (H3, q, 7.2 Hz), 4.09 
(H12, d-t, 7.3 Hz).
NMR (CDCb): 14.04 (CH3), 14.18 (CH3), 35.44 (CHg), 47.42 (CHg), 49.20 (CHg),
60.67 (CH), 61.25 (CHg), 61.99 (CHg), 170.98 (C=0), 171.24 (C=0).
FTIR (NaCI plate): 2984, 1730, 1464, 1387
6.26: Purification method (3) -  biphasic separation: alumina 
chromatography eluted with DCM 95%, MeOH 5%
The crude from reaction 6.23 was taken up into DCM (10 ml) and washed with water 
( 3 x 1 0  ml); the organic was dried over magnesium sulfate and filtered. The solvent 
was removed using reduced pressure. The resulting product was then 
chromatographed on alumina eluting with DCM (100%), giving one product from the
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column as a streak on TLC (alumina DCM 95%, MeOH 5%) between Rf 0.35 and Rf 
0.00. There was found to be no separation between sD02A-(ethyl) and sD03A- 
(ethyl).
Yield of mixture 0.42 g
LCMS (positive): 517.31 [M(109)^"], 556.10 [M(109)+K+"], 689.84 [M(107)^"], 728.74 
[M(107)+K^H].
6.27: Purification method (4) -  biphasic separation: alumina 
chromatography eluted with DCM 70%, THF 30%
The crude from reaction 6.23 was taken up into DCM (10 ml) and washed with water 
( 3 x 1 0  ml); the organic was dried over magnesium sulfate and filtered. The solvent 
was removed using reduced pressure. The resulting product was then 
chromatographed on alumina eluting with DCM (100%), giving one product from the 
column as a streak on TLC (alumina DCM 70%, THF 30%) at Rf 0.86 (diethyl 2- 
bromosuccinate (103)) and a streak between Rf 0.1 and Rf 0.00. There was found to 
be no separation between sD02A-(ethyl) and sD03A-(ethyl).
LCMS (positive): 517.32 [M(109)^"], 689.74 [M(107)"^"]
6.28: Purification method (5) -  biphasic separation: alumina 
chromatography eluted with DCM 99%, MeOH 1%
The crude from reaction 6.23 was taken up into DCM (10 ml) and washed with water
(3x10 ml); the organic was dried over magnesium sulfate and filtered. The solvent
was removed using reduced pressure. The resulting product was chromatographed
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on alumina using DCM and MeOH (99:1). The TLC showed three products 0.78 
(diethyl 2-bromosuccinate), 0.30 (sDO3A-(ethyl)(107), and 0.21 (sDO2A-(ethyl)(109).
Yield = 0.11 9 , 0.000159 mol, 5.6%
NMR (CDCb): 1.19 (HIS, q, 3.0 Hz)(a), 2.5-2 8  (H22, m)(e), 3.75 (H3, q, 7.1 
Hz)(c), 4.10 (H12, d-t, 7.3 Hz)(d).
"C  NMR (CDCb): 14.03 (CH3)(>4), 14.18 (CH3)(G), 35.43 (CH2)(D), 47.42 (Ch2)(/), 
49.19 (CH2)(H), 60.67 (CH)(E), 61.24 (CH2)(S), 61.97 (CHz), 170.96 (C=0)(R). 
171.24 (C=0)(C).
HRMS 689.3892 [M(107)^"] (found), 689.3895 [M(107)*^] (predicted)
FTIR (NaCI plate): 2985, 1731, 1465,1389
a107
a
107
6,2^: Characterisation of compound (107), proton (left) carbon (right)
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6.29: Synthesis of sD03A-(ethyl) (103) via cyclen (9) using Sep-Pak 
columns.
1,4,7,10-tetraazacyclododecane (9) (0.50 g, 0.00285 mol) was dissolved in 
anhydrous acetonitrile (50 ml),. To this potassium carbonate (1.9 g, 0.01 mol) was 
added. To the reaction a solution of diethyl 2-bromosuccinate (103) (4.50 g, 0.01775 
mol) in anhydrous acetonitrile (50 ml) was added dropwise over 1 hour. The reaction 
was stirred at room temperature for 18 hours, after which the reaction was refluxed 
for 72 hours. The reaction was cooled, the solids removed by centrifuge and the 
liquid decanted. The solvent was then removed using reduced pressure to yield a 
crude oil. Chromatography of the crude product was performed on a Sep-Pak (Si- 
60) 25 g column. 500 mg of the crude oil was infused onto the Sep-Pak 
chromatographic column, which was then eluted with DOM 95% /  EtOH 5%.
The product from the column:
Rf = 0.91 = diethyl 2-bromosuccinate (103)
Rf = 0.55 = diethyl maleate (126), 0.20 mg, 0.001416 mol, 40% of crude oil
Rf = 0.19 = sDOSA-(ethyl) (107), 0.12 g, 0.000174 mol, 24% of crude oil product (for
500 mg sample of crude oil).
Reaction product = sD03A-(ethyl) (107)
NMR (CDCb): 1.22 (18H, q, 7.5 Hz), 2.48-2.76 (22H, m), 3.79 (3 H, t, 6.2 Hz), 
4.12(12H ,t, 7.1 Hz),
NMR (CDCb): 14.25 (CH3), 14.39 (CH3), 35.32 (CH2), 49.87 (CH2), 51.21 (CH2), 
60.47 (CH2), 171.46 (C=0), 171.90 (C=0).
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LCMS (positive): 688.32 [M(107)^J
Reaction product = diethyl maleate (126)
NMR (CDCI3); 1.25 (H6 , t, 6 . 8  Hz), 4.20 (H4, q, 7.0 Hz), 6.80 (H2, s).
NMR (CDCI3 ): 14.2 (CH3 ), 61.4 (CHg), 133.7 (CH), 165.1 (C =0).
FTIR (thin-film CDCI3 NaCI): 3431, 2985, 2255, 1719, 1644, 1368, 1303, 1262, 1160 
LCMS (positive): 212.81 [M(126)+K^"]
6.30: Reaction of diethyl 2-succinate (103) with potassium carbonate to 
form diethyl maleate (126)
Potassium carbonate (1 . 0 0  g, 0.0072 mol) was combined with diethyl 2 - 
bromosuccinate (103) (3.00 g, 0.0118 mol). The sealed flask was then heated to 60 
°C for 72 hours. The reaction was cooled and the product was extracted by washing 
with DCM (2 X 50 ml), and any solids removed by filtration. The solvent was then 
removed using reduced pressure.
Yield 1.78 g, 87%, 0.001034 mol
'H NMR (CDCI3): 1.25 (H6 , t, 6.9 Hz), 4.20 (H4, q, 7.1 Hz), 6.81 (H2 , s).
NMR (CDCi3): 14.2 (CHs), 61.46 (CH2), 133.7 (CH), 165.1 (0 = 0 ).
FTIR (thin-flim CDCi3 NaCi): 3428, 2985, 2255, 1718, 1646, 1370, 1303, 1262, 1159, 
1036.
LCMS (positive) 212.99 [M(126)+K*"]
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6.31: Synthesis of sD03A-(ethyl) (107) from cyclen (9) via caesium 
carbonate -  version 1
Cyclen (9) (0.5 g, 0.0028 mol) and caesium carbonate (4.56 g, 0.0014 mol) were 
dissolved in anhydrous acetonitrile (50 ml) under argon. To this solution diethyl 2- 
bromosuccinate (103) (1.90 g, 0.0075 mol) in acetonitrile (50 ml) was added 
dropwise over a period of 1.5 hours. The reaction was stirred at room temperature 
for 18 hours, after which the mixture was refluxed for 24 hours. Then another amount 
of diethyl 2-bromosuccinate (103) (1.00 g, 0.00395 mol) was added and the reflux 
continued for a further 24 hours. The reaction was cooled to room temperature and 
the solids removed using a centrifuge. The solvent was removed using reduced 
pressure, yielding a viscous oil. The crude oil was chromatographed on silica eluted 
with DCM (98%), MeOH (2%).
18 hours LCMS (positive): 307.87 [M(9)+Cs*"], 477.26 [M(108)+Cs^"], 649.12 
[M(109)+Cs*"].
32 hours LCMS (positive): 515.39 [M(109)^"], 649.12 [M(109)+Cs*"], 821.61 
[M(107)+Cs^"].
92 hour LCMS (positive): 516.40 [M(109)*"], 690 [M(107)*“].
The crude was then chromatographed on aiumina eluting with DCM (99%), MeOH 
(1%). Yield = 0.11 g, 0.000159 mol, 5.6%
’H NMR (CDCia): 1.19 (H18, q, 3.1 Hz), 2.5-2 9 (H2 2 , m), 3.76 (H3, q, 7.0 Hz), 4.08 
(H12, d-t, 7.1 Hz).
'®C NMR (CDCia): 14.03 (CHs), 14.20 (CH3), 35.44 (CH2), 47.42 (CH2), 49.20 (CH2),
60.65 (CH), 61.23 (CH;), 61.98 (CH2), 170.97 (C=0), 171.26 (C=0).
LCMS positive: 689.38 [M(107)*^]
FTIR (NaCi plate): 2986, 1729, 1464,1388
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6.32: Synthesis of sD03A-(ethyl) (107) from cyclen (9) via caesium
carbonate -  version 2
1,4,7,10-tetraazacyclododecane (9) (0.50 g, 0.00286 mol) and caesium carbonate 
(4.5 g, 0.01385 mol) were cooled to -1 5  °C using ice/NaCI/IMS. To this mixture 
diethyl 2-bromosuccinate (103) (7 g, 0.02755 mol) was added and the reaction was 
stirred for 48 hours at room temperature, after which the reaction was heated to 60 
°C for 48 hours. The reaction was cooled and the crude was taken up into DCM (2 x 
50 ml). The solids were removed by centrifugation, and the solvent was extracted 
using reduced pressure to yield a viscous oil.
The oil was split into two aliquots.
After 10 minutes-at room temperature LCMS (positive): 173.60 [M(9)" "^] or 
[M(130)+"], 516.29 [M(109)+"].
After 48 hours at room temperature LCMS (positive): 341.70 [M(108)'"^], 516.32 
[M(109)+"], 689.98 [M(107)+"].
After 96 hours (48 hours at room temperature, 48 hours at 60 °C)
516.34 [M(109)^"], 689.71 [M(107)+"].
253
6.32.1: Work-up method 1: Chromatography
The crude product was chromatographed on silica eluting with DCM (95%) MeOH 
(5%). sD03A-(ethyl) (107) was collected at Rf 0.2.
LCMS (positive): 690.53 [M(107)^"]
Yield 2 2  mg, 0.0000319 mol, 1.1%
'H NMR (CDCb): 1.20 (H18, t, 5.0 Hz), 1.81-2.42 (H22, m), 3.54 (H I, q, 5.38 Hz), 
3.78 (H3, q, 7.003 Hz), 4.10 (H12, q, 7.00).
^^ C NMR (CDCb): 14.20 (CH;), 35.58 (CHz), 46.49 (CHg), 47.46 (CHz), 50.18 (CHz), 
50.41 (CHz), 59.58 (C=0 ), 60.53 (CHs), 170.94 (C=0), 171.47 (C=0).
FTIR (thin-film, KBrdisk): 2983,1736, 1464,1368, 1302, 1256, 1170.
6.32.2: Work-up method 2: Vacuum distillation
The oil underwent vacuum distillation. The sample was slowly heated using an oil 
bath to 80 °C, yielding a white solid which was collected at 60 °C.
Product found (E)-3-(ethoxycarbonyl) acrylic acid (125)
^H NMR (CDCb): 2.12 (H3, t, 7.14 Hz)(a), 5.05 (H2, q, 7.14 Hz)(5), 7.66 (H2, q, 
15.72 Hz)(c+d).
®^C NMR (CDCb): 14.04 (CHs)(/1), 61.60 (CH2)(B), 132.54 (CH)(£), 135.84 (CH)(D), 
164.65 (C=0)(C), 170.21 (C=0)(F)
LCMS (negative): 143.20 [M(125)' ]^, 287.12 [2M(125)""].
MP: 6 8  °C
HRMS: 145.0495 [M(125)™] (Found), 145.0423 [M(125)'"“) (predicted)
FTIR (KBrdisk): 3155, 2904, 2254, 1708, 1306, 1269, 1174
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6.32: Characterisation of compound (125), proton (left) carbon (right)
6.33: Reaction of diethyi 2-bromosuccinate (103) with caesium carbonate 
to form (E)-3-(ethoxycarbonyi) acryiic acid (125)
Diethyl 2-bromosuccinate (103) (1.00 g, 0.0039 mol) was added to caesium 
carbonate (1.3 g, 0.0039 mol). The reaction was heated to 60 °C for 1 hour. The 
reaction was then cooled and the product was extracted from the solid residue by 
washing with DCM (2 x 25 ml). The solvent was removed using reduced pressure to 
yield a crude, light-yellow oil. The oil was then distilled under vacuum to yield a white 
solid.
Before heating LCMS (negative): 143.20 [M(125)'"], 287.13 [2M(125) "].
LCMS (positive): 174.19 [M(1G3)-Br*^].
White solid produced:
Yieid = 0.11 g, 0.000076 moi, 19% MP: 69.5 °C.
LCMS (negative ion): 143.21 [M(125)'"], LCMS (positive ion): no ions detected 
'H NMR (CDCia): 2.11 (H3, t, 7.14 Hz), 5.05 (H2 , q, 7.16 Hz), 7.66 (H2 , q, 15.70 Hz).
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NMR (CDCb): 14.05 (CH3), 61.60 (CH2), 132.54 (CH), 135.84 (CH2), 164.65 
(C=0), 170.21 (C=0).
FTIR (KBrdisk): 3155, 2904, 2254, 1710, 1306, 1269, 1174
6.34: Synthesis of sD03A-(ethyi) (107) from diethyi maieate
Cyclen (9) (0.5 g, 0.0029 mol) was dissolved in anhydrous acetonitrile (30 ml) 
containing potassium carbonate (1.40 g, 0.0101 mol). To this a solution of diethyl 
maleate (153) (2.7 g, 0.0157 mol, 2.54 ml) dissolved in anhydrous acetonitrile (30 
ml) was added dropwise over a period of 2 hours. The reaction was stirred for 24 
hours at room temperature, after which it was heated to 60 °C for 6  hours. Then 
diethyl maleate (126) (2 . 0 0  g, 0.0116 mol) was added and the reaction continued for 
another 48 hours. The reaction was cooled, the solid residue was removed, the liquid 
layer was decanted, and the solvent removed using reduced pressure. The crude 
was then chromatographed on silica eluted with 95% DCM and 5% EtOH.
Yield 2 0 0  mg, 0.00029 mol, 1 0 .0 2 %
(1 hour) LCMS (positive): 211.07 [M(9)+K^"], 345.30 [M(108)^"], 384.28 
[M(108)+K^"], 517.33 [M(109)^"].
(24 hours) LCMS (positive): 210.89 [M (9 )+ 0 ,  383.15 [M(108)+K^"], 516.82 
[M(109)"^"], 554.08 [M(109)+K^"], 727.24 [M(107)+K^"]
(30 hours) LCMS (positive): 210.91 [M(9)+K^"], 382.77 [M(108)+K^"], 516.82 
[M(109)+"], 554.08 [M (1 0 9 )+ O , 727.24 [M(107)+K^"].
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(54 hours) LCMS (positive): 210.83 [M(9)+K^"], 382.92 [M(108)+K^"], 516.82 
[M(109)+"], 554.08 [M(109)+K^"], 728.62 [M(107)+K^"].
NMR (CDCb) 1.19 (H18, q, 3.4 Hz), 2.40-2.81 (H25, m), 3.73 (H3, q, 5.31 Hz), 
4.08 (H12,q, 4.95 Hz).
NMR (CDCb): 13.99 (CHs), 14.97 (CHs), 35.52 (CHg), 47.53 (CHs), 49.41 (CHs),
60.70 (CH), 63.40 (CHs), 170.94 (C=0), 171.29 (C=0)
FTIR (thin-film, KBrdisk): 2984, 1736, 1462, 1370, 1300, 1255, 1170.
6.35: Synthesis of sD03A-(ethyl) (107) via diethyl fumarate (130)
Cyclen (9) (0.5 g, 0.0029 mol) was dissolved in anhydrous acetonitrile (30 ml) 
containing potassium carbonate (1.40 g, 0.0101 mol). To this a solution of diethyl 
fumarate (130) (2.7 g, 0.0157 mol, 2.57 ml) dissolved in anhydrous acetonitrile (30 
ml) was added dropwise over a period of 2  hours. The reaction was stirred for 24 
hours at room temperature, after which it was heated to 60 °C for 6  hours. Then 
diethyl fumarate (2 . 0 0  g, 0.0116 mol) was added and the reaction continued for 
another 48 hours. The reaction was cooled, the solid residue was removed, the liquid 
layer was decanted and the solvent removed using reduced pressure. The crude 
was then chromatographed on silica eluted with 95% DCM and 5% EtOH.
Yield 200 mg, 0.00029 mol, 10%.
’H NMR: 1.21 (18H, q, 7.5 Hz), 2.49-2.78 (22H, m), 3.72 (3H, t, 6.0 Hz), 4.07-^.14  
( 1 2  m).
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NMR: 14.39 (ÇH3-C H 2-O ), 35.37 (CH-ÇH2-C = 0 ). 49.87 (H2Ç -N -Ç H 2), 51.19 
(-N -Ç H 2), 60.49 (-CH 2-C H 3), 171.44 (0 -Ç = 0 -C H ), 171.90 (0 -Ç = 0 -C H 2).
FTIR (thin-film. KBrdisk): 2987, 1737, 1464, 1367, 1302, 1255, 1172.
LCMS: 689.32 [M(107)+"]
HRMS: predicted 711.3787 [M(107)+Na^^], found 711.3796 [M(107)+Na^"]
6.36: Synthesis of sD03A-(ethyl) (107) via diethyl maleate (126) -  scaled- 
up version (final version)
1,4,7,10-tetraazacyclododecane (9) (3 g, 0.01734 mol) and potassium carbonate 
(7.8 g, 0.05652 mol) were dissolved in anhydrous acetonitrile (100 ml). To this a 
solution of diethyl maleate (126) (42 g, 0.2439 mol) in anhydrous acetonitrile (100 
ml) was added dropwise over 2 hours. The reaction was heated to 80 °C and stirred 
for 72 hours. The reaction was cooled to room temperature and the solids were 
removed. The solvent was removed using reduced pressure to yield a crude oil.
The crude extract was chromatographed on silica (Si-60) (350 g), made up of slurry 
packed into a sintered glass filter column with an internal diameter of 95 mm. The 
most relevant factor for successful purification was the way the bed was compacted 
before and after the addition of the crude reaction mixture. When the silica-solvent 
mixture was added first, the solvent was drained until the solvent layer was just 
below the top of the silica. The column was then compacted using a heavy steel rod 
fitted with a suba seal to stop contamination. This step enabled a greater replication 
of the chromatographic performance, as well as removing small imperfections in the 
column bed. The chromatography column was eluted with DCM/EtOH (95:5).
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Product at Rf 0.2. The solvent was removed using reduced pressure yielding a clear, 
viscous oil.
Yield = (4.25 g, 0.00617 mol, 35.58%).
'H NMR (CDCb): 1.21 (H I8 , t, 5.01 Hz), 1.80-2.41 (H22, m), 3.54 (H I, q, 5.35 Hz),
3.77 (H3, q, 7.03 Hz), 4.08 (H12, q, 7.01).
^^ C NMR (CDCb): 14.18 (CHs), 35.58 (CHs), 46.46 (CHs), 47.44 (CHs), 50.18 (CHs), 
50.40 (CHs), 59.58 (C=0), 60.52 (CHs), 170.93 (C=0), 171.46 (C=0).
FTIR (thin-film, KBrdisk): 2983, 1736, 1464,1368,1302, 1256, 1170.
LCMS: 689.39 [M(107)^"]
HRMS: predicted 711.3787 [M(107)+Na*"], found 711.3792 [M(107)+Na*"]
6.37: Synthesis of butene-sD03A-(ethyl) (101) via sD03A-(ethyl) (107)
sD03A-(ethyl) (107) (0.64 g, 0.00093 mol) was dissolved in anhydrous acetonitrile 
(20 ml) to which potassium carbonate (1.00 g, 0.0072 mol) had been added. The 
reaction was cooled in an Ice/NaCI/IMS bath. To this 4-bromobutene (78) (2.66 g, 
0.0197 mol, 2.00 ml) was added and the reaction was allowed to warm up to room 
temperature overnight. The reaction was then stirred for 78 hours at room 
temperature. The solids within the reaction mixture were removed using a 
centrifuge, and the solvent was decanted. The solvent was then removed using 
reduced pressure, followed by 24 hours on high vacuum to yield a clear, light-yellow 
oil. The crude product was then chromatographed on silica eluted with DCM and 
EtOH (95:5%)
Yield 0.54 g, 0.00072, 77.92%
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Crude sample LCMS (positive): 742.40 [M(101)^"], 799.31 [M(132)*”]
Product LCMS (positive): 742.40 [M(101)*"]
’H NMR (CDCb): 1.18 (H18, q, 5.7 Hz)(a), 2.09 (H2 , d, 6.98 Hz)(/), 2 .3-2 8  (H24, 
m)(c,e,f,g,h,i), 3.75 (H3, t, 6.0 Hz)(d), 4.11 (H12, m)(6 ), 4.93 (H2, q, 17.4 Hz)(m), 
5.71 (H I, t-t, 6.75 Hz)(/f).
’^C NMR (CDCb): 14.12 (CHs)(A), 14.38 (CH3){A1), 29.64 (CH2)(/W), 35.52 (CH2)(D), 
49.87 (CH2)(£), 50.60 (CH2)(F), 51.18 (CH2)(G), 53.55 (CH2)(H), 53.92 (CH2)(J),
54.66 (CH2)(L), 59.57 (CH)(E), 59.84 (CH)(£), 59.92 (CH)(£), 60.44 (CH2)(B), 60.84 
(CH2)(B2), 115.31 (CH2)(0), 137.09 (CH)(N), 171.39 (C=0)(F), 171.89 (C=0)(C). 
HRMS: calculated 743.4437 [M(101)*"], found 743.4445 [M(101)^"].
FTIR (thin-film CDCb NaCI): 2982, 2253,1723,1461,1371,1300,1260.
N  O
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6.37: Characterisation of compound (101), proton (left) carbon (right)
6.38: Synthesis of pentene-sD03A-(ethy!) (133) from sD03A-(ethyl) (107)
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sD03A-(ethyl) (107) (4.06 g, 0.0059 mol) was dissolved in anhydrous acetonitrile (40 
ml) to which potassium carbonate (4.1 g, 0.03 mol) was added. The reaction was 
cooled to -18  °C, then 5-bromopent-1-ene (134) (2.65 g, 0.0177 mol) was added, 
followed by stirring for a period of 48 hours while being kept at room temperature. 
The solid was removed using a centrifuge, and the solvent layer was decanted. The 
solvent was then removed using reduced pressure to yield a dark-yellow oil. The 
crude product was then chromatographed on silica eluted with DCM and EtOH 
(95:5%)
Yield, 2.77 g, 0.00366 mol, 62%
NMR (CDCb): 1.18 (H18, q, 5.6 Hz)(a), 2.10 (H2, d, 6.70 Hz)(/), 2.3-2 8  (H26, 
m)(e,f,m,c) 3.76 (H3, t, 6.0 Hz)(d), 4.11 (H12, m)(6 ), 4.94 (H2, q, 17.5Hz)(k), 5.72 
(H I, t-t, 6.75 Hz)(/).
'®C NMR (CDCb): 14.12 (CH3)(/41), 14.40 (CHs)(/\2 ), 29.71 (CH2)(J), 30.21 (CH2)(K), 
35.50 (CH2)(D), 49.90 (CH2)(6 ), 50.58 (CH2)(G), 51.19 (CH2)(G), 53.55 (CH2)(H), 
53.92 (CH2)(H), 54.67 (CH2)(/), 59.60 (CH)(£1), 59.82 (CH)(£2), 59.90 (CH)(E3), 
60.46 (CH2)(B1), 60.82 (CH2)(B2), 115.30 (CH2)(A/), 137.11 (CH)(M), 171.41 
(C=0)(F), 171.91 (C=0)(C).
FTIR (thin-film NaCI): 2981, 2940, 2832, 1728. 1448, 1372, 1297,1258,1175, 1117 
LCMS: (positive): 757.98 [M(133)*"]
HRMS: predicted 757.4593 [M(133)*"], found 757.4590 [M(133)^"]
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6,38: Characterisation o f compound (133), proton (left) carbon (right)
6.39: Hydrolysis of sD03A-(ethyl) (107) to form sD03A (32) -  DC! method
sD03A-(ethyl) (107) (1.00 g, 0.00145 mol) was dissolved in D2O (5 ml) to which DCI 
(0.8 ml, 35%) was added. The reaction was heated to 90 °C in a sealed tube for 24 
hours. The DCI was removed using reduced pressure and the D2O was removed 
using freeze-drying. The sample was retaken up into water (20 ml) and freeze-dried 
again. Yield 588 mg, 0.001339 mol, 92.3%
'H (CD3OD): 0.56 (H4, t, 3.3 Hz), 2.16 (H7, m), 2.35 (H8 , s) 2.52 (H6 , s), 2.54 (H3, 
s), 3.42 (H4, m) 4.15(H3, s)
NMR (CD3OD); 13.960 (CH3), 43.235 (CH;), 58.122 (CH2), 134.816 (CH),
169.232 (0 = 0 ), 175.253 (0 =0 ), 175.944 (0 = 0 ), 176.478 (0 = 0 )
FTIR (KBrdisk): 3414, 2969, 1722, 1408, 1273, 1229, 1174.
LOMS (positive): 231.35 [1/2M(138)-NaOF"], 403.69 [M(138) *"], 439.97 
[M(109)or"].
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6.40: Hydrolysis of sD03A-(ethyl) (107) to form sD 03A  via formic acid
sD03A-(ethyl) (107) (0.25 g, 0.00036 mol) was dissolved in ethanol (1  ml), and was 
added to a solution of formic acid (2.5 ml, 3.05 g, 0.06587 mol) and water (2 ml). The 
reaction was heated to 90 °C for 24 hours, then cooled to room temperature. The 
solvents and formic acid were removed using lyophilisation. The lyophilisation was 
repeated three times by dissolving the crude material in water ( 1 0  ml).
(D2O): 1.31 (H4, t, 3.3 Hz). 2.16 (H7, m), 2.35 (H8 , s) 2.52 (H6 , s), 2.54 (H3, s),
3.42 (H4, m )4.15(H3, s)
NMR (CD3OD): 13.960 (CH3), 43.235 (CH2), 58.122 (CH2), 134.816 (CH),
169.232 (C=0), 175.253 (C=0), 175.944 (C=0), 176.478 (0 = 0 )
6.41: Hydrolysis of butene-sD03A-(ethyl) (101) to form butene-sD03A  
(105) via 1.4M formic acid
Butene-sD03A-(ethyl) (101) (0.25 g, 0.0003355 mol) was dissolved in formic acid 
(1.4M, 15 ml), and heated to 60 °C for 48 hours. The temperature was increased to 
70 °C for 24 hours. The solvent was removed using lyophilisation, the solid residue 
was taken up into water ( 2 0  ml) and the reaction unden/vent a second round of 
lyophilisation.
Yield 0 . 2 1  g, 0.000305 mol, 91%
H^ NMR (CDCy: 1.26 (H I2, t, 6.01 Hz), 2.05 (H2, q, 8.61 Hz), 2.54-2.99 (H24, m),
3.77 (H3, q, 3.87 Hz), 4.12 (H8 , 4.98 Hz), 5.02 (H2, q, 8.43 Hz), 5.66 (H, q, 10.53 
Hz).
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NMR (CDCb): 14.09 (CH3), 35.33 (CHg), 44.82 (CHg), 48.11 (CHg), 49.89 (CHg),
61.10 (CH2), 63.16 (CHz), 116.87 (CHg), 134.85 (CH), 166.59 (C=0 -formic acid), 
170.79 (C=0), 170.81 (C=0), 170.92 (C=0).
LCMS (positive): 687.81 [M(107)+"] [C32H54N4O12]-
FTIR (CDCb-NaCI): 2983, 2858, 2254, 1729, 1609, 1465, 1372, 1299, 1262, 1180.
6.42: Hydrolysis of butene-sD03A-(ethyl) (101) to form butene-sD03A 
(105) via 2.2M formic acid
Butene-sD03A-(ethyl) (101) (0.25 g, 0.0003365 mol) was dissolved in formic acid 
(2.2M, 10 ml) and heated to 80 °C in a sealed tube for 48 hours. The reaction was 
cooled, the solvent removed using lyophilisation, then the solid residue was taken up 
into water ( 2 0  ml) and the reaction underwent a second 
lyophilisation step.
24 hour LCMS (positive): 744.47 [M(101)^^]
48 hours LCMS (positive): 257.93 [%M(109)'^"], 286.45 [%M(butene-sD02A- 
(ethyl)+H], 516.26 [M(109)"^"], 542.74 [M(32)+Na+"], 572.45 [M(butene-sD02A)+"] 
FTIR (thin-film CDCb): 3400, 2254, 1793, 1726, 1630, 1599, 1469, 1383, 1095, 908, 
733.
HRMS (positive): 571.3708 -  [M(C28Hsi0 8 N4)'^ "] minor peak 625.4173 -
[M (C 3 2 H 5 7 0 8 N 4 ^ T
6.43: Hydrolysis of sD03A-(ethyi) (107) via sodium hydroxide in D2O
The reaction was performed in a sealed-tube vessel sD03A-(ethyl) (107) (0.1 g, 
0.000145 mol) was dissolved in deuterium dioxide (5 ml) in which sodium hydroxide
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(0.2 g, 0.005 mol) was dissolved. The reaction was stirred for 1.5 hours at room 
temperature, after which a sample was taken for NMR. The reaction was then 
heated to 80 °C for 24 hours.
After 1.5 hours
NMR (D2O): 1.22 (t, 15H, 5.5 Hz), 2.2-3.05 (m, 22H,), 3.69 (q, 7H, 6.9 Hz). 3.84 
(m, 3H).
After 25.5 hours
'H NMR (D2O): 2.2-3.05 (m, 22H,), 3.84 (m, 3H)
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6.44: Preparation of ion-exchange resins
The ion-exchange resins have to be prepared with the correct counter ion before 
use. This was done using a batch method, in which the resin was added to a solution 
of the desired counter ion. For example in the cation-exchange system, the 
counter ion was needed for the absorption of Na^ ion. This was achieved by adding 
the resin to a large volume (500 ml to 100 g of resin) of 1M hydrochloric acid; this 
was stirred for around 30 minutes and then the acid was decanted and the resin 
washed with water until the pH of the eluent stabilised. The same principle was used 
for the generation of the anion-exchange resins, using NaOH, to give the hydroxide 
counter ion form. The resin was then placed in a glass-walled preparative HPLC 
column designed for protein purification. The solvents were pumped into the column 
using a gradient pump (Dionex, UK), which allowed for elution and gradient control. 
A Foxy Fraction Collector (ISCO, USA) was used for the collection of the fractions. 
The size of the column used depended on the volume of resin needed. For large- 
scale chromatography a 3 cm (internal diameter) by 100 cm (length) column was 
used, and for the small-scale chromatography a 3 cm (internal diameter) by 30 cm 
(length) column was used.
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6.44.2: Cation-exchange resin preparation
Dowex SOW X 8 (H  ^form) was converted from the (N H /) form by suspension of the 
resin in hydrochloric acid solution (1 M) ( 6  times the volume of resin) for 2 0  minutes. 
The used acid was decanted and the resin was washed with ultra-pure water (5 x 
200 ml) so that the pH was stabilised.
6.44.3: Anion-exchange resin preparation
Bio-Rad AG1 A41 was supplied in the 01" ion form; the experiment required the 
conversion of the resin to the HO" form. This was performed by stirring the resin in 
sodium hydroxide (5 times the volume of the resin), for 10 minutes. The solvent was 
decanted and the resin was washed with ultra-pure water (5 x 200 ml) until the pH 
reached a stable, constant pH value of 6-7.
6.45: Cation-exchange chromatography of reaction solution from the 
hydrolysis of sD03A-(ethyl) (107) via NaOD
The reaction solution from the hydrolysis of sD03A-(ethyl) (107) via NaOD (SOOpI) 
was injected into the head of the ion-exchange column containing Dowex 2x-8 (OH" 
form), bed volume 8  cm ,^ eluting with ultra-pure water at a rate of 4 ml/min. The pH 
was monitored until it reached equilibrium at a pH of 6-7. The ion-exchange column 
was then eluted with a gradient of ammonia solution (2%). The fractions were 
collected and analysed using negative-ion LCMS. The solvent was removed from the 
product containing fractions by lyophilisation, to yield a brown solid.
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NMR H’ d = 2.49 (s, H?) , 2.84 (s, H?), 3.07 (s, H?), 3.59 (s, H?), 4.28 (s, H?) 
(base line meant no integration possible).
LCMS (negative): 278.55 [1/2M(sD03A-(NH4)2)"^]. 403.07 [M(138)""], 521.05 
[M(32)-"], 559.03 [M(32)+(NH4)2"^]
6.46: Hydrolysis of sD03A-(ethyl) (107) via lithium hydroxide
The reaction was performed in a sealed-tube vessel. sD03A-(ethyl) (107) (0.1 g, 
0.000145 mol) was dissolved in deuterium dioxide (5 ml) in which 1M LiOH (5 ml) 
was dissolved. The reaction was then heated to 90 °C for 38 hours.
6.47: Anion-exchange chromatography of sD03A (32)
The crude reaction mixture from the LiOH hydroxide hydrolysis method was injected 
into the head of an ion-exchange column containing Bio-Rad AGI A4I (OH" form), 
bed volume 500 cm ,^ eluting with ultra-pure water at a rate of 4 ml/min. The pH was 
monitored until it reached equilibrium. The column was then eluted with a gradient of 
formic acid (1M). The fractions were collected and analysed using negative-ion 
LCMS. The solvent was removed from the product containing fractions by 
lyophilisation, yielding a white solid.
Yield: = 350 mg, 0.000672 mol, 46.3%
’H NMR {D2O): 2.4-2 7 (H 22, m), 3.83 (H3, m)
'®C NMR (D2O): 37.5 (CH2), 43.9 (CH2), 50.2 (CH2), 52.4 (CH2) 60.6 (CH), 174.9 
(0 = 0 ), 177.3 (0 = 0 ).
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CHN analysis: found C = 43.3%, H = 6.52%, N = 9.84%; calculated C = 43.17%, H = 
6.52%, N = 10.06% as C2oH32N4 0 i2 .(H2 0 ) 2
HRMS: (electro spray (positive)): found 521.2088 [M(32)'"^], predicted 521.2089 
[M(32)+"].
6:48: Anion-exchange chromatography of sD02A (162)
Crude reaction mixture from formic acid hydrolysis of sD03A-(ethyl) (107) (588 mg) 
was dissolved into water (5 ml) and injected into the head of an ion-exchange 
column containing Bio-Rad AGI A41 (OH" form), bed volume 500 cm ,^ eluting with 
ultra-pure water at a rate of 4 ml/min. The pH was monitored until it reaching 
equilibrium. The column was then eluted with a gradient of ammonia solution (2%). 
The fractions were collected and analysed using negative-ion LCMS. The solvent 
was removed from the product containing fractions by lyophilisation to yield a white 
solid.
Yield: = 212 mg
NMR (D2O): 2.06-2.53 (H20, m), 3.42 (H2, dd, 6.78 Hz)
LCMS (negative): 405.18 [M(138) "]
FTIR: (KBrdisk): 3414, 2969,1722,1408, 1273,1229,1174.
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6.49: Formation of TgHg [HSiOa/Js (33)
Ferrie chloride (anhydrous) (100 g, 0.625 mol), hydrochloric acid (conc., 40 cm )^ 
methanol (80 cm )^, hexane (700 cm )^ and toluene (100 cm )^ were placed in a 2 I 
reaction vessel. To this a solution of HSiCb (154) (54 g, 0.4 mmol, 40 cm^) in hexane 
(250 cm^) was added dropwise over 8  hours and stirred for another 30 minutes. The 
upper hexane layer was removed and was added to a mixture of sodium carbonate 
(28 g) and calcium chloride (20 g). The mixture was stirred overnight. The solid was 
removed by filtration and the solvent was removed using reduced pressure to yield a 
white, crystalline solid.
This was then recrystallised from hexane to yield a white powder.
Yield: 2.5 g, 0.0059 mol, 1 1 .8 %.
NMR (CDCb): 4.27 (H8 , s)
^^ Si NMR (CDCb): -84.44  
FTIR (KBrdisk): 2305, 2214, 1668.
6.50: Formation of A/,Af-diethylbut-3-en-1-amine (156)
4-bromobut-1 -ene (78) (5 ml, 6.65 g, 0.04925 mol) was dissolved in acetonitrile (5 
ml) to which diethylamine (155) (3.3 ml, 2.33 g, 0.03189 mol) was added. The 
reaction was heated in a sealed tube for 48 hours at 60 °C. The solvent was 
removed using reduced pressure and the crude product was then dissolved into 
water (25 ml) and the pH adjusted to pH 9 using potassium carbonate. The product 
was extracted using DCM (2 x 50 ml); the organic layer was then dried using
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magnesium sulfate and filtered to remove solid residue. The solvent was removed 
using reduced pressure.
NMR (CDCI3): 1.06 (H6 , t, 7.1 Hz)(a), 2.26 (H2 , q, 6.9 Hz){d), 2.61 (H6 , q, 7.1 
Hz)(6 ,c), 4.98 (H2, t, 11.0 Hz){/), 5.73 (H, d-t, 6.7 Hz)(e).
NMR (CDCI3): 10.53 (CH3)(A), 30.11 (CH2)(D), 46.42 (CH2)(6 ), 51.43 (CH2)(C),
115.95 (CH2)(F), 135.42 (CH)(E).
LCMS (positive): 128.15 [M(156)*"]
FTiR (thin-fiim NaCi): 3436, 2922, 2738, 2690, 2653, 2360, 1701, 1653, 1639, 1543, 
1472, 1438, 1397, 1261, 1166, 1099, 1035.
a
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650: Characterisation of compound (156), proton (left) carbon (right)
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6.51: Reaction of yv,A/-diethylbut-3-en-1-amine (156) with TgHg to form 
compound (167)
A/,A/-diethylbut-3-en-1-amine (156) (6.7 mg, 0.00005112 mol) was dissolved in 
anhydrous toluene (1 ml) to which TgHs (33) (2.7 mg, 0.0000064 mol) was added. To 
this Speier’s catalyst (10 pi) was added and the flask was flushed with argon. The 
reaction was heated to 60 °C for 48 hours, forming a white precipitate that was 
removed by centrifugation. The solvent was removed using reduced pressure to 
yield a clear gum. This was then taken up into CDCI3 . The white solid formed was 
not soluble in any solvent studied.
Yield; 8 mg.
’H NMR (CDCI3): 0.01(H, s), 0.68 (H1.6, d, 4.2 Hz), 1.14 (H0.7, s), 1.37 (H6 , t, 7.3 
Hz), 1.88 (H I.4, s), 2.19 (H0.4, s), 2.24 (H0.9, d, 2.4 Hz), 3.08 (H6 , s)
NMR (CDCI3): 8.95 (CH3 ), 20.89 (CH3 ), 46.26 (CHg), 66.42 (CH2 )
NMR (CDCI3): -66.0
6.51: Reaction of A/,A/-diethylbut-3-en-1-amine with QgHg to form compound 
(168)
A/,A/-diethylbut-3-en-1-amine (156) (58 mg, 0.00045 mol) was dissolved in anhydrous 
toluene (1 ml) to which QeHs (38) (11 mg, 0.0000108 mol) was added. To this 
Speier’s catalyst (10 pi) was added and the flask was flushed with argon and sealed. 
The reaction was heated to 80 °C for 48 hours. The solvent was removed using 
reduced pressure. The resulting gel was taken up into CDCI3 . Yield extracted 50mg, 
72%
272
’ H NMR (CDCb); 0.14 (H158, s), 1.14 (H150, d, 6.03 Hz), 1.41 (H27, t, 7.32 Hz),
1.58 (H8, s), 2.33 (H72, s,), 3.11 (H 18.90, s,), 4.13 (H15, t, 5.85), 5.21 (H4, t, 11.7 
Hz), 5.71 (H1, m), 7.16 (H65, d, 7.53 Hz), 7.26 (H65, d, 6.95 Hz).
NMR (CDCb): -11.31, -109.5 8
6.52: Reaction of butene-sD03A-(ethyl) (101) with TgHg (33) via Speier’s 
catalyst -  version 1
[HSiOsds (33) (0.1 g, 0.000236 mol) and butene-sD03A-(ethyl) (101) (0.57 g, 
0.000767 mol) were dissolved in a solution of 0.02 mol H2PtCl6 in propan-2-ol (10 pl) 
and placed in a 1.5 ml sealed-tube reaction vessel. The reaction was heated to 80 
°C for 24 hours. The reaction was then cooled to room temperature and the reaction 
mixture was dissolved into chloroform (10 ml). The solution was then passed though 
an activated charcoal plug. The fractions collected were centrifuged to collect the gel 
formed in the chloroform, the solution layer was decanted and the solvent was 
removed using reduced pressure to yield a mixture of oil and solid. The oil was 
extracted by washing the reaction mixture with CDCb (1.5 ml) and extraction of the 
resulting solid with CDCN3  (1.5 ml) was then attempted. The remaining solid was 
placed under high vacuum for 24 hours.
Yield 40 mg (CDCb-soluble)
^H NMR (CDCb): 1.20 (H18, q, 5.8 Hz,), 2.12 (H2, s,), 2.3-28 (H24, m), 3.75 (H3, t,
6.1 Hz), 4.11 (H12, m), 4.93 (H2, q, 17.5 Hz), 5.71 (H I, t-t, 6.69 Hz).
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NMR (CDCb): 14.13 (CHs), 14.16 (CHs), 29.38 (CHs), 35.13 (CHz), 49.61 (CHz), 
50.40 (CHs), 50.96 (CHz), 53.34 (CHj), 54.44 (CHs), 54.66 (CHs), 59.32 (CH), 59.69 
(CH), 59.84 (CH), 60.44 (CHs), 61.00 (CHs), 115.307 (CHs), 133.34 (CH), 171.15 
(C=0), 171.63 (C=0).
®^Si NMR (CDCb): -109.15, - 1 1 1 .1 2 , -111.44, -112.31, -113.00
FTIR (CDCb, thin-film NaCI): 2982, 2824, 2256, 1724, 1458, 1447, 1261, 1176.
6.53: Reaction of butene-sD03A-(ethyl) (101) with TgHg (33) via Speier’s 
catalyst -  version 2
Butene-sD03A-(ethyl) (101) ( 1 0  eq, 0.15 g, 2.07"^ mol), TgHg (33) (2.07"^ mol, 
8.7mg) and Pt solution (20 pl) were combined in a sealed-tube reaction vessel and 
heated to 80 °C for 24 hours. The cooled reaction was extracted with chloroform (5 
ml), producing a precipitate. The ppt was removed using a centrifuge, forming a gel. 
The chloroform layer was removed using reduced pressure and the resulting product 
was taken up into CDCIg. The gel from the centrifuge was then washed using hexane 
(2 X 20 ml), yielding a white solid. The hexane layer did not yield any product after 
the solvent was removed using reduced pressure. The solid was then placed under 
high vacuum, yielding an insoluble, glass-type product.
Yield of CDCIs-soluble product 2 0  mg
^H NMR (CDCb): 1.31 (H I8 , t, 2.7 Hz), 1.87 (H2 , s), 2.34-3.2 (H28, m), 4 .12 - 
4.32(H15, m), 5.31 (H2, q, 17.2 Hz), 6.05 (H, m).
®^Si (CDCb): -21.49
FTIR (CDCb, thin-film NaCI): 2926, 2855, 2254 (CDCb), 1713, 1465, 1378, 1303, 
1262, 1216.
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6.54: Reaction of butene-sD03A-(ethyl) (101) with TgHg (33) via Speier’s 
catalyst dried over molecular sieve
Butene-sD03A-(ethyl) (101) (250 mg, 3.35-4 mol, 10 eq) was toluene (1 ml) and 
dried over activated molecular sieve (4 A) for 24 hours. The solution was filtered 
through a 5-micron filter to which TgHg (33) (0.0000355 mol, 14 mg) was added. To 
the reaction Speier’s catalyst (20ul) was added. The reaction vessel was flushed with 
argon and sealed, then heated to 80 °C for 48 hours. The reaction was cooled and 
the solvent was removed using reduced pressure. The crude product was taken up 
in CDCI3 (1.5 ml), and the remaining crude was then extracted using CeDsCDs (1.0 
ml), leaving a trace of insoluble material.
Silica TLC plate (glass backed as opposed to plastic backed 95% DCM with 5% 
EtOH) two spots; one at zero, and the other at Rf 0.56, co-spotted to butene-sD03A- 
(ethyl).
6.54.1: Chloroform extraction
NMR (CDCI3): 0.04 (H I, s), 1 . 2 1  (H18, t, 2.5 Hz), 2 . 1 2  (H1.05, d, 7.1 Hz), 2 .28-
2.82 (H I8.99, m,), 3.75 (H2.17, t, 5.67 Hz), 4.01 (H I0.59, m), 4.98 (H I.12, t, 16 Hz), 
5.77 (H0.56, td, 6.75 Hz, 10.26 Hz)
NMR (CDCI3): 0.94 (CH3), 14.10 (CH3), 14.36 (CH3), 31.95 (CH2), 35.25 (CH2), 
35.53 (CH2), 49.89 (CH2), 50.30 (CH2 ), 50.63 (CH2), 51.21 (CH2), 53.58 (CH2), 53.93 
(CH2), 54.67 (CH2), 59.58 (CH), 59.85 (CH), 59.93 (CH), 60.07 (CH2), 60.35 (CH2),
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60.45 (GHz), 61.23 (GHz), 115.26 (GHz), 133.46 (GH), 137.09 (GH), 171.36 (G=0), 
171.89 (G=0).
NMR (GDGI3): -21.41, -116.27, 171.47 
FTIR (NaCI plate, thin-film): 2980, 2937, 2819, 2360 (minor), 2257 (minor), 1733, 
1640 (minor), 1464, 1448, 1372, 1256, 1162, 1113, 1032.
6.54.2: Toluene extraction
^H NMR (G6D5GD3): 1.18 (H18, s), 2.09-2.80 (H26, m), 4.00 (H15, m). 4.93 (H2, t,), 
5.71 (H I, m).
NMR (G6D5GD3): -21.40, -111.06, -116.14.
FTIR (G6D5GD3 thin-film NaGi): 2275, 2240, 2211, 2120, 2084, 2051, 1582, 1571, 
1387, 1331, 1283, 1256, 1200, 1174, 1051.
6.55: Reaction of butene-sD03A-(ethyl) (101) with QgMg" (38) via Speier’s 
catalyst dried over molecular sieve
Butene-sD03A-(ethyl) (101) (628 mg, 0.000778 mol) was dissolved in toluene (3 ml) 
(dried over 4 A molecular sieve) along with Speier’s catalyst ( 2 0  pi), to which QgMg  ^
(38) (0.00009 mmol, 96.7 mg) was added. The reaction was then flushed with argon 
and sealed. The mixture was then heated for a total of 65 hours at 80 °C. The 
reaction was cooled and the product filtered through an activated charcoal filter and 
the solvent removed using reduced pressure, yielding a clear, gum-like product. The 
gum was then extracted using CeDgCDs ( 1  ml), leaving a gel that formed a glass-type 
product after being placed in high vacuum.
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After 24 hours FTIR (thin-film NaCI); 3027, 2961, 2920, 2866, 2365, 2141, 1940, 
1861, 1801, 1734, 1604, 1495, 1461, 1379, 1257, 1174, 1100, 1031.
After 47 hours FTIR (thin-film NaCI): 3027, 2971, 2921, 2866, 2141, 1940, 1857, 
1735, 1604, 1496, 1462, 1376, 1259, 1170, 1099, 1031.
After 57 hours FTIR (thin-film NaCI): 2980, 2929, 2365, 2143, 1735, 1602, 1495, 
1460, 1372, 1201, 1257, 1161, 1098.
After 65 hours FTIR (thin-film NaCI): 2980, 2930, 2357, 1944, 1861, 1733, 1604, 
1496, 1463, 1370, 1266, 1160,1098.
Soluble product
’ H NMR (CeDsCDs): 0.14 (H26, s), 0 . 2 2  (H22, s), 0.95 (H I8 , s), 1.17 (H12, s), 2 .20- 
2.66 (H28, m), 3.91 (H15, s),4.91 (H I.6 , s)
’^C NMR (CeDsCDs): 0.00 (CH3), 1.16 (CH3), 14.08 (CH3), 14.28 (CH3), 25.86 (CHz), 
28.90 (CH3), 35.64 (CH3), 51.47 (CHz), 60.05 (CH), 65.05 (CHz), 137.26 (CH), 
171.01 (C=0), 171.47 (C=0)^®Si NMR (CeDgCDs): -1.10 (trace), -11.23 (trace), 
-21.47, -108.06, -109.22, -109.49
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6.56: Reaction of butene-sD03A with QgHg via Speier’s catalyst (Dean-Stark
reaction method)
Butene-sD03A-(ethyl) (101) (400 mg, 0.000538 mol) was dissolved in toluene 
(26ml), and the reaction was then refluxed in a Dean-Stark apparatus with a 12 ml 
trap for 4 hours, with 12 ml of solvent removed.
From the dried solution 5 ml was removed, containing butene-sD03A-(ethyl) (101) 
(205 mg, 0.000276 mol). It was added to Speier’s catalyst (dried solvent) (10 pi), to 
which QgMg  ^ (38) (0.0000338 mol, 34.5 mg) was added and the reaction sealed 
under argon and heated to 60 °C for 48 hours. The solvent was removed using 
reduced pressure, yielding a yellow gel. The product was then taken up into CDCI3  
( 2  ml) leaving an insoluble product, which formed a glassy solid under high vacuum.
'H NMR (CDCI3): 0.017 (H48, s), 1.18 (H198.8, q, 7.71 Hz), 2.11 (H10.5, 3.48 Hz), 
2.19-2.82 (H I94, m), 3.64 (H14.25, q, 6.96 Hz), 3.73 (H14.25, t, 8.58 Hz), 4.08 
(H94.33, m), 4.92 (H8.17, 4.32 Hz), 5.71 (H4.08, 6.75 Hz).
NMR (CDCI3 ) (593-ii) -21.50 ppm 
FTIR (thin-film NaCI): 2980, 2931, 2358, 1732, 1604, 1495, 1463,1371, 1264, 1160.
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6.57: Reaction of pentene-sD03A (133) with QgHg via Karstedt’s catalyst
Pentene-sD03A-(ethyl) (133) (2.27 g, 0.003 mol) was dissolved in toluene (20 ml) 
and then dried over 4Â molecular sieve ( 2 x1 0  g). The reaction was then placed in a 
sealed tube, to which QglVIg" (38) (368 mg, 0.000362 mol) and Karstedt’s catalyst 
(100 pi) were added. The reaction was sealed under argon, and heated to 80 °C for 
18 hours. The reaction was cooled and the solvent was removed using reduced 
pressure. The crude was then taken up into DCM (50 ml) to which activated charcoal 
was added, and the reaction was heated to reflux for 30 minutes. The solids were 
removed using filtration, and the solvent removed using reduced pressure. The 
product was then washed with CDCI3 leaving a residual product, which formed a 
glass-type solid after drying in a high vacuum.
NMR (CDCI3); 0.00 (H7, s), 0.06 (H35, s), 0.53 (H8 , s), 0.81 (H I05, t, 6.9 Hz), 
1.18 (H409, t, 3.6 Hz), 2.19-2.82 (H87, m), 3.73 (H13, 4.4 Hz), 4.0 (H70, q, 7.1 Hz)
NMR (CDCI3): 0.00 (v small), 1.43 (minor), 14.78 (major), 14.78 (minor), 23.02 
(major), 29.30 (minor), 30.07 (minor), 31.96 (major) 35.82 (small), 60.81 (minor), 
61.00 (minor), 61.64 (minor), 133.99 (minor), 165.33 (small), 171.89 (small), 172.31 
(small), 172.68 (small)
NMR (CDCI3) : -21.49  
FTIR (thin-film NaCI plate): 3027, 2920, 2868, 2361, 1942, 1861, 1801, 1734, 1604, 
1495, 1461, 1379, 1255, 1177, 1082, 1031.
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6.58: Test reaction of TgHg (33) with Speier’s catalyst
TgHg (33) (0.0000335 mol, 14 mg) was dissolved in toluene (2 ml) to which Speier’s 
catalyst (10 pi) was added. The reaction was sealed under argon and heated to 80 
°C for 48 hours. The solvent was then removed using reduced pressure, yielding a 
white solid. The solid was taken up into C6 D5CD3 .
Yield 13.5 mg 96.4%
’ H NMR (CDCI3): 4.28 (H8 , s)
®^Si NMR (CDCI3); -84.46  
FTIR (KBrdisk): 2305, 2215, 1667.
6.59: Formation of Q8>(1-bromobutane)8 (166)
QsMb  ^ (38) (50 mg, 0.0000491 mol) was dissolved in toluene (1 ml) to which 5- 
bromopent-1-ene (134) (0.10 ml, 133 mg, 0.000985 mol) and Speier’s catalyst (10 
pi) were added. The reaction was sealed under argon and heated to 80 °C for 24 
hours. The solvent was then removed using reduced pressure to yield a clear gum. 
The crude product was taken up into DCM (50 ml) to which activated charcoal was 
added and the solution was refluxed for 30 minutes. The solids were removed using 
filtration, and the solvent removed using reduced pressure. This was then taken up 
into CDCI3 .
Yield 90.7 mg, 0.0000412 mol, 83.9%
'H NMR (CDCI3): 0.00 (H48, s)(/), 0.47 (H16, t, 8.9 Hz)(e), 1.23 (H32, t, 7.1 Hz)(c,d),
1.74 (H I6 , t, 7.1 Hz)(b), 3.27 (H16, t, 6 . 8  Hz)(a).
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NMR (CDCI3): 0.60 (CH3)(/=), 17.81 (CH2)(£), 22.53 (CH2 )(D), 32.07 (CH2)(C),
32.88 (CH2)(6 ), 34.14 (CH2)(>4).
NMR (CDCI3): -11.32, -109.5  
FTIR {thin-film NaCI): 2980, 2930, 2357, 1496, 1370, 1265
Si— O— !
Si 0„
Si— O— !
Si-----
166
Si— 0 — 1
Si— O— Si
Si-----
166
6,59: Characterisation of compound (166), proton (left) carbon (right)
6.60: Reaction of Qg(1 -bromopentene)8 (166) with sD03A-(ethyl) (107) to form 
compound (167)
Q8(5-bromopentane)8 (166) (0.000034 mol, 53.6 mg) was dissolved in acetonitrile 
(15 ml) to which potassium carbonate (15 eq, 0.00051 mol, 71 mg) and sD03A- 
(ethyl) (107) (10 eq, 0.000343 mol, 236 mg) were added. The reaction was then 
heated to 60 °C for 48 hours.
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The solids were removed from the reaction by centrifuge, and the liquid was 
decanted. The solvent was then removed using reduced pressure to yield a yellow 
solid. The solid was washed with DCM (2 x 10 ml). The organic phases were 
combined and the solvent removed using reduced pressure, yielding an oil.
NMR (CDCI3): 0.00 (H48, s), 1.19 (H163, t, 7.86 Hz), 1.942.91 (H230, m), 3.81 
(H22, m), 4.08 (H I 03, m)
NMR (CDCI3): 0.96 (CH3), 14.24 (CH3), 14.37 (CH3), 34.05 (CH2), 35.58 (CH2), 
42.63 (CH2), 45.01 (CH3), 48.50 (CH2), 49.44 (CH2), 58.51 (CH2), 59.93 (CH), 60.60 
(CH2), 171.52 (C=0 ), 171.66 (C=0 ).
NMR (CDCI3): -21.40, -97.21 (trace)
FTIR (thin-film NaCI): 2981, 2930, 2357, 1732, 1605, 1497, 1463, 1371, 1266, 1160, 
1098.
6.61: Reaction of triethoxysilane (13) and butene-sD03A-(ethyl) (101)
Butene-sDOSA-(ethyl) (1 0 1 ) (114 mg, 0.00015 mol) was dissolved into toluene ( 1  ml) 
to which triethoxysilane (183) (0.0002 mol, 0.0328 g, 0.037 ml) was added, along 
with Speier’s catalyst (20pl), sealed under argon and heated to 80 °C for 48 hours. 
The reaction produced large amounts of insoluble material, which were removed 
using a centrifuge; the liquid layer was decanted and the solvent removed using 
reduced pressure, giving rise to a clear, gum-like product, which was taken up into 
CDCb.
'H NMR (CDCI3): 1.19 (H I8, t, 6 . 8  Hz), 1.79 (H2, m), 2.20-2.82 (H28, m), 3.81 (H3, 
q, 7.1 Hz), 4.09 (H12, m). 5.02 (H I, t, 19.0 Hz), 5.73 (H0.45 , m).
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NMR (CDCI3): 1.3 (CH3), 14.10 (CH3), 14.36 (CH3), 18.07 (CH2), 18.36 (CH2), 
25.50 (CH2), 35.25 (CH2), 50.62 (CH2), 58.31 (CH2), 59.25 (CH2), 60.00 (CH), 60.53 
(CH2), 67.87 (CH2), 172.65 (C=0), 173.32 (C=0 )
(CDCI3): -21.38
FTIR (thin-film NaCI plate): 3030, 2921, 2868, 2362, 1943, 1734, 1604, 1495, 1461, 
1379.
6.62: Reaction of 1,1,3,3,5,5 hexamethyl-trisiloxane (182) with butene-sD03A- 
(ethyl) (1 0 1 )
Butene-sD03A-(ethyl) (101) (114 mg, 0.000153 mol) was dissolved in toluene (1 ml) 
to which 1,1,3,3,5,5-hexamethyl-trisiloxane (182) (160 mg, 0.019 ml, 0.0000765 mol) 
was added along with Speier’s catalyst (20pl). The reaction was heated to 80 °C for 
48 hours. The solvent was removed using reduced pressure to yield a clear gel. The 
gel was taken up into CDCI3 , leaving an insoluble residue.
^H NMR (CDCI3): 0.00 (H9, d, 8 . 6  Hz), 0.07 (H9, t, 7.5 Hz), 1.18 (H33, m), 1.78 
(H4.2, pent, 3.1 Hz), 2.4-2.7 (H14.03, m,), 3.7 (H4.72, t, 9.7 Hz), 4.11 (H17.9, m),
4.99 (H I.2, m), 5.81 (H0.4, m)
’^C NMR (CDCIs): -0 .69 (CH3), -0 .13 (CH3), 13.82 (CH3), 14.08 (CH3), 2 1 . 6 8  (CH2 ),
25.27 (CH2), 27.52 (CH2), 60.22 (CH), 67.62 (CH2), 133.27 (CH2), 171.09 (C=0),
I / i .z z  (u = u ; ,  (u = u ) .
®^Si NMR (CDCI3): minor -7.79, major -21.46  
Hexamethyl-trisiloxane (182)
'H NMR (CDCis): -0.15 (H6 , s), 0.01 (H12, s), 4.57 (H2, t, 2.7Hz) 
®^Si (CDCI3): - 6 .2 0 , -17.30
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6.63: Reaction of triethylsiiane (181) with butene-sD03A-(ethyl) (101) to give 
compound (186)
Butene-sD03A-(ethyl) (250 mg, 0.000336 mol) was dissolved in toluene (1 ml), to 
which triethylsiiane (58 mg, 0.0005 mol, 0.08 ml) was added. To the stirred reaction 
mixture Speier’s catalyst (20 pi) was added and the reaction was heated to 80 °C for 
24 hours. The reaction was cooled and passed though an activated charcoal plug. 
The solvent was then removed using reduced pressure, yielding a clear gum.
’ H NMR (CDCIS): 0.53 (H6 , q, 7.86 Hz)(k), 0.98 (H9, t, 5.54 Hz)(/), 1.09 (H2, d, 6.03 
Hz)(/), 1.21 (H20, t, 7.14 Hz)(a), 1.67 (H I, s,)(, 2.28-2.83 (H22, m)(e,/;c,m), 3.73 
(H3, m)(e), 4.09 (H I2, q, 4.57 Hz)(6 ).
^^ C NMR (CDCl3):0.93 (CH3)(0), 5.75 (CH2)(A/), 6.51 (CH2)(M), 14.02 (CH3)(711), 
14.35 (CH3)(>42), 21.35 (CH2)(K), 22.57 (CH2)(/), 26.59 (CH2), 29.13(CH2), 29.78 
(CH2), 35.22 (CH2)(D), 35.40 (CH2 )(D), 49.98 (CH2), 50.65 (CH2), 51.05 (CH2), 51.19 
(CH2), 53.68 (CH2), 53.98 (CH2), 55.40 (CH2), 59.59 (CH)(£), 60.43 (CH3), 171.39 
(C=0)(F), 171.44 (C=0)(F), 171.86 (C=0)(C).
®^Si NMR (CDCI3): 19.57, -21.49
FTIR (thin-film NaCI): 3027, 2920, 2874, 1734, 1604, 1495,1461,1379, 1177 
LCMS (positive): 859.53 [M(186)*"]
Triethylsiiane FTIR (thin-film NaCI plate): 2955, 2912, 2876, 2101, 1460, 1415, 1379, 
1235, 1016,975, 811.
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6,63: Characterisation of compound (188), proton (left) carbon (right)
6.64: Formation of tri-(dimethylsilyl) benzene (193)
Dimethyl chlorosilane (37.60 g, 0.3968 mol) was dissolved in THF (120 ml) to which 
magnesium turnings (9.68 g, 0.3968 mol) were added and stirred until dissolved. The 
solution was then added dropwise to a slowly refluxing solution of 1,3,5- 
tribromobenzene (194) (25 g, 0.078 mol) dissolved in THF (80 ml). The reaction was 
then refluxed for 3 hours, after which the solvent was removed using reduced 
pressure to yield an orange solid. The product was extracted using hexane (4 x 50 
ml); the organic phases were combined and filtered and the solvent removed using 
reduced pressure, yielding a crude oil. The oil was then distilled under high vacuum 
and a product collected at 60-65°C.
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Yield 6.98 g, 0.02768 mol, 35.5%
FTIR (thin-film NaCi plates): 3004, 2960, 2902, 2122,1558,1426,1380, 1365,1249
HRMS calculated 251.1102 [M(193)^”], found 251.1104 [M(193)^"j
’H NMR (CDCis): 0.24 (H18, t, 2.7 Hz)(a), 4.34 (H3, q, 3.7H)(5), 7.63 (H3, s)(c)
'^C NMR (CDCia): -3.72 (CH3)(4). 136.75 (CH)(C), 140.54 (C)(8 ).
®^Si NMR (CDCI3): -15.99
193
a
6,64: Characterisation of compound (193), proton (left) carbon (right)
6.65: Reaction of trl-(dimethylsilyl) benzene (193) with pentene-sD03A-(ethyl) 
(133) to form 1,3,5-tris((pentane-sD03A(ethyl))dimethylsily[) benzene (189)
Pentene-sD03A-(ethyl) (133) (417 mg, 0.0005508 mol) was dissolved in toluene (20 
ml), to which Speier’s catalyst (100 pi) was added. To the reaction 1,3,5- 
dimethylsilane benzene (193) (46.3 mg, 0.0001836 mol) was added and the reaction 
sealed under argon was heated to 80 °C for 72 hours, after which the solvent was 
removed using reduced pressure. The crude was taken up into DCM (50 ml) to 
which activated charcoal was added, and then refluxed for 30 minutes. The solids 
were filtered out, and the solvent removed using reduced pressure to yield a crude 
product. The sample was then split into two fractions; the first one was
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chromatographed on silica eluted with DCM (92%) and acetone (8 %), while the 
second one was vacuum distilled.
Crude = 440 mg, 0.00017437 mol, 94.9%
’H NMR (CDCb): -0 .29 (H2, s), -0 .02 (H18, s), 0.50 (H3, d, 4.6 Hz), 0.74 (H12, d,
6.2 Hz), 0.94 (H18, t, 4.7 Hz), 1.78 (H8 , d), 3.60 (H2, m), 3.86 (H7, q, 7.1 Hz), 4.93 
(H11,s), 6.46 (H2, s), 6 . 8 8  (H, s).
=^'C NMR (CDCb): -1.11 (CH;), 0.00 (CH;), 0.97 (CHs), 14.06 (CH3), 25.60 (CH3),
29.14 (CHz), 39.66 (CH2), 30.88 (CH), 53.40 (CH2), 60.64 (CH2), 61.29 (CH2), 65.26 
(CH), 164.97 (C=0).
NMR (CDCb): 5.19, 4.38, -0.80, -21.49  
FTIR (thin-film NaCI plate): 2981, 2935, 2872, 2256, 1725, 1468, 1464, 1372, 1301, 
1257.
6.65.1: Distillation results:
Thermometer:
H^ NMR (CDCb): -0.01 (H16, s), 0.045 (H2, s), 0.78 (H18, t, 7.8 Hz), 3.61 (H2.6, 
pent, 6.1 Hz), 3.87 (H10, q, 7.1 Hz), 6.47 (H0.74, s), 7.24 (H3, s).
’^C NMR (CDCb): -1.11 (CH3), 14.15 (CH3), 61.37 (CH2), 65.36 (CH), 133.67 (CH), 
139(C), 165.06 (C=0).
®^Si NMR (CDCb): 5.37
FTIR 2972, 2930, 1716, 1467, 1370, 1303, 1261, 1160, 1032, 905 
Condenser:
^H NMR (CDCb): -0.19 (H4, s), -0.02 (H18, s), 0.73 (H18, d, 7.1 Hz), 0.91 (H54, t,
5.3 Hz), 1.19 (H15, s), 3.89 (H24, q, 7.1 Hz), 6.46 (H12, s), 6 . 8 8  (H8 , s), 7.24 (H3, s).
288
NMR (CDCb): -1.18 (CH3), 14.08 (CH3), 61.29 (CHz), 132.71 (CH), 133.61 (C),
164.99 (C=0).
NMR (CDCb): 5.71
Flask:
^H NMR (CDCb): 0 . 0 1  (H2, s), 0.25 (H2, s), 0.29 (H3, s), 0.84 (H3, 3.2 Hz), 1.07 (H2, 
d, 6.0 Hz) 1.18 (H18, q, 6.0 Hz), 2.18-2.85 (H22, m), 3.74 (H3, t, 4.2 Hz), 4.10 (H12, 
q, 6.5 Hz), 7.46-7.52 (H2, s).
'^C NMR (CDCb): -1.35 (CH3), 0 . 0 0  (CH3), 13.96 (CH3), 14.23 (CH3), 17.79 (CH2), 
25.48 (CH2), 26.46 (CH2), 29.57 (CH2), 31.51 (CH2), 34.78 (CH2), 35.26 (CH2), 45.08 
(CH2), 45.36 (CH2), 45.70 (CH2), 46.89 (CH2), 48.89 (CH2), 49.79 (CH2). 50.15
(CH2), 50.45 (CH2), 50.87 (CH2), 51.03 (CH2), 51.16 (CH2), 53.54 (CH2), 53.81
(CH2), 53.92 (CH2), 54.96 (CH2), 55.23 (CH2), 59.35 (CH2), 60.00 (CH2 ), 60.18
(CH2), 60.20 (CH2), 60.24 (CH2), 60.44 (CH2), 60.60 (CHz), 61.08 (CH2), 65.08
(CH2), 132.19 (CH), 133.46 (CH), 138.48 (C), 139.53 (C),171.32 (C=0), 171.72 
(C=0).
NMR (CDCb): 6.25, 5.19, 5.09, 0.73, 0.63
6.66: Reaction of pentene-sD03A-(ethyl) (133) with bis(dimethyi 
siiyi)benzene (192) to form 1,4-bis((5-bromopentyi) dimethyisiiyi) 
benzene (198)
A solution of pentene-sD03A-(ethyi) (133) (1.00 g, 0.001321 moi), was dissolved in 
toluene (10 ml) to which Speier’s catalyst (lOpI) was added. To this reaction 
bis(dimethyisilyl)benzene (192) (0.000629 mol, 0.12 g) was added. The reaction was
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flushed with argon and the reaction sealed within a tube. The reaction was then 
heated to 80 °C for 48 hours. The solvent was removed using reduced pressure and 
the crude material was then taken up into DCM (100 ml) and refluxed with activated 
charcoal for 30 minutes. The solids were removed using filtration and the solvent 
was removed using reduced pressure, yielding a clear, gum-like residue.
TLC (100% DCM alumina) shows three spots: Rf 0.02, Rf 0.30 (pentene-sD03A- 
(ethyl), Rf 0.97.
NMR (CDCb): 0.23 (H2 , s), 0.27 (H10, s), 1.04 (H4, d, 5.9 Hz), 1.17 (H36, q, 6.7 
Hz), 1.42 (H2, s), 1.95 (H4, d, 6 . 6  Hz), 2.24 (H4, s), 2.4-2.77 (H48, m), 3.71 (H6 , s), 
4.05 (H24, m), 4.87 (H3, q, 5.85 Hz), 5.69 (H I.5, m), 7.10 (H4, m), 7.46 (H3, m).
^^ C NMR (CDCb): -3 .22 (CH3), -1.28(CH3), 0 .0 0 (CH3), 0.72(CH3), 14.04(CH3), 
14.30(CH3), 21.28(CH3), 22.52 (CH2), 25.56(CH3), 26.13 (CH2), 29.00 (CH2), 31.58 
(CH2), 35.13 (CH2), 35.27 (CH2), 49.85 (CH2), 50.56 (CH2), 50.90 (CH2), 51.07 
(CH2), 53.44 (CH2), 53.61 (CH2), 5 3 .8 6 (CH2), 54.72 (CH2), 59.46(CH2), 59.73 (CH2), 
59.83 (CH2), 60.28 (CH2), 60.38 (CH2), 61.13(CH3), 65.14(CH3), 114.36(CH2), 
125.166 (CH), 128.07 (CH), 128.86 (CH), 132.10 (CH), 132.25 (CH), 133.47(CH), 
137.59(C), 138.51 (C), 164.73 (COOH), 171.24 (C=0), 171.28(C=0), 171.34(C=0), 
171.72(C=0).
NMR (CDCb): 5.22, 5.00, -0.86  
FTIR (thin-film NaCI): 3535 (small), 2981, 2938, 2844, 2257, 1726, 1641, 1464, 
1448, 1372, 1347, 1299, 1256, 1175, 1137, 1096, 1030.
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6.67; Synthesis of bis(succinate)dimethyl phenylsilane (196)
Bis(dimethylsilyl)benzene (192) (350 mg, 0.0018229 mol), was mixed with diethyl 
maleate (126) (2.1 eq, 659 mg, 0.003828 mol) to which Speier’s catalyst (100 pi) 
was added, along with toluene (5 ml). The reaction was sealed under argon and 
heated to 80 °C for 72 hours. The reaction was then dissolved in DCM (150 ml) to 
which activated charcoal was added, and then the reaction was refluxed for 30 
minutes. The solids were filtered out and the solvent was removed using reduced 
pressure, yielding a clear oil.
Yield 670 mg, 0.0012 mol, 68%
NMR (CDCis): 0.00 (H12, s), 0.89 (H12, t, 7.1 Hz), 1.84 (H2, d, 2.2 Hz), 2.33 (H2, 
m), 3.66 (H8, t, 5.5 Hz), 3.90 (H2, q, 4.6 Hz), 7.18 (H2, s), 7.22 (H2, s).
^^ C NMR (CDCis): -4.9 (CHs), -3.71 (CHs), -1.77 (CHs), 0.00 (CHs), 14.10 (CHs), 
25.67 (CH), 29.19 (CHs), 60.61 (CHs), 128.20 (CH), 128.99 (CH), 129.81 (CH),
132.74 (C), 133.90 (C), 172.31 (C=0), 172.73 (C=0).
5.72, 5.63 (minor), 5.37, 5.22, 4.87, 4.79, 0.70, 0.60 (major)
FTIR (neat thin-fiim NaCi): 3536, 2979, 1736, 1466, 1447, 1409, 1372, 1301, 1254, 
1136,1036
HRMS: caicuiated 556.2756 [M(196)*^""j, found 556.2761 [M(196)^^"'"]
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6.68: Formation of diethyl 2-(diethylamino)succinate (197)
Diethylamine (155) (5.00 g, 0.0683 mol) was dissolved in acetonitrile (100 ml) to 
which potassium carbonate (28.3 g, 0.205 mol) was added. To the stirred reaction 
diethyl fumarate (130) (28.3 g, 0.13672 mol) was added. The reaction was then 
refluxed for 48 hours. The solids were removed by filtration and the solvent was 
removed using reduced pressure to yield a crude oil. The oil was then 
chromatographed on silica eluted with DCM (96%) EtOH (4%), eluting the product at 
Rf 0.28. The remaining diethyl fumarate was eluted at Rf 0.86.
NMR (CDCb): 1.28 (H6, t, 5.3 Hz)(h), 1.49 (H6, t, 5.5 Hz)(a,/), 2.77 (H4, q, 4.1 
Hz)(g), 2.91 (H I, d, 4.2 Hz)(d), 3.02 (H I, t, 4.5 Hz)(c), 4.38 (H4, q, 8.8 Hz)(ft).
’®C NMR (CDCb): 13.51 (CHs)(J), 14.31 (CH3)(AH), 34.34 (CHz)(D), 46.56 {CH2M
59.89 (CH)(£), 61.23 (CH2)(6,G), 171.39 (C=0)(C), 173.23 (C=0)(F).
Yield 2.96 g, 0.012 mol, 17.66%
HRMS: calculated 246.1700 [M(197)^"], found 246.1697 [M(197)*”]
H
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6.68: Characterisation o f compound (197), proton (left) carbon (right)
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6.69: Reaction of diethyl 2-(diethylamino)succinate (197) with 
dimethylphenyi silane (190)
Diethyl 2-(diethylamino)succinate (197) (300 mg, 0.0012195 mol) was dissolved in 
toluene (5 ml) to which dimethylphenyi silane (190) (150 mg, 0.0011086 mol) and 
Speier’s catalyst (100 pi) were added. The reaction was then heated to 60 °C for 48 
hours. The solvent was removed using reduced pressure, and the resulting gum was 
taken up into DCM (50 ml) along with activated charcoal and refluxed for 30 minutes. 
The solids were removed using filtration and the solvent was removed using reduced 
pressure. The product was then taken up into CDCb, leaving an insoluble, gum-like 
residue.
'H NMR (CDCIS): 0.12 (H, s), 0.48 (H ,s), 1.10 (H6, s),1.13 (H , s), 1.28 (H6, s,), 2.15 
(H , d, 3.7 Hz), 2.36 (H1,s), 2.56 (H4, q, 3.1 Hz), 2.62 (H2 m), 2.81 (H I, m), 3.97 
(H I, t, 3.28 Hz), 4.17 (H4, m), 5.29 (H , d, 3.7 Hz), 7.17 (H2, t, 7.1 Hz), 7.25 (H3, t,
7.3 Hz).
®^Si NMR (CDCb): 5.91 (major), 5.18.
FTIR (thin-film NaCI plate): 2978, 2936, 1729, 1475, 1447,1372, 1299,1259, 1178.
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6.70: Stability of pentene-sD03A-(ethyl) (133) with Speier’s catalyst
Pentene-sD03A-(ethyl) (133) (25 mg, 0.000033 mol) was dissolved in CDCb (1.25 
ml) to which Speier’s catalyst (10 pi) was added, and the reaction was placed in an 
NMR tube. The tube was then warmed for 48 hours, after which the and ^^ C 
NMR spectra were taken.
’H NMR (CDCb): 1.12 (H60, dd, 6.0 Hz), 1.21 (HIS, q, 6.5 Hz), 2.10 (H I, s), 2.42 
(H2, d, 5.5 Hz), 2.49 (H4, d, 5.7 Hz), 2.69 (H22, s), 3.72 (H3, q, 3.1 Hz), 3.92 (H15, 
pent, 6.0 Hz), 4.07 (H20, m), 4.90 (H2, m), 5.71 (H I, dq, 6.8 Hz), 6.77 (H0.26, s).
’®C NMR (CDCb): 13.83 (CHs), 13.89 (CHs), 14.16 (CHs), 24.72 (CHz), 24.99 (CHg), 
25.24 (CHs), 25.98 (CHs), 27.39 (CHg), 29.71 (CHs), 30.64 (CHs), 31.50 (CHs), 35.16 
(CHs), 49.71 (CHs), 50.41 (CHs), 50.78 (CHs), 53.62 (CHs), 54.62 (CHs), 59.38 
(CHs), 57.73 (CHs), 60.37 (CHs), 61.51 (CH), 63.79 (CHs), 64.53 (CH), 114.24 (CHs),
115.27 (CHs), 116.3 (CHs), 133.31, (CH), 133.41 (CH), 133.48 (CH), 138.44 (CH),
164.82 (C=0), 171.31 (C=0), 171.73 (C=0)
6.71: Stability of pentene-sD03A-(ethyl) (133) with Karstedt’s catalyst
Pentene-sD03A-(ethyl) (133) (25 mg, 0.000033 mol) was dissolved in CDCb (1.25 
ml) to which Karstedt’s catalyst (10 pi) was added, and the reaction was placed in an 
NMR tube. The tube was then warmed for 48 hours, after which and ^^ C NMR 
spectra were taken.
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’h NMR (CDCb): 0.00 (H0.5, s), 0.05 (H0.5, s), 1.16 (H18, q, 6.1 Hz), 1.45 (H2, m),
1.95 (H2, d, 7.1 Hz), 2.01 (H2, s), 2.24 (H14, s, toluene), 2.40-2.72 (H24, m), 3.72 
(H3, t, 5.7 Hz), 4.07 (H12, m), 4.98 (H2, m), 5.89 (H, m), 7.12 (H25, m, toluene).
’®C NMR (CDCb): 0.00 (CHs), 0.79 (CHs), 13.81 (CHs), 13.89 (CHs), 14.14 (CHs),
21.15 (CHs), 25.29 (CHs), 26.03 (CHs), 27.38 (CHs), 29.70 (CHs), 30.51 (CHs), 31.46 
(CHs), 31.74 (CHs), 35.00 (CHs), 49.76 (CHs), 50.46 (CHs), 50.80 (CHs), 50.96 
(CHs), 53.48 (CHs), 53.76 (CHs), 54.61 (CHs), 59.33 (CH), 59.60 (CH), 59.81 (CH), 
59.98 (CHs), 60.15 (CHs), 60.19 (CHs), 60.24 (CHs), 60.99 (CHs), 114.22 (CHs), 
115.22 (CHs), 125.03 (CH), 128.16 (CH), 128.75 (CH), 131.19 (CH), 133.33 (CH), 
137.52 (C) (toluene), 138.42 (CH), 164.65 (C=0), 171.81 (C=0), 171.62 (C=0).
6.72: Synthesis of (5-bromopentyl)dimethyl(phenyl)silane (191)
Dimethylphenyi silane (190) (1.0 ml, 876 mg, 0.007338 mol) was added to 5- 
bromopent-1-ene (134) (1.4 eq, 1.04 ml, 1.31 g, 0.008806 mol) along with Speier’s 
catalyst (100 pi). The reaction mixture was sealed under argon and heated to 60 °C 
for 34 hours. The cooled reaction was added to DCM (150 ml) and activated 
charcoal was added; the reaction was then refluxed for 30 minutes. The solids were 
removed using filtration and the solvent was removed by reduced pressure. The 
excess 5-bromopent-1 -ene was removed using reduced pressure (50 mbar) at 40 
°C; the product was then placed under high vacuum for 34 hours. The resulting oil 
was centrifuged to remove trace amounts of activated charcoal, yielding a pure 
product as shown by TLC.
Yield 1.23 g, 0.00433 mol, 59.0%.
296
NMR (CDCI3): 0.03 (H6, s)(f), 0.52 (H2, t, 6.2 Hz)(e), 1.13 (H4, m)(c,cO, 1.54 (H2, 
t, 6.8 Hz){b), 3.03 (H2, t, 6.9 Hz)(a), 7.07 (H3, t, 3.8 Hz){h,i), 7.26 (H2, q, 3.5 Hz)(g).
NMR (CDCI3): -1 .15 (CH3)(F), 15.49 (CHzXE), 23.01 (CHaXD). 31.80 (CHsXC),
32.27 (CHzKS), 33.52 (CHz)(A), 127.60 (CH)(J), 129.27 (CH)(/), 133.35 (CH)(H),
139.02 (C)(G).
®^Si NMR (CDCI3); -2 .65
FTIR (thin-film NaCI plate): 3068, 2961, 2935, 1642,1579,1475, 1252, 1119.
LCMS (positive): 206.15 [M(191)-Br^^]
672: Characterisation of compound (191) proton (left) carbon (right)
6.73: Formation of 1,4-bis((5-bromopentyl)dlmethylsilyl)benzene (198)
1,4-Bis(dimethylsilyl)benzene (192) (1 ml, 875 mg. 0.0045 mol) and 5-bromo-pent-1- 
ene (134) (2.8 eq, 0.0126 mol, 1.877 g, 1.50 ml) were combined in a sealed tube, to 
which Speier’s catalyst (100 pi) was added. The reaction was sealed under argon 
and heated to 60 °C for 48 hours. After this step the reaction was added to DCM 
(100 ml) and activated charcoal was added; a further stage of reflux for 30 minutes 
followed. The solids were filtered out and the solvent removed using reduced
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pressure, yielding a clear oil. The oil was then placed under high vacuum for 48 
hours.
Yield 0.0028035 mol, 1.37 g, 62.3%
NMR (CDCb): 0.00 (H12, s)(/), 0.49 (H4, t, 6.8 Hz)(e), 1.18 (H8, m)(c,d), 1.53 
(H4, pent, 7.3 Hz){b). 3.03 (H4, t, 6.9 Hz)(a), 7.22 (H4, s)(h).
’^C NMR (CDCb): -3.09 (CH3)(F). 23.03 (CH2)(E), 30.67 (CHz)(D), 31.87 (CHz)(C),
33.58 (CH2)(4), 132.22 (CH)(H), 139.66 (C)(G).
NMR (CDCb): -2.66.
FTIR (thin-film NaCI plate): 2955, 2926, 1459, 1438, 1379, 1250, 1135, 1056 
HRMS: calculated 508.1061 [M(198)*'^^''], found 508.1054 [M(198)*'^"'']
198198
6,73: Characterisation of compound (198), proton (left) carbon (right)
6.74: Synthesis of 1,3,5-tris((5-bromopentyl)dlmethylsilyl)benzene (199)
1,3,5-tri(dimethylsilyl)benzene (193) (1.00 g, 0.004 mol), was added to 5-bromopent- 
1-ene (134) (4 eq, 2.39 g, 0.016 mol, 1.90 ml) along with Speier’s catalyst (100 pi). 
The reaction was sealed under argon and heated to 60 °C for 48 hours. The cooled 
reaction was added to DCM (100 ml) alongside activated charcoal, and refluxed for
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30 minutes. The solids were removed using filtration and the solvent removed, 
yielding a clear oil. The oil was then placed under high vacuum for 48 hours.
Yield 1.51 g, 0.002169 mol, 54.1%
NMR (CDCb): 0,00 (H18, s)(0, 0.49 (H6, t, 6.9 Hz)(e), 1.14 (H12, m)(d,c), 1.54 
(H6, t, 6.8 Hz)(6), 3.08 (H6, t, 6.8 Hz)(a), 7.35 (H3, s){g).
'^C NMR (CDCb): -3.08 (CH3)(F), 15.46 (CH2)(£), 23.05 (CH2)(D), 31.79 (CH2)(C), 
32.39 (CH2)(6), 33.66 (CH2)(/\), 137.02 (CH)(H), 139.11 (C)(G).
NMR (CDCb): -2.59
FTIR (thin-film NaCI plate): 2957, 2927, 1711, 1460, 1439, 1411, 1367, 1252, 1222, 
1138, 1070.
199
Br
199
Br
6,74: Characterisation o f compound (199), proton (left) carbon (right)
6.75: Synthesis of (pentane-sDu3Â-(ethyi))dimethyi(phenyl)siiane (187)
sD03A-(ethyl) (107) (1.15 g, 0.00152 mol) was dissolved in anhydrous acetonitrile 
(10 ml) to which potassium carbonate (0.90 g, 0.00666 mol) was added along with
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(5-bromopentyl)dimethyl(phenyl)silane (191) (450 mg, 0.00158 mol). The reaction 
was sealed under argon and heated to 60 °C for 48 hours. The reaction was cooled 
and the solids removed using a centrifuge. The solvent was then removed using 
reduced pressure to yield a yellow oil.
The crude product was then chromatographed on silica, eluted with a gradient of 
100% DCM to 95% DCM + 5% EtOH, with the fractions monitored using LCMS. 
Yield 550 mg, 0.0006144 mol, 40.5%
’H NMR (CDCb): 0.20 (H6 , s)(n), 0.69 (H2, t, 6.4 Hz)(m), 1.16 (H2, d, 3.5 Hz)(/), 1.19 
(H4, t, 2.7 H z)(M , 124 (HIS, t, 6.9 Hz)(a), 2.20 (H2, s)(/), 2.43-2.65 (H22, 
m)(e,f,g,h), 3.74 (H3, m)(d), 4.10 (H12, q, 7.0 Hz)(c), 7.29 (H3, t, 3.3 Hz)(p,q), 7.64 
(H2, dd, 2.5 Hz)(o).
NMR (CDCb): -3 .17 (CH3)(P), 14.09 (CH3)(/4), 14.30 (CH3)(/\2 ), 15.65 (CH2)(0),
18.28 (CHzX/V), 23.77 (CH2)(iM), 26.43 (CH2)(L), 31.48 (CH2)(D), 35.31 (CH2), 49.81 
(CH2)(K), 50.51 (CH2)(H), 51.06 (CHsXG), 53.94 (CH2)(J), 55.26 (CH2)(/), 58.09 
(CH)(£), 59.89 (CH2), 60.38 (CH2), 127.56 (CH)(T), 128.61 (CH)(S), 133.39 (CH)(R), 
139.43 (C)(Q), 171.28 (C=0)(C), 171.76 (C=0)(/=).
NMR (CDCb): -2.73.
FTIR: 2922, 2361, 1724, 1634, 1645, 1284, 1252, 1180, 1110, 1088.
HRMS: calculated 893.5302 [M(187)*"], found 893.5286 [M(187)*"]
w
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6.75: Characterisation of compound (187), proton (left) carbon (right)
6.76; Synthesis of 1,4-bis((pentane-sD03A(ethyl))dimethyls[lyl) benzene 
(188)
sD03A-(ethyl) (107) (590 mg, 0.0008576 mol) was dissolved in acetonitrile (10 ml) to 
which potassium carbonate (1.00 g, 0.007407 mol) was added. To the reaction 
mixture 1,4-bis((5-bromopentyl)dimethylsilyl)benzene (198) (211 mg, 0.0004288 mol) 
was added and the reaction was sealed under argon and heated to 60 °C for 48 
hours. The solids were removed using centrifugation and the solvent was extracted 
by reduced pressure. The crude product was then taken up into DCM (100 ml) to 
which activated charcoal was added, and then refluxed for 30 minutes. The solids 
were removed by filtration and the solvent by reduced pressure to yield a clear oil. 
The product was then chromatographed on silica eluted with a gradient of DCM 
(100%) to DCM (95%) / EtOH (5%), then elution with DCM (70%) / EtOH (30%), 
yielding the product.
Yield 0.000 1778mol, 303.7 mg, 41.5%
’H NMR (CDCb): 0.22 (H12, s), 0.72 (H4, s), 1.21 (H8 , m), 1.26 (H36, m),
1.9 (H4, s), 2.23-2.75 (H48, m), 3.71 (H6 , m), 4.07 (H24, m), 7.49 (H4, s).
®^C NMR (CDCb): -3.21 (CH3), 14.09 (CH3 ), 14.30 (CH3 ), 15.65 (CH2 ), 18.28 (CH /  
CH 3), 23.77 (CH2). 26.43 (CH2), 31.48 (CH 2), 35.31 (CH2 ), 49.81 (CH 2), 50.51 (CH 2),
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51.06 (CH2), 53.94 (CH2), 55.26 (CH2), 58.09 (CH), 59.89 (CH2), 60.38 (CH2), 
127.56 (CH), 128.61 (CH), 133.39 (CH), 139.43 (C), 171.28 (C=0), 171.76 (C=0). 
NMR (CDCI3): -2 .85
FTIR (thin-film NaCI plates): 2983, 2930, 1724, 1465, 1447, 1371, 1302, 1260, 1170, 
1031, 909
The isotope pattern from the FAB mass spectrum matches the predicted pattern for 
compound (188)
Theoretical isotope profile: 1708.0 (92%), 1709.0 (1 0 0 %), 1710.0 (62%), 1711.0 
(32%), 1712 (10%). Found 1707.9 (90%), 1709.0 (100%), 1709.9 (50%), 1710.9 
(36%), 1712.0(10%). Also present was a compound at 1917 m/z. 208 difference.
6.77: Synthesis of 1,3,5-tris((pentane-sD03A(ethyl))dimethy[silyl)
benzene (189)
1,3,5-bis((5-bromopentyl)dimethylsilyl)benzene (199) (674.5 mg, 0.00109 mol), was 
dissolved in acetonitrile (10 ml) to which sD03A-(ethyl) (107) (2.25 g, 0.00327 mol) 
was added, along with potassium carbonate (2.20 g, 0.016 mol). The reaction was 
heated to 60 °C for 48 hours under argon, after which the solids were removed using 
centrifugation and the solvent was removed using reduced pressure. The crude oil 
was then taken up into DCM (100 ml) to which activated charcoal was added. The 
reaction was refluxed for 30 minutes, and the solids were removed using filtration. 
The solvent was then removed using reduced pressure to yield the crude product. 
The oil was chromatographed on silica eluted with a gradient of DCM (100%) to
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DCM (95%) EtOH (5%), then to DCM (70%) EtOH (30%). The main product was 
found in the fractions of the DCM 70% /  EtOH 30% elution range.
Yield: 0.000469 mol, 1.18 g, 43.0%
'H NMR (CDCb): 0.33 (H18, s), 0.72 (H6 , m), 1.37 (H72, m), 2.36-2.71 (H72, m), 
3.88 (H9, m), 4.12 (H36, m), 7.69 (H3, s).
’^C NMR (CDCb): -3 .13 (CH;), 13.98 (CH 3), 14.25 (CH3 ), 15.68 (CH2 ), 18.19 (CH3), 
23.90 (CH2 ), 25.96 (CH2 ), 28.12 (CH2 ), 31.66 (CH2 ), 35.52 (CH2 ). 35.17 (CH 2 ), 35.31 
(CH2 ), 46.58 (CH2 ), 47.83 (CH2 ), 49.81 (CH2 ), 51.06 (CH2 ), 53.70 (CH2 ), 57.92 
(CH2), 58.54 (CH), 59.88 (CH), 60.33 (CH2 ), 60.37 (CH2), 60.53 (CH2), 137.23 (CH), 
139.05 (C), 171.33 (C =0), 171.82 (C =0 ).
FTIR (flush sample CDCb, NaCI plate): 2981, 2932, 2854, 2360, 2258, 1729, 1448, 
1372, 1299, 1254, 1175, 1030 
NMR (CDCb): -2.83
6.78: Hydrolysis of (sDOSA- (ethyl)-pentyl)dlmethyl(phenyl) (187) to form 
(pentane-sD03A-)dimethyl(phenyl)sllane (200)
(sD03A- (ethyl)-pentyl)dimethyl(phenyl) (187) (0.55 g, 0.0006162 mol) was 
dissolved in 1M LiOH (5 ml) and heated to 100 °C for 24 hours. The solution was 
cooled to room temperature, then was injected into the head of the ion-exchange 
column containing Bio-Rad AGI A4I (OH" form), bed volume 500 cm®, eluting with 
ultra-pure water at a rate of 5 ml/mln. After collection of 500 ml of eluent, the eluent 
was changed to formic acid (1M), while the fraction was collected In 5 ml units and
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analysed using negative-ion LCMS. The solvent was removed from the product- 
containing fractions by lyophilisation to yield a white solid, which was then dissolved 
in water ( 1 0  ml) and the lyophilisation repeated.
Yield 143 mg, 0.0001974 mol, 32%.
’H NMR (D2O); 0.00 (H6 , s), 0.53 (H2, s), 1.09 (H4, s), 1.43 (H2, s), 2.11-2.79 (H24, 
m), 3.83 (H3, m), 7.17 (H3, m), 7.39 (H2, m).
'®C NMR (D2O): -3.21 (CH3), 129.03 (CH), 131.52 (CH), 135.11 (CH), 137.21 (C). 
NMR (D2O): -2.80
CHN analyses: found 0  46.64%, H 6.69%, N 6.9%; calculated to be 
dimethyl(phenyl)silane-pentyl-sD03A (HC0 0 H)3 , (H2 0 )3 , (NH4)o.5 (0  46.72%, H 
7.13%, N 6.81%).
FTIR (KBrdisk): 3012, 2880, 2583, 1726, 1512, 1485, 1376, 1327, 1296.
6.79: Hydrolysis of 1,4,bis-(sD03A-(ethyl)-pentyi)dlmethyl(phenyl) (188) 
to form 1,4-bls((pentane-sD03A)dlmethylsiiyl)benzene (201)
Bis-dimethyl(phenyl)silane-pentyl-sD03A-(ethyl) (188) (1.72 g, 0.001 mol) was 
dissolved in LiOH (5 ml) and heated to 100 °C for 24 hours. The solution was cooled 
to room temperature, then was injected into the head of the ion-exchange column 
containing Bio-Rad AGI A4I (0H “ form), bed volume 500 cm ,^ eluting with ultra-pure 
water at a rate of 5 ml/min. After collection of 500 ml of eluent, the eluent was 
changed to formic acid (1M), while the fraction was collected in 5 ml units and 
analysed using negative-ion LCMS. The solvent was removed from the product- 
containing fractions by lyophilisation to yield a white solid, which was then dissolved 
in water ( 1 0  ml) and the lyophilisation repeated.
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Yield, 629 mg, 0.00046 mol, 46%
'H NMR (D2O); 0.00 (H12, s)(/), 0.89 (H4, s)(/), 1.06 (H4, s,){h), 1.09 (H4, s)(g), 2.47 
(H44, m)(b,d,e,f). 3.89 (H6 , m)(c), 7.62 (H4, m)(/c).
FTIR: 3218, 3052, 2953, 2576, 1927, 1725, 1631, 1580, 1467, 1392, 1248, 1187, 
1135, 1086.
CHN analysis: found C 40.45%, H 6.27%, N 6.61%; calculated bis- 
dimethyl(phenyl)silane-pentyl-sD03A -(HCOO")io, (NH4)i, (H20)i2 (C 40.91%, H 
6.62%, N 6.13%).
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6.79: Characterisation of compound (201), proton (left) carbon (right)
6.80: Hydrolysis of 1,3,5,-tris-(sD03A-(ethyl)-pentyl)dimethyl(phenyl) (232) to 
form 1,3,5-tris((pentane-sD03A)dimethylsilyl)benzene (202)
1,3,5-Tris-dimethyl(phenyl)silane-pentyl-sD03A-(ethyl) (189) (2.00 g, 0.000788 mol) 
was dissolved in LiOH (25 ml) and heated to 100 °C for 48 hours, forming a colloidal 
solution. The solution was filtered through a 5 pm glass-fibre filter pad, then the 
solution was neutralised using formic acid (1M). The solution was lyophilised to form
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a white solid, which was then taken up into LiOH (1M) (50 ml) forming a clear 
solution. The solution was injected into the head of the ion-exchange column 
containing Bio-Rad AG1 A4I (OH" form), bed volume 500 cm ,^ eluting with ultra-pure 
water at a rate of 5 ml/min. After collection of 500 ml of eluent, the eluent was 
changed to formic acid (1M), while the fraction was collected in 5 ml units and 
analysed using negative-ion LCMS [1/32M(202)'^j « 64. The solvent was removed 
from the product-containing fractions by lyophilisation to yield a white solid, which 
was then dissolved in water ( 1 0  ml) and lyophilisation was repeated.
Yield 283 mg, 0.00014 mol, 18%
NMR (D2O): -0 .05 (H18. s), 0.48 (H6 , s), 0.87 (H6 , s), 1.15 (H6 , s), 1.60 (H6 , s), 
2.35-3.03 (H72, m), 3.93 (H9, m), 7.46 (H3, s).
’®C NMR (D2O): -3.41, 20.25, 30.79, 31.27, 31.32, 67.40, 179.48.
NMR (D2O): -2 .83
FTIR (KBrdisk): 3402, 3132, 2975, 2858, 1734, 1639, 1597, 1384, 1251, 1179. 
Elemental analyses C 0.32%, H 7.25%, N 7.82%; theory C 51.77%, H 7.16%, N 
8.32%; calculated C 50.92%, H 7.30%, N 7.82% for C87Hi44Ni2 0 3 6 Sl3 (H2 0 )3.3
6.81 : Luminescence emission defaults
The luminescence emissions were recorded on a Fluoromax-P (Jobin-Yvon, 
England). Samples were placed in a 3 ml, 1 cm path-length quartz fluorescence 
cuvette and measured using right-angle geometry. The excitation wavelength was 
set at 395 nm with a slit size of 2 nm, and the emissions obtained were in the range 
550-750 nm with 0.5 nm increments, with slits set at 0.2 nm. These settings were 
derived by experimentation until the optimum resolution of the graph was obtained.
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The samples were dissolved in ultra-pure water, at a concentration of 1 mg/ml. As 
the lanthanides are not quenched by O2 , there was no need for degassing of the 
solvent prior to luminescence a n a l y s i s T h e  measurements were taken at room 
temperature and at the compounds' natural pH.
6.82: Formation of butene-sD03A-(ethyl)-Gd (203)
Butene-sD03A-(ethyl) (101) (600 mg, 0.00081 mol) was dissolved in EtOH (3 ml), to 
which GdCb (180 mg, 0.00068 mol) was added. The reaction was refluxed for 48 
hours. The cooled reaction was added to ice-cold diethyl ether (25 ml). The solid 
formed was collected by centrifuge and washed with cold diethyl ether (2 x 50 ml) 
and dried under vacuum. The solid was taken up into methanol (1 ml) and room- 
temperature diethyl ether added until precipitation occurred. The sample was then 
cooled to -18°C for 18 hours. The solid formed was collected by centrifugation.
Yield 180 mg, 24.6%. Decomposes at 275 °C. FTIR (KBr disk): 3376, 2360, 1732, 
1615, 1440, 1242.
Elemental Analyses: Found C% 27.66, H 5.28%, N, 4.64%, Calculates to butene- 
sD03A-(ethyl) -G d .3 5 H2O. KuCheNsHis. predicted as (C 22.68%, H 4.04.45%, N 
3.31%)
6.83: Formation of butene-sD03A-(ethyl)-Eu (204)
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Butene-sD03A-(ethyl) (101) (370 mg, 0.00049 mol) was dissolved in EtOH (3 ml), to 
which EuCIs (118 mg, 0.000456 mol) was added. The reaction was refluxed for 48 
hours. The cooled reaction was added to ice-cold diethyl ether (25 ml). The solid 
formed was collected by centrifuge and washed with cold diethyl ether (2 x 50 ml) 
and dried under vacuum. The solid was taken up into methanol (1 ml) and room- 
temperature diethyl ether added until precipitation occurred. The sample was then 
cooled to -1 8  °C for 18 hours. The solid formed was collected by centrifugation.
Yield 109 mg, 0.000127 mol, 24.8%
FTIR (KBrdisk): m 2268, 2984, 2360, 1728, 1641, 1467, 1278, 1179.
MADLI-MS: Predicted 757.92 [butene-sD03A-(ethyl)-Eu+H]-Eu. Found 757.4 [butene- 
sD03 A-(ethyl)-Eu+H] -Eu.
6.84: Formation of sD03A-(ethyl)-Gd (205)
sD03A-(ethyl) (107) (400 mg, 0.00058 mol) was dissolved in EtOH (2 ml) to which 
GdCIs (139 mg, 0.00051 mol) was added. The reaction was refluxed for 24 hours. 
The cooled reaction was added to ice-cold diethyl ether (25 ml). The solid formed 
was collect3ed by centrifuge and washed with cold diethyl ether (2 x 50 ml) and dried 
under vacuum. The solid was taken up into methanol (1 ml) and room-temperature 
diethyl ether added until precipitation occurred. The sample was then cooled to -18  
°C for 18 hours. The solid formed was collected by centrifugation.
Yield: 227 mg, 0.000268 mol, 46.3%.
FTIR (KBrdisk): 3397, 1729, 1594, 1439, 1371, 1302, 1179, 1089.
Elemental Analyses: Found C% 22.69, H 4.11%, N, 3.32%, Calculates to sD03A- 
(ethyl) -Eu .IO.2 5 H2O. 9KCI predicted as (0 22.58%, H 4.53%, N 3.29%)
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6.85; Formation of sD03A-(ethyl)-Eu (206)
sD03A-(ethyl) (107) (457 mg, 0.00069 mol) was dissolved in EtOH (2 ml) to which 
EuCIs (162 mg, 0.000627 mol) was added. The reaction was refluxed for 24 hours. 
The cooled reaction was added to ice-cold diethyl ether (25 ml). The solid formed 
was collected by centrifuge and washed with cold diethyl ether (2 x 50 ml) and dried 
under vacuum. The solid was taken up into methanol (1 ml) and room-temperature 
diethyl ether added until precipitation occurred. The sample was then cooled to -18  
°C for 18 hours. The solid formed was collected by centrifugation.
Yield: 356 mg, 0.00052 mol, 75.4%.
FTIR (KBr disk): 3429, 2920, 2857, 2360, 1601, 1441, 1314, 1268, 1185, 1153, 
1094.
Elemental Analyses: Found C% 22.37, H 4.01%, N, 3.98%, Calculates to sD03A- 
(ethyl) -E u  .6 H2O. 10KCI predicted as (C 22.68%, H 4.45%, N 3.31%) '
6.86; Formation of sD03A-Gd (207)
sD03A (32) (108 mg, 0.0002105 mol) was dissolved in HCI solution (2 ml, pH 3) to 
which Gd2 0 s (37.8 mg 0.000105 mol) was added. The reaction was then heated to 
80 °C for 24h, after which it was allowed to cool, and then passed through a 5 pm 
filter. The resulting filtrate was freeze-dried, producing a white solid.
Yield 112 mg, 0.0001659 mol, 78.8%
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FTIR (KBr disk): 3229, 2981, 2830, 2254, 1631, 1415, 1368, 1311, 1274, 1222, 
1204, 1174.
CHN analyses: found C 23.17%, H 3.69%, N 5.1%; calculated sD03A-Gd-Ke 
(HC00H)3.4 (C 23.50%, H 3.24%, N 5.48%).
6.87: Formation of sD03A-Eu (208)
sD03A (32) (20 mg, 0.0000384 mol) was dissolved in water (5 ml) to which to which 
EU2O3 (6 . 8  mg 0,0000194 mol) was added. The reaction was then refluxed for 24 
hours, after which it was allowed to cool, and then passed through a 5 pm filter. The 
resulting filtrate was freeze-dried, producing a white solid.
Yield 21 mg, 0.00003133 mol, 81.5%
FTIR (KBr disk): 3420, 2975, 2921,2884,1720, 1592,1413, 1186,1091
MALDIMS: Predicted 743.91 [sD03A-(ethyl)-Eu^“]-Eu, Found 743.40 [sD03A-Ethyl)-
Eu^"]-Eu.
6.88: Formation of sD02A-Gd (209)
sD02A (138) (200 mg, 0.00049 mol) was dissolved in MeOH (2 ml) to which GdCb 
(118 mg, 0.00045 mol) was added and the reaction refluxed for 48 hours, after which 
it was allowed to cool, and then passed though a 5 pm filter. The resulting filtrate 
was freeze-dried, producing a white solid.
Yield: 104 mg, 0.000186 mol, 38%
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FTIR (KBr disk): 3366 (OH), 2357, 1724 (C=0), 1630 (N-C), 1440, 1368, 1289, 
1229, 1090.
Sample used for relaxation measurements resulting in not enough sample for 
elemental analysis.
6.89: Formation of sD02A-Eu (210)
sD02A (138) (200 mg, 0.00049 mol) was dissolved in MeOH (2 ml) to which EuCIs 
(116 mg, 0.00045 mol) was added and the reaction refluxed for 48 hours, after which 
it was allowed to cool, and then passed though a 5 pm filter. The resulting filtrate 
was freeze-dried, producing a white solid.
Yield: 235 mg, 0.0004233mol, 68.3%
FTIR (KBr disk): 3501, 3261, 2951, 2759, 2415, 2141, 1730, 1627, 1440, 1361, 
1280, 1220, 1094, 1003.
Elemental Analyses: Found C% 28.54, H 4.95%, N, 9.03%, Calculates to sD02A- 
Gd.6 H2 0  predicted as (C 28.86%, H 5.45%, N 8.41%)
6.90: Formation of DOTA-Gd (2)
DOTA (13) (43 mg, 0.000106 mo!) and Gd2 0 3  (19.25 mg, 0.0000531 mol) were 
dissolved in HCI solution (2 ml, pH 3) and refluxed for 25 hours, after which the 
mixture was allowed to cool and was then passed through a 5 pm filter. The resulting 
filtrate was freeze-dried, producing a white solid.
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Yield: 57 mg, 0.000102mol, 96%
FTIR (KBr disk): 3400, 2984, 2916, 2361, 1728, 1579, 1448, 1407, 1321, 1243, 
1156, 1084, 1003.
Elemental Analyses: Found C% 28.54, H 4.95%, N, 9.03%, Calculates to DOTA-Gd. 
(H2 0 )5.75 predicted as (C 29.06%, H 5.411 %, N 8.47%)
6.91: Formation of DOTA-Eu (211)
DOTA (13) (75mg, 0.000185 mol) and EU2O3 (45.5mg, 0.0000531 mol) were 
dissolved in HCI solution (2ml, pH 3) and refluxed for 25 hours, after which the 
mixture was allowed to cool and was then passed through a 5 pm filter. The resulting 
filtrate was freeze-dried to produce a white solid.
Yield: 57 mg, 0 . 0 0 0 1 0 2  mol, 96%
FTIR (KBr disk): 3400. 3099, 2359, 1731, 1576, 1443, 1411, 1322, 1250, 1217, 
1158, 1084.
Florescence spectra match that of published data.
6.92: Formation of (pentane-sD03A-)dimethyl(phenyl)silane-Gd (212)
Dimethyl(phenyl)silane-pentyl-sD03A (188) (11.3 mg, 0.0000157 mol) was dissolved 
in water (10 ml) to which Gd2 0 3  (2.8 mg, 0.00000785 mol) was added. The pH of the 
solution was adjusted from pH 5 to pH 8-8.5 by addition of LiOH (1M) solution. The 
reaction was then heated to 80 °C for 48 hours. The solution was cooled and the
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solids removed using a centrifuge, then the solution was decanted and passed 
though a 0.5 pm filter. The solution was lyophilised, producing a white powder.
Yield 10mg, 0.000011487 mol, 73%
CHN analyses: found C 41.15%, H 5.34%, N 6.05%; calculated
[dimethyl(phenyl)silane-pentyl-sD03A-Gd]-(HC00H)i.5, (H2 0 )2.8 (C 41.49%, H 
5.81%, N 5.61%).
FTIR (KBr disk): 3415, 2954, 2932, 2867, 2359, 1587, 1392, 1317, 1252, 1182, 
1153, 1115, 1084.
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6.93: Formation of (pentane-sD03A-)dimethyl(phenyl)silane-Eu (213)
(pentane-sD03A-)dimethyl(phenyl)silane (188) (26.7 mg, 0.000031 mol) was 
dissolved in water (20 ml) to which EU2O3 ( 5.5 mg, 0.0000155 mol) was added. The 
pH was adjusted from pH 5 to pH 8.5 using LiOH and the reaction was heated to 80 
°C for 48 hours. The solution was centrifuged and then passed though a 0.5 pm 
filter, after which it was lyophilised, producing a white powder.
Yield 22.5 mg, 0.0000257 mol, 83%
FTIR (KBr disk); 3417, 2954, 2932, 2867, 2359, 1588, 1393, 1317, 1253, 1184, 
1152, 1115, 1083.
6.94: Formation of 1,4-bis((pentane-sD03A)dimethylsilyl)benzene-Gd2 
(214)
1,4-bis((pentane-sD03A)dimethylsilyl)benzene (188) (60 mg, 0.00004377 mol) was 
dissolved in water (10 ml) to which Gd2 0 3  (7.9 mg, 0.00002188 mol) was added. The 
pH of the solution was raised from pH 5 to pH 8.5 by addition of LiOH (1M). The 
reaction was then heated to 80 °C for 24 hours. The cooled reaction was passed 
though a 0.5 pm filter and lyophilised, producing a white powder.
Yield 61 mg, 0.000036 mol, 83%
CHN analysis: found C = 38.78%, H = 6.04%, 5.94%; calculated C = 38.74%, H =
6.07%, N = 6.02%. C6oH92N8024Si2Gd2.(H20)io
FTIR (KBrdisk): 3427, 2957, 2849, 1592, 1418, 1248, 1102.
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6.95: Formation of 1,4-bis((pentane-sD03A)dimethylsilyl)benzene-Eu2 
(215)
1,4-bis((pentane-sD03A)dimethylsilyl)benzene (188) (60 mg, 0.00004377 mol) was 
dissolved in water (10 ml) to which EU2O3 (7.7 mg, 0.00002188 mol) was added. The 
pH of the solution was raised from pH 5 to pH 8.5 by addition of LiOH (1M). The 
reaction was then heated to 80 °C for 24 hours. The cooled reaction was passed 
though a 0.5 pm filter and lyophilised, producing a white powder.
Yield 59mg, 0.0000352 mol, 80%
FTIR (KBr disk): 3427, 2959, 2851, 1623, 1599, 1589, 1417, 1368, 1248, 1168, 
1135.
CHN analysis: found C = 31.06%, H = 5.51%, N = 4.78%; calculated C = 31.12%, H 
= 6.18 %, N = 4.83 %. C60H92N8O24Si2EU2.(H2O)25 K4
6.96: Formation of 1,3,5-tris((pentane-sD03A)dimethylsilyl) benzene-Gda 
(216)
1,3,5-tris((pentane-sD03A)dimethylsilyl) benzene (189) (60 mg, 0.0000297 mol) was 
dissolved in water (10 ml) to which Gd2 0 3  (5.4 mg, 0.0000148 mol) was added. The 
pH of the solution was raised from pH 5 to pH 8.5 by addition of LiOH (1M). The 
reaction was then heated to 80 °C for 24 hours. The cooled reaction was passed 
though a 0.5 pm filter and lyophilised, producing a white powder.
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FTIR (KBrdisk): 3399, 2360, 1596, 1419. 1315, 1249, 1085 
Yield: 58.3 mg, 0.0000235 mol, 79.2%
CHN analysis: found C = 28.51%, H = 5.21%, N = 4.41%; calculated C = 28.84%, H 
= 5.81%, N = 4.41%. 1,3,5-tris((pentane-sD03A)dimethylsilyl) benzene-Gd3 -(H2 0 ) 2 2  
(HC00H)i5, Ke.
6.97: Formation of 1,3,5-tris((pentane-sD03A)dimethylsilyi) benzene-Eus 
(217)
1,3,5-tris((pentane-sD03A)dimethylsilyl) benzene (189) (60 mg, 0.0000297 mol) was 
dissolved in water (10 ml) to which EU2O3 (5.2 mg, 0.0000148 mol) was added. The 
pH of the solution was raised from pH 5 to pH 8.5 by addition of LiOH (1M). The 
reaction was then heated to 80 °C for 24 hours. The cooled reaction was passed 
though a 0.5 pm filter and lyophilised, producing a white powder.
FTIR (KBrdisk): 3414, 2964, 2927, 2857, 1589. 1414.30
Elemental analysis: found C 40.72%, H 5.67%, N 6.18%; calculated C 40.60%, H 
5.75%, N 6.52% for 1,3,5-tris((pentane-sD03A)dimethylsilyl)benzene-Eu + 6 H2O. 
Yield: 59 mg, 0.000024 mol, 81%
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6.98: MOPS buffer -  (lOmmol)
4-Morpholinepropanesulfonic acid (2.09 g, 10 mmol) was dissolved in ultra-pure 
water (1000 ml). The pH of the solution was then adjusted using ammonia solution to 
pH 7.72.
6.99: Anionic background, simulated extracellular environment
The anionic background used for the pH measurements was taken from Messeri et 
al.^ ® The original make-up of the background required potassium lactate and 
potassium citrate. These were not available, so were substituted by the sodium 
forms. This was accounted for and the amount of NaCI added was adjusted, along 
with the addition of KCI to keep the ion concentration and composition the same.
concentration w ater- 500 
ml
D2O — 25 
ml
NaHCOs 30 mM 126 mg 63 mg
NaCI 96.57 mM 2819 mg 140 mg
KCI 3.43 mM 128 mg 6.4 mg
KH2PO4 0.9 mM 103 mg 5.1 mg
Na lactate 3.3 mM 185 mg 9.2 mg
Na citrate 0.13 mM 19 mg 1 mg
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